Motif 705 (n=119)
Position-wise Probabilities
Download
uniprot | genes | site | source | protein | function |
---|---|---|---|---|---|
A0A0B4J1V8 | PPAN-P2RY11 | S228 | ochoa | HCG2039996 (PPAN-P2RY11 readthrough) | None |
O14920 | IKBKB | S733 | psp | Inhibitor of nuclear factor kappa-B kinase subunit beta (I-kappa-B-kinase beta) (IKK-B) (IKK-beta) (IkBKB) (EC 2.7.11.10) (I-kappa-B kinase 2) (IKK-2) (IKK2) (Nuclear factor NF-kappa-B inhibitor kinase beta) (NFKBIKB) (Serine/threonine protein kinase IKBKB) (EC 2.7.11.1) | Serine kinase that plays an essential role in the NF-kappa-B signaling pathway which is activated by multiple stimuli such as inflammatory cytokines, bacterial or viral products, DNA damages or other cellular stresses (PubMed:20434986, PubMed:20797629, PubMed:21138416, PubMed:30337470, PubMed:9346484). Acts as a part of the canonical IKK complex in the conventional pathway of NF-kappa-B activation (PubMed:9346484). Phosphorylates inhibitors of NF-kappa-B on 2 critical serine residues (PubMed:20434986, PubMed:20797629, PubMed:21138416, PubMed:9346484). These modifications allow polyubiquitination of the inhibitors and subsequent degradation by the proteasome (PubMed:20434986, PubMed:20797629, PubMed:21138416, PubMed:9346484). In turn, free NF-kappa-B is translocated into the nucleus and activates the transcription of hundreds of genes involved in immune response, growth control, or protection against apoptosis (PubMed:20434986, PubMed:20797629, PubMed:21138416, PubMed:9346484). In addition to the NF-kappa-B inhibitors, phosphorylates several other components of the signaling pathway including NEMO/IKBKG, NF-kappa-B subunits RELA and NFKB1, as well as IKK-related kinases TBK1 and IKBKE (PubMed:11297557, PubMed:14673179, PubMed:20410276, PubMed:21138416). IKK-related kinase phosphorylations may prevent the overproduction of inflammatory mediators since they exert a negative regulation on canonical IKKs (PubMed:11297557, PubMed:20410276, PubMed:21138416). Phosphorylates FOXO3, mediating the TNF-dependent inactivation of this pro-apoptotic transcription factor (PubMed:15084260). Also phosphorylates other substrates including NAA10, NCOA3, BCL10 and IRS1 (PubMed:17213322, PubMed:19716809). Phosphorylates RIPK1 at 'Ser-25' which represses its kinase activity and consequently prevents TNF-mediated RIPK1-dependent cell death (By similarity). Phosphorylates the C-terminus of IRF5, stimulating IRF5 homodimerization and translocation into the nucleus (PubMed:25326418). Following bacterial lipopolysaccharide (LPS)-induced TLR4 endocytosis, phosphorylates STAT1 at 'Thr-749' which restricts interferon signaling and anti-inflammatory responses and promotes innate inflammatory responses (PubMed:38621137). IKBKB-mediated phosphorylation of STAT1 at 'Thr-749' promotes binding of STAT1 to the ARID5A promoter, resulting in transcriptional activation of ARID5A and subsequent ARID5A-mediated stabilization of IL6 (PubMed:32209697). It also promotes binding of STAT1 to the IL12B promoter and activation of IL12B transcription (PubMed:32209697). {ECO:0000250|UniProtKB:O88351, ECO:0000269|PubMed:11297557, ECO:0000269|PubMed:14673179, ECO:0000269|PubMed:15084260, ECO:0000269|PubMed:17213322, ECO:0000269|PubMed:19716809, ECO:0000269|PubMed:20410276, ECO:0000269|PubMed:20434986, ECO:0000269|PubMed:20797629, ECO:0000269|PubMed:21138416, ECO:0000269|PubMed:25326418, ECO:0000269|PubMed:30337470, ECO:0000269|PubMed:32209697, ECO:0000269|PubMed:38621137, ECO:0000269|PubMed:9346484}. |
O15357 | INPPL1 | S300 | ochoa | Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 (EC 3.1.3.86) (Inositol polyphosphate phosphatase-like protein 1) (INPPL-1) (Protein 51C) (SH2 domain-containing inositol 5'-phosphatase 2) (SH2 domain-containing inositol phosphatase 2) (SHIP-2) | Phosphatidylinositol (PtdIns) phosphatase that specifically hydrolyzes the 5-phosphate of phosphatidylinositol-3,4,5-trisphosphate (PtdIns(3,4,5)P3) to produce PtdIns(3,4)P2, thereby negatively regulating the PI3K (phosphoinositide 3-kinase) pathways (PubMed:16824732). Required for correct mitotic spindle orientation and therefore progression of mitosis (By similarity). Plays a central role in regulation of PI3K-dependent insulin signaling, although the precise molecular mechanisms and signaling pathways remain unclear (PubMed:9660833). While overexpression reduces both insulin-stimulated MAP kinase and Akt activation, its absence does not affect insulin signaling or GLUT4 trafficking (By similarity). Confers resistance to dietary obesity (By similarity). May act by regulating AKT2, but not AKT1, phosphorylation at the plasma membrane (By similarity). Part of a signaling pathway that regulates actin cytoskeleton remodeling (PubMed:11739414, PubMed:12676785). Required for the maintenance and dynamic remodeling of actin structures as well as in endocytosis, having a major impact on ligand-induced EGFR internalization and degradation (PubMed:15668240). Participates in regulation of cortical and submembraneous actin by hydrolyzing PtdIns(3,4,5)P3 thereby regulating membrane ruffling (PubMed:21624956). Regulates cell adhesion and cell spreading (PubMed:12235291). Required for HGF-mediated lamellipodium formation, cell scattering and spreading (PubMed:15735664). Acts as a negative regulator of EPHA2 receptor endocytosis by inhibiting via PI3K-dependent Rac1 activation (PubMed:17135240). Acts as a regulator of neuritogenesis by regulating PtdIns(3,4,5)P3 level and is required to form an initial protrusive pattern, and later, maintain proper neurite outgrowth (By similarity). Acts as a negative regulator of the FC-gamma-RIIA receptor (FCGR2A) (PubMed:12690104). Mediates signaling from the FC-gamma-RIIB receptor (FCGR2B), playing a central role in terminating signal transduction from activating immune/hematopoietic cell receptor systems (PubMed:11016922). Involved in EGF signaling pathway (PubMed:11349134). Upon stimulation by EGF, it is recruited by EGFR and dephosphorylates PtdIns(3,4,5)P3 (PubMed:11349134). Plays a negative role in regulating the PI3K-PKB pathway, possibly by inhibiting PKB activity (PubMed:11349134). Down-regulates Fc-gamma-R-mediated phagocytosis in macrophages independently of INPP5D/SHIP1 (By similarity). In macrophages, down-regulates NF-kappa-B-dependent gene transcription by regulating macrophage colony-stimulating factor (M-CSF)-induced signaling (By similarity). Plays a role in the localization of AURKA and NEDD9/HEF1 to the basolateral membrane at interphase in polarized cysts, thereby mediates cell cycle homeostasis, cell polarization and cilia assembly (By similarity). Additionally promotion of cilia growth is also facilitated by hydrolysis of (PtdIns(3,4,5)P3) to PtdIns(3,4)P2 (By similarity). Promotes formation of apical membrane-initiation sites during the initial stages of lumen formation via Rho family-induced actin filament organization and CTNNB1 localization to cell-cell contacts (By similarity). May also hydrolyze PtdIns(1,3,4,5)P4, and could thus affect the levels of the higher inositol polyphosphates like InsP6. Involved in endochondral ossification (PubMed:23273569). {ECO:0000250|UniProtKB:F1PNY0, ECO:0000250|UniProtKB:Q6P549, ECO:0000250|UniProtKB:Q9WVR3, ECO:0000269|PubMed:11016922, ECO:0000269|PubMed:11349134, ECO:0000269|PubMed:11739414, ECO:0000269|PubMed:12235291, ECO:0000269|PubMed:12676785, ECO:0000269|PubMed:12690104, ECO:0000269|PubMed:15668240, ECO:0000269|PubMed:15735664, ECO:0000269|PubMed:16824732, ECO:0000269|PubMed:17135240, ECO:0000269|PubMed:21624956, ECO:0000269|PubMed:23273569, ECO:0000269|PubMed:9660833}. |
O43166 | SIPA1L1 | S1391 | ochoa | Signal-induced proliferation-associated 1-like protein 1 (SIPA1-like protein 1) (High-risk human papilloma viruses E6 oncoproteins targeted protein 1) (E6-targeted protein 1) | Stimulates the GTPase activity of RAP2A. Promotes reorganization of the actin cytoskeleton and recruits DLG4 to F-actin. Contributes to the regulation of dendritic spine morphogenesis (By similarity). {ECO:0000250}. |
O43379 | WDR62 | S614 | ochoa | WD repeat-containing protein 62 | Required for cerebral cortical development. Plays a role in neuronal proliferation and migration (PubMed:20729831, PubMed:20890278). Plays a role in mother-centriole-dependent centriole duplication; the function also seems to involve CEP152, CDK5RAP2 and CEP63 through a stepwise assembled complex at the centrosome that recruits CDK2 required for centriole duplication (PubMed:26297806). {ECO:0000269|PubMed:20729831, ECO:0000269|PubMed:20890278, ECO:0000269|PubMed:26297806}. |
O43379 | WDR62 | S1436 | ochoa | WD repeat-containing protein 62 | Required for cerebral cortical development. Plays a role in neuronal proliferation and migration (PubMed:20729831, PubMed:20890278). Plays a role in mother-centriole-dependent centriole duplication; the function also seems to involve CEP152, CDK5RAP2 and CEP63 through a stepwise assembled complex at the centrosome that recruits CDK2 required for centriole duplication (PubMed:26297806). {ECO:0000269|PubMed:20729831, ECO:0000269|PubMed:20890278, ECO:0000269|PubMed:26297806}. |
O60292 | SIPA1L3 | S451 | ochoa | Signal-induced proliferation-associated 1-like protein 3 (SIPA1-like protein 3) (SPA-1-like protein 3) | Plays a critical role in epithelial cell morphogenesis, polarity, adhesion and cytoskeletal organization in the lens (PubMed:26231217). {ECO:0000269|PubMed:26231217}. |
O75475 | PSIP1 | S482 | ochoa | PC4 and SFRS1-interacting protein (CLL-associated antigen KW-7) (Dense fine speckles 70 kDa protein) (DFS 70) (Lens epithelium-derived growth factor) (Transcriptional coactivator p75/p52) | Transcriptional coactivator involved in neuroepithelial stem cell differentiation and neurogenesis. Involved in particular in lens epithelial cell gene regulation and stress responses. May play an important role in lens epithelial to fiber cell terminal differentiation. May play a protective role during stress-induced apoptosis. Isoform 2 is a more general and stronger transcriptional coactivator. Isoform 2 may also act as an adapter to coordinate pre-mRNA splicing. Cellular cofactor for lentiviral integration. {ECO:0000269|PubMed:15642333}. |
O94876 | TMCC1 | S382 | ochoa | Transmembrane and coiled-coil domains protein 1 | Endoplasmic reticulum membrane protein that promotes endoplasmic reticulum-associated endosome fission (PubMed:30220460). Localizes to contact sites between the endoplasmic reticulum and endosomes and acts by promoting recruitment of the endoplasmic reticulum to endosome tubules for fission (PubMed:30220460). Endosome membrane fission of early and late endosomes is essential to separate regions destined for lysosomal degradation from carriers to be recycled to the plasma membrane (PubMed:30220460). {ECO:0000269|PubMed:30220460}. |
O95163 | ELP1 | S173 | ochoa | Elongator complex protein 1 (ELP1) (IkappaB kinase complex-associated protein) (IKK complex-associated protein) (p150) | Component of the elongator complex which is required for multiple tRNA modifications, including mcm5U (5-methoxycarbonylmethyl uridine), mcm5s2U (5-methoxycarbonylmethyl-2-thiouridine), and ncm5U (5-carbamoylmethyl uridine) (PubMed:29332244). The elongator complex catalyzes the formation of carboxymethyluridine in the wobble base at position 34 in tRNAs (PubMed:29332244). Regulates the migration and branching of projection neurons in the developing cerebral cortex, through a process depending on alpha-tubulin acetylation (By similarity). ELP1 binds to tRNA, mediating interaction of the elongator complex with tRNA (By similarity). May act as a scaffold protein that assembles active IKK-MAP3K14 complexes (IKKA, IKKB and MAP3K14/NIK) (PubMed:9751059). {ECO:0000250|UniProtKB:Q06706, ECO:0000250|UniProtKB:Q7TT37, ECO:0000269|PubMed:9751059, ECO:0000303|PubMed:29332244}. |
O95427 | PIGN | S94 | ochoa | GPI ethanolamine phosphate transferase 1 (EC 2.-.-.-) (GPI-ethanolamine transferase I) (GPI-ETI) (MCD4 homolog) (Phosphatidylinositol-glycan biosynthesis class N protein) (PIG-N) | Ethanolamine phosphate transferase that catalyzes an ethanolamine phosphate (EtNP) transfer from phosphatidylethanolamine (PE) to the 2-OH position of the first alpha-1,4-linked mannose of the alpha-D-Man-(1->6)-alpha-D-Man-(1->4)-alpha-D-GlcN-(1->6)-(1-radyl,2-acyl-sn-glycero-3-phospho)-2-acyl-inositol (also termed H3) intermediate to generate an alpha-D-Man-(1->6)-2-PEtn-alpha-D-Man-(1->4)-alpha-D-GlcN-(1->6)-(1-radyl,2-acyl-sn-glycero-3-phospho)-2-acyl-inositol and participates in the eighth step of the glycosylphosphatidylinositol-anchor biosynthesis (By similarity). May act as suppressor of replication stress and chromosome missegregation (PubMed:23446422). {ECO:0000250|UniProtKB:Q9R1S3, ECO:0000269|PubMed:23446422}. |
P00505 | GOT2 | S360 | ochoa | Aspartate aminotransferase, mitochondrial (mAspAT) (EC 2.6.1.1) (EC 2.6.1.7) (Fatty acid-binding protein) (FABP-1) (Glutamate oxaloacetate transaminase 2) (Kynurenine aminotransferase 4) (Kynurenine aminotransferase IV) (Kynurenine--oxoglutarate transaminase 4) (Kynurenine--oxoglutarate transaminase IV) (Plasma membrane-associated fatty acid-binding protein) (FABPpm) (Transaminase A) | Catalyzes the irreversible transamination of the L-tryptophan metabolite L-kynurenine to form kynurenic acid (KA). As a member of the malate-aspartate shuttle, it has a key role in the intracellular NAD(H) redox balance. Is important for metabolite exchange between mitochondria and cytosol, and for amino acid metabolism. Facilitates cellular uptake of long-chain free fatty acids. {ECO:0000269|PubMed:31422819, ECO:0000269|PubMed:9537447}. |
P01100 | FOS | S308 | psp | Protein c-Fos (Cellular oncogene fos) (Fos proto-oncogene, AP-1 transcription factor subunit) (G0/G1 switch regulatory protein 7) (Proto-oncogene c-Fos) (Transcription factor AP-1 subunit c-Fos) | Nuclear phosphoprotein which forms a tight but non-covalently linked complex with the JUN/AP-1 transcription factor. In the heterodimer, FOS and JUN/AP-1 basic regions each seems to interact with symmetrical DNA half sites. On TGF-beta activation, forms a multimeric SMAD3/SMAD4/JUN/FOS complex at the AP1/SMAD-binding site to regulate TGF-beta-mediated signaling. Has a critical function in regulating the development of cells destined to form and maintain the skeleton. It is thought to have an important role in signal transduction, cell proliferation and differentiation. In growing cells, activates phospholipid synthesis, possibly by activating CDS1 and PI4K2A. This activity requires Tyr-dephosphorylation and association with the endoplasmic reticulum. {ECO:0000269|PubMed:16055710, ECO:0000269|PubMed:17160021, ECO:0000269|PubMed:22105363, ECO:0000269|PubMed:7588633, ECO:0000269|PubMed:9732876}. |
P07355 | ANXA2 | S184 | ochoa | Annexin A2 (Annexin II) (Annexin-2) (Calpactin I heavy chain) (Calpactin-1 heavy chain) (Chromobindin-8) (Lipocortin II) (Placental anticoagulant protein IV) (PAP-IV) (Protein I) (p36) | Calcium-regulated membrane-binding protein whose affinity for calcium is greatly enhanced by anionic phospholipids. It binds two calcium ions with high affinity. May be involved in heat-stress response. Inhibits PCSK9-enhanced LDLR degradation, probably reduces PCSK9 protein levels via a translational mechanism but also competes with LDLR for binding with PCSK9 (PubMed:18799458, PubMed:22848640, PubMed:24808179). Binds to endosomes damaged by phagocytosis of particulate wear debris and participates in endosomal membrane stabilization, thereby limiting NLRP3 inflammasome activation (By similarity). Required for endothelial cell surface plasmin generation and may support fibrinolytic surveillance and neoangiogenesis (By similarity). {ECO:0000250|UniProtKB:P07356, ECO:0000269|PubMed:18799458, ECO:0000269|PubMed:22848640, ECO:0000269|PubMed:24808179}.; FUNCTION: (Microbial infection) Binds M.pneumoniae CARDS toxin, probably serves as one receptor for this pathogen. When ANXA2 is down-regulated by siRNA, less toxin binds to human cells and less vacuolization (a symptom of M.pneumoniae infection) is seen. {ECO:0000269|PubMed:25139904}. |
P12882 | MYH1 | S668 | ochoa | Myosin-1 (Myosin heavy chain 1) (Myosin heavy chain 2x) (MyHC-2x) (Myosin heavy chain IIx/d) (MyHC-IIx/d) (Myosin heavy chain, skeletal muscle, adult 1) | Required for normal hearing. It plays a role in cochlear amplification of auditory stimuli, likely through the positive regulation of prestin (SLC26A5) activity and outer hair cell (OHC) electromotility. {ECO:0000250|UniProtKB:Q5SX40}. |
P12883 | MYH7 | S664 | ochoa | Myosin-7 (Myosin heavy chain 7) (Myosin heavy chain slow isoform) (MyHC-slow) (Myosin heavy chain, cardiac muscle beta isoform) (MyHC-beta) | Myosins are actin-based motor molecules with ATPase activity essential for muscle contraction. Forms regular bipolar thick filaments that, together with actin thin filaments, constitute the fundamental contractile unit of skeletal and cardiac muscle. {ECO:0000305|PubMed:26150528, ECO:0000305|PubMed:26246073}. |
P13535 | MYH8 | S667 | ochoa | Myosin-8 (Myosin heavy chain 8) (Myosin heavy chain, skeletal muscle, perinatal) (MyHC-perinatal) | Muscle contraction. |
P19634 | SLC9A1 | S648 | ochoa|psp | Sodium/hydrogen exchanger 1 (APNH) (Na(+)/H(+) antiporter, amiloride-sensitive) (Na(+)/H(+) exchanger 1) (NHE-1) (Solute carrier family 9 member 1) | Electroneutral Na(+) /H(+) antiporter that extrudes Na(+) in exchange for external protons driven by the inward sodium ion chemical gradient, protecting cells from acidification that occurs from metabolism (PubMed:11350981, PubMed:11532004, PubMed:14680478, PubMed:15035633, PubMed:15677483, PubMed:17073455, PubMed:17493937, PubMed:22020933, PubMed:27650500, PubMed:32130622, PubMed:7110335, PubMed:7603840). Exchanges intracellular H(+) ions for extracellular Na(+) in 1:1 stoichiometry (By similarity). Plays a key role in maintening intracellular pH neutral and cell volume, and thus is important for cell growth, proliferation, migration and survival (PubMed:12947095, PubMed:15096511, PubMed:22020933, PubMed:8901634). In addition, can transport lithium Li(+) and also functions as a Na(+)/Li(+) antiporter (PubMed:7603840). SLC9A1 also functions in membrane anchoring and organization of scaffolding complexes that coordinate signaling inputs (PubMed:15096511). {ECO:0000250|UniProtKB:P26431, ECO:0000269|PubMed:11350981, ECO:0000269|PubMed:11532004, ECO:0000269|PubMed:12947095, ECO:0000269|PubMed:14680478, ECO:0000269|PubMed:15035633, ECO:0000269|PubMed:15096511, ECO:0000269|PubMed:15677483, ECO:0000269|PubMed:17073455, ECO:0000269|PubMed:17493937, ECO:0000269|PubMed:22020933, ECO:0000269|PubMed:27650500, ECO:0000269|PubMed:32130622, ECO:0000269|PubMed:7110335, ECO:0000269|PubMed:7603840, ECO:0000269|PubMed:8901634}. |
P23497 | SP100 | S223 | ochoa | Nuclear autoantigen Sp-100 (Nuclear dot-associated Sp100 protein) (Speckled 100 kDa) | Together with PML, this tumor suppressor is a major constituent of the PML bodies, a subnuclear organelle involved in a large number of physiological processes including cell growth, differentiation and apoptosis. Functions as a transcriptional coactivator of ETS1 and ETS2 according to PubMed:11909962. Under certain conditions, it may also act as a corepressor of ETS1 preventing its binding to DNA according to PubMed:15247905. Through the regulation of ETS1 it may play a role in angiogenesis, controlling endothelial cell motility and invasion. Through interaction with the MRN complex it may be involved in the regulation of telomeres lengthening. May also regulate TP53-mediated transcription and through CASP8AP2, regulate FAS-mediated apoptosis. Also plays a role in infection by viruses, including human cytomegalovirus and Epstein-Barr virus, through mechanisms that may involve chromatin and/or transcriptional regulation. {ECO:0000269|PubMed:11909962, ECO:0000269|PubMed:14647468, ECO:0000269|PubMed:15247905, ECO:0000269|PubMed:15592518, ECO:0000269|PubMed:15767676, ECO:0000269|PubMed:16177824, ECO:0000269|PubMed:17245429, ECO:0000269|PubMed:21274506, ECO:0000269|PubMed:21880768}. |
P29350 | PTPN6 | S26 | ochoa | Tyrosine-protein phosphatase non-receptor type 6 (EC 3.1.3.48) (Hematopoietic cell protein-tyrosine phosphatase) (Protein-tyrosine phosphatase 1C) (PTP-1C) (Protein-tyrosine phosphatase SHP-1) (SH-PTP1) | Tyrosine phosphatase enzyme that plays important roles in controlling immune signaling pathways and fundamental physiological processes such as hematopoiesis (PubMed:14739280, PubMed:29925997). Dephosphorylates and negatively regulate several receptor tyrosine kinases (RTKs) such as EGFR, PDGFR and FGFR, thereby modulating their signaling activities (PubMed:21258366, PubMed:9733788). When recruited to immunoreceptor tyrosine-based inhibitory motif (ITIM)-containing receptors such as immunoglobulin-like transcript 2/LILRB1, programmed cell death protein 1/PDCD1, CD3D, CD22, CLEC12A and other receptors involved in immune regulation, initiates their dephosphorylation and subsequently inhibits downstream signaling events (PubMed:11907092, PubMed:14739280, PubMed:37932456, PubMed:38166031). Modulates the signaling of several cytokine receptors including IL-4 receptor (PubMed:9065461). Additionally, targets multiple cytoplasmic signaling molecules including STING1, LCK or STAT1 among others involved in diverse cellular processes including modulation of T-cell activation or cGAS-STING signaling (PubMed:34811497, PubMed:38532423). Within the nucleus, negatively regulates the activity of some transcription factors such as NFAT5 via direct dephosphorylation. Also acts as a key transcriptional regulator of hepatic gluconeogenesis by controlling recruitment of RNA polymerase II to the PCK1 promoter together with STAT5A (PubMed:37595871). {ECO:0000269|PubMed:10574931, ECO:0000269|PubMed:11266449, ECO:0000269|PubMed:11907092, ECO:0000269|PubMed:14739280, ECO:0000269|PubMed:21258366, ECO:0000269|PubMed:29925997, ECO:0000269|PubMed:34811497, ECO:0000269|PubMed:37595871, ECO:0000269|PubMed:37932456, ECO:0000269|PubMed:38166031, ECO:0000269|PubMed:38532423, ECO:0000269|PubMed:9065461, ECO:0000269|PubMed:9733788}. |
P29972 | AQP1 | T239 | psp | Aquaporin-1 (AQP-1) (Aquaporin-CHIP) (Channel-like integral membrane protein of 28 kDa) (Urine water channel) | Forms a water channel that facilitates the transport of water across cell membranes, playing a crucial role in water homeostasis in various tissues (PubMed:1373524, PubMed:23219802). Could also be permeable to small solutes including hydrogen peroxide, glycerol and gases such as amonnia (NH3), nitric oxide (NO) and carbon dioxide (CO2) (PubMed:16682607, PubMed:17012249, PubMed:19273840, PubMed:33028705, PubMed:8584435). Recruited to the ankyrin-1 complex, a multiprotein complex of the erythrocyte membrane, it could be part of a CO2 metabolon, linking facilitated diffusion of CO2 across the membrane, anion exchange of Cl(-)/HCO3(-) and interconversion of dissolved CO2 and carbonic acid in the cytosol (PubMed:17012249, PubMed:35835865). In vitro, it shows non-selective gated cation channel activity and may be permeable to cations like K(+) and Na(+) in vivo (PubMed:36949749, PubMed:8703053). {ECO:0000269|PubMed:1373524, ECO:0000269|PubMed:16682607, ECO:0000269|PubMed:17012249, ECO:0000269|PubMed:19273840, ECO:0000269|PubMed:23219802, ECO:0000269|PubMed:33028705, ECO:0000269|PubMed:35835865, ECO:0000269|PubMed:36949749, ECO:0000269|PubMed:8584435, ECO:0000269|PubMed:8703053}. |
P31431 | SDC4 | S97 | ochoa | Syndecan-4 (SYND4) (Amphiglycan) (Ryudocan core protein) | Cell surface proteoglycan which regulates exosome biogenesis in concert with SDCBP and PDCD6IP (PubMed:22660413). {ECO:0000269|PubMed:22660413}. |
P35368 | ADRA1B | S470 | ochoa | Alpha-1B adrenergic receptor (Alpha-1B adrenoreceptor) (Alpha-1B adrenoceptor) | This alpha-adrenergic receptor mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system. Its effect is mediated by G(q) and G(11) proteins. Nuclear ADRA1A-ADRA1B heterooligomers regulate phenylephrine (PE)-stimulated ERK signaling in cardiac myocytes. {ECO:0000269|PubMed:18802028, ECO:0000269|PubMed:22120526}. |
P37802 | TAGLN2 | S83 | psp | Transgelin-2 (Epididymis tissue protein Li 7e) (SM22-alpha homolog) | None |
P42166 | TMPO | S59 | ochoa | Lamina-associated polypeptide 2, isoform alpha (Thymopoietin isoform alpha) (TP alpha) (Thymopoietin-related peptide isoform alpha) (TPRP isoform alpha) [Cleaved into: Thymopoietin (TP) (Splenin); Thymopentin (TP5)] | May be involved in the structural organization of the nucleus and in the post-mitotic nuclear assembly. Plays an important role, together with LMNA, in the nuclear anchorage of RB1.; FUNCTION: TP and TP5 may play a role in T-cell development and function. TP5 is an immunomodulating pentapeptide. |
P43490 | NAMPT | S472 | ochoa | Nicotinamide phosphoribosyltransferase (NAmPRTase) (Nampt) (EC 2.4.2.12) (Pre-B-cell colony-enhancing factor 1) (Pre-B cell-enhancing factor) (Visfatin) | Catalyzes the condensation of nicotinamide with 5-phosphoribosyl-1-pyrophosphate to yield nicotinamide mononucleotide, an intermediate in the biosynthesis of NAD. It is the rate limiting component in the mammalian NAD biosynthesis pathway. The secreted form behaves both as a cytokine with immunomodulating properties and an adipokine with anti-diabetic properties, it has no enzymatic activity, partly because of lack of activation by ATP, which has a low level in extracellular space and plasma. Plays a role in the modulation of circadian clock function. NAMPT-dependent oscillatory production of NAD regulates oscillation of clock target gene expression by releasing the core clock component: CLOCK-BMAL1 heterodimer from NAD-dependent SIRT1-mediated suppression (By similarity). {ECO:0000250|UniProtKB:Q99KQ4, ECO:0000269|PubMed:24130902}. |
P48681 | NES | S1521 | ochoa | Nestin | Required for brain and eye development. Promotes the disassembly of phosphorylated vimentin intermediate filaments (IF) during mitosis and may play a role in the trafficking and distribution of IF proteins and other cellular factors to daughter cells during progenitor cell division. Required for survival, renewal and mitogen-stimulated proliferation of neural progenitor cells (By similarity). {ECO:0000250}. |
P50402 | EMD | S29 | ochoa | Emerin | Stabilizes and promotes the formation of a nuclear actin cortical network. Stimulates actin polymerization in vitro by binding and stabilizing the pointed end of growing filaments. Inhibits beta-catenin activity by preventing its accumulation in the nucleus. Acts by influencing the nuclear accumulation of beta-catenin through a CRM1-dependent export pathway. Links centrosomes to the nuclear envelope via a microtubule association. Required for proper localization of non-farnesylated prelamin-A/C. Together with NEMP1, contributes to nuclear envelope stiffness in germ cells (PubMed:32923640). EMD and BAF are cooperative cofactors of HIV-1 infection. Association of EMD with the viral DNA requires the presence of BAF and viral integrase. The association of viral DNA with chromatin requires the presence of BAF and EMD. {ECO:0000269|PubMed:15328537, ECO:0000269|PubMed:16680152, ECO:0000269|PubMed:16858403, ECO:0000269|PubMed:17785515, ECO:0000269|PubMed:19323649, ECO:0000269|PubMed:32923640}. |
P51788 | CLCN2 | S76 | psp | Chloride channel protein 2 (ClC-2) | Voltage-gated and osmosensitive chloride channel. Forms a homodimeric channel where each subunit has its own ion conduction pathway. Conducts double-barreled currents controlled by two types of gates, two fast glutamate gates that control each subunit independently and a slow common gate that opens and shuts off both subunits simultaneously. Displays inward rectification currents activated upon membrane hyperpolarization and extracellular hypotonicity (PubMed:16155254, PubMed:17567819, PubMed:19191339, PubMed:23632988, PubMed:29403011, PubMed:29403012, PubMed:36964785, PubMed:38345841). Contributes to chloride conductance involved in neuron excitability. In hippocampal neurons, generates a significant part of resting membrane conductance and provides an additional chloride efflux pathway to prevent chloride accumulation in dendrites upon GABA receptor activation. In glia, associates with the auxiliary subunit HEPACAM/GlialCAM at astrocytic processes and myelinated fiber tracts where it may regulate transcellular chloride flux buffering extracellular chloride and potassium concentrations (PubMed:19191339, PubMed:22405205, PubMed:23707145). Regulates aldosterone production in adrenal glands. The opening of CLCN2 channels at hyperpolarized membrane potentials in the glomerulosa causes cell membrane depolarization, activation of voltage-gated calcium channels and increased expression of aldosterone synthase, the rate-limiting enzyme for aldosterone biosynthesis (PubMed:29403011, PubMed:29403012). Contributes to chloride conductance in retinal pigment epithelium involved in phagocytosis of shed photoreceptor outer segments and photoreceptor renewal (PubMed:36964785). Conducts chloride currents at the basolateral membrane of epithelial cells with a role in chloride reabsorption rather than secretion (By similarity) (PubMed:16155254). Permeable to small monovalent anions with chloride > thiocyanate > bromide > nitrate > iodide ion selectivity (By similarity) (PubMed:29403012). {ECO:0000250|UniProtKB:P35525, ECO:0000250|UniProtKB:Q9R0A1, ECO:0000269|PubMed:16155254, ECO:0000269|PubMed:17567819, ECO:0000269|PubMed:19191339, ECO:0000269|PubMed:22405205, ECO:0000269|PubMed:23632988, ECO:0000269|PubMed:23707145, ECO:0000269|PubMed:29403011, ECO:0000269|PubMed:29403012, ECO:0000269|PubMed:36964785, ECO:0000269|PubMed:38345841}. |
P55082 | MFAP3 | S334 | ochoa | Microfibril-associated glycoprotein 3 | Component of the elastin-associated microfibrils. |
P55347 | PKNOX1 | S33 | ochoa | Homeobox protein PKNOX1 (Homeobox protein PREP-1) (PBX/knotted homeobox 1) | Activates transcription in the presence of PBX1A and HOXA1. {ECO:0000250|UniProtKB:O70477}. |
P56524 | HDAC4 | S611 | ochoa | Histone deacetylase 4 (HD4) (EC 3.5.1.98) | Responsible for the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4). Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events. Histone deacetylases act via the formation of large multiprotein complexes. Involved in muscle maturation via its interaction with the myocyte enhancer factors such as MEF2A, MEF2C and MEF2D. Involved in the MTA1-mediated epigenetic regulation of ESR1 expression in breast cancer. Deacetylates HSPA1A and HSPA1B at 'Lys-77' leading to their preferential binding to co-chaperone STUB1 (PubMed:27708256). {ECO:0000269|PubMed:10523670, ECO:0000269|PubMed:24413532, ECO:0000269|PubMed:27708256}. |
P78312 | FAM193A | S965 | ochoa | Protein FAM193A (Protein IT14) | None |
P98161 | PKD1 | S916 | psp | Polycystin-1 (PC1) (Autosomal dominant polycystic kidney disease 1 protein) | Component of a heteromeric calcium-permeable ion channel formed by PKD1 and PKD2 that is activated by interaction between PKD1 and a Wnt family member, such as WNT3A and WNT9B (PubMed:27214281). Both PKD1 and PKD2 are required for channel activity (PubMed:27214281). Involved in renal tubulogenesis (PubMed:12482949). Involved in fluid-flow mechanosensation by the primary cilium in renal epithelium (By similarity). Acts as a regulator of cilium length, together with PKD2 (By similarity). The dynamic control of cilium length is essential in the regulation of mechanotransductive signaling (By similarity). The cilium length response creates a negative feedback loop whereby fluid shear-mediated deflection of the primary cilium, which decreases intracellular cAMP, leads to cilium shortening and thus decreases flow-induced signaling (By similarity). May be an ion-channel regulator. Involved in adhesive protein-protein and protein-carbohydrate interactions. Likely to be involved with polycystin-1-interacting protein 1 in the detection, sequestration and exocytosis of senescent mitochondria (PubMed:37681898). {ECO:0000250|UniProtKB:O08852, ECO:0000269|PubMed:12482949, ECO:0000269|PubMed:27214281, ECO:0000269|PubMed:37681898}. |
P98175 | RBM10 | S797 | ochoa | RNA-binding protein 10 (G patch domain-containing protein 9) (RNA-binding motif protein 10) (RNA-binding protein S1-1) (S1-1) | Binds to ssRNA containing the consensus sequence 5'-AGGUAA-3' (PubMed:21256132). May be involved in post-transcriptional processing, most probably in mRNA splicing (PubMed:18315527). Binds to RNA homopolymers, with a preference for poly(G) and poly(U) and little for poly(A) (By similarity). May bind to specific miRNA hairpins (PubMed:28431233). {ECO:0000250|UniProtKB:P70501, ECO:0000269|PubMed:18315527, ECO:0000269|PubMed:21256132, ECO:0000269|PubMed:28431233}. |
Q00341 | HDLBP | S804 | ochoa | Vigilin (High density lipoprotein-binding protein) (HDL-binding protein) | Appears to play a role in cell sterol metabolism. It may function to protect cells from over-accumulation of cholesterol. |
Q00587 | CDC42EP1 | S180 | ochoa | Cdc42 effector protein 1 (Binder of Rho GTPases 5) (Serum protein MSE55) | Probably involved in the organization of the actin cytoskeleton. Induced membrane extensions in fibroblasts. {ECO:0000269|PubMed:10430899}. |
Q05397 | PTK2 | S390 | ochoa | Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (Protein phosphatase 1 regulatory subunit 71) (PPP1R71) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK) | Non-receptor protein-tyrosine kinase that plays an essential role in regulating cell migration, adhesion, spreading, reorganization of the actin cytoskeleton, formation and disassembly of focal adhesions and cell protrusions, cell cycle progression, cell proliferation and apoptosis. Required for early embryonic development and placenta development. Required for embryonic angiogenesis, normal cardiomyocyte migration and proliferation, and normal heart development. Regulates axon growth and neuronal cell migration, axon branching and synapse formation; required for normal development of the nervous system. Plays a role in osteogenesis and differentiation of osteoblasts. Functions in integrin signal transduction, but also in signaling downstream of numerous growth factor receptors, G-protein coupled receptors (GPCR), EPHA2, netrin receptors and LDL receptors. Forms multisubunit signaling complexes with SRC and SRC family members upon activation; this leads to the phosphorylation of additional tyrosine residues, creating binding sites for scaffold proteins, effectors and substrates. Regulates numerous signaling pathways. Promotes activation of phosphatidylinositol 3-kinase and the AKT1 signaling cascade. Promotes activation of MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling cascade. Promotes localized and transient activation of guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs), and thereby modulates the activity of Rho family GTPases. Signaling via CAS family members mediates activation of RAC1. Phosphorylates NEDD9 following integrin stimulation (PubMed:9360983). Recruits the ubiquitin ligase MDM2 to P53/TP53 in the nucleus, and thereby regulates P53/TP53 activity, P53/TP53 ubiquitination and proteasomal degradation. Phosphorylates SRC; this increases SRC kinase activity. Phosphorylates ACTN1, ARHGEF7, GRB7, RET and WASL. Promotes phosphorylation of PXN and STAT1; most likely PXN and STAT1 are phosphorylated by a SRC family kinase that is recruited to autophosphorylated PTK2/FAK1, rather than by PTK2/FAK1 itself. Promotes phosphorylation of BCAR1; GIT2 and SHC1; this requires both SRC and PTK2/FAK1. Promotes phosphorylation of BMX and PIK3R1. Isoform 6 (FRNK) does not contain a kinase domain and inhibits PTK2/FAK1 phosphorylation and signaling. Its enhanced expression can attenuate the nuclear accumulation of LPXN and limit its ability to enhance serum response factor (SRF)-dependent gene transcription. {ECO:0000269|PubMed:10655584, ECO:0000269|PubMed:11331870, ECO:0000269|PubMed:11980671, ECO:0000269|PubMed:15166238, ECO:0000269|PubMed:15561106, ECO:0000269|PubMed:15895076, ECO:0000269|PubMed:16919435, ECO:0000269|PubMed:16927379, ECO:0000269|PubMed:17395594, ECO:0000269|PubMed:17431114, ECO:0000269|PubMed:17968709, ECO:0000269|PubMed:18006843, ECO:0000269|PubMed:18206965, ECO:0000269|PubMed:18256281, ECO:0000269|PubMed:18292575, ECO:0000269|PubMed:18497331, ECO:0000269|PubMed:18677107, ECO:0000269|PubMed:19138410, ECO:0000269|PubMed:19147981, ECO:0000269|PubMed:19224453, ECO:0000269|PubMed:20332118, ECO:0000269|PubMed:20495381, ECO:0000269|PubMed:21454698, ECO:0000269|PubMed:9360983}.; FUNCTION: [Isoform 6]: Isoform 6 (FRNK) does not contain a kinase domain and inhibits PTK2/FAK1 phosphorylation and signaling. Its enhanced expression can attenuate the nuclear accumulation of LPXN and limit its ability to enhance serum response factor (SRF)-dependent gene transcription. {ECO:0000269|PubMed:20109444}. |
Q08379 | GOLGA2 | S981 | ochoa | Golgin subfamily A member 2 (130 kDa cis-Golgi matrix protein) (GM130) (GM130 autoantigen) (Golgin-95) | Peripheral membrane component of the cis-Golgi stack that acts as a membrane skeleton that maintains the structure of the Golgi apparatus, and as a vesicle thether that facilitates vesicle fusion to the Golgi membrane (Probable) (PubMed:16489344). Required for normal protein transport from the endoplasmic reticulum to the Golgi apparatus and the cell membrane (By similarity). Together with p115/USO1 and STX5, involved in vesicle tethering and fusion at the cis-Golgi membrane to maintain the stacked and inter-connected structure of the Golgi apparatus. Plays a central role in mitotic Golgi disassembly: phosphorylation at Ser-37 by CDK1 at the onset of mitosis inhibits the interaction with p115/USO1, preventing tethering of COPI vesicles and thereby inhibiting transport through the Golgi apparatus during mitosis (By similarity). Also plays a key role in spindle pole assembly and centrosome organization (PubMed:26165940). Promotes the mitotic spindle pole assembly by activating the spindle assembly factor TPX2 to nucleate microtubules around the Golgi and capture them to couple mitotic membranes to the spindle: upon phosphorylation at the onset of mitosis, GOLGA2 interacts with importin-alpha via the nuclear localization signal region, leading to recruit importin-alpha to the Golgi membranes and liberate the spindle assembly factor TPX2 from importin-alpha. TPX2 then activates AURKA kinase and stimulates local microtubule nucleation. Upon filament assembly, nascent microtubules are further captured by GOLGA2, thus linking Golgi membranes to the spindle (PubMed:19242490, PubMed:26165940). Regulates the meiotic spindle pole assembly, probably via the same mechanism (By similarity). Also regulates the centrosome organization (PubMed:18045989, PubMed:19109421). Also required for the Golgi ribbon formation and glycosylation of membrane and secretory proteins (PubMed:16489344, PubMed:17314401). {ECO:0000250|UniProtKB:Q62839, ECO:0000250|UniProtKB:Q921M4, ECO:0000269|PubMed:16489344, ECO:0000269|PubMed:17314401, ECO:0000269|PubMed:18045989, ECO:0000269|PubMed:19109421, ECO:0000269|PubMed:19242490, ECO:0000269|PubMed:26165940, ECO:0000305|PubMed:26363069}. |
Q13492 | PICALM | S20 | ochoa | Phosphatidylinositol-binding clathrin assembly protein (Clathrin assembly lymphoid myeloid leukemia protein) | Cytoplasmic adapter protein that plays a critical role in clathrin-mediated endocytosis which is important in processes such as internalization of cell receptors, synaptic transmission or removal of apoptotic cells. Recruits AP-2 and attaches clathrin triskelions to the cytoplasmic side of plasma membrane leading to clathrin-coated vesicles (CCVs) assembly (PubMed:10436022, PubMed:16262731, PubMed:27574975). Furthermore, regulates clathrin-coated vesicle size and maturation by directly sensing and driving membrane curvature (PubMed:25898166). In addition to binding to clathrin, mediates the endocytosis of small R-SNARES (Soluble NSF Attachment Protein REceptors) between plasma membranes and endosomes including VAMP2, VAMP3, VAMP4, VAMP7 or VAMP8 (PubMed:21808019, PubMed:22118466, PubMed:23741335). In turn, PICALM-dependent SNARE endocytosis is required for the formation and maturation of autophagic precursors (PubMed:25241929). Modulates thereby autophagy and the turnover of autophagy substrates such as MAPT/TAU or amyloid precursor protein cleaved C-terminal fragment (APP-CTF) (PubMed:24067654, PubMed:25241929). {ECO:0000269|PubMed:10436022, ECO:0000269|PubMed:16262731, ECO:0000269|PubMed:21808019, ECO:0000269|PubMed:22118466, ECO:0000269|PubMed:23741335, ECO:0000269|PubMed:24067654, ECO:0000269|PubMed:25241929, ECO:0000269|PubMed:25898166, ECO:0000269|PubMed:27574975}. |
Q14318 | FKBP8 | S323 | ochoa | Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) | Constitutively inactive PPiase, which becomes active when bound to calmodulin and calcium. Seems to act as a chaperone for BCL2, targets it to the mitochondria and modulates its phosphorylation state. The BCL2/FKBP8/calmodulin/calcium complex probably interferes with the binding of BCL2 to its targets. The active form of FKBP8 may therefore play a role in the regulation of apoptosis. Involved in the inhibition of viral infection by influenza A viruses (IAV) (PubMed:28169297). {ECO:0000269|PubMed:12510191, ECO:0000269|PubMed:15757646, ECO:0000269|PubMed:16176796, ECO:0000269|PubMed:28169297}. |
Q14677 | CLINT1 | S282 | ochoa | Clathrin interactor 1 (Clathrin-interacting protein localized in the trans-Golgi region) (Clint) (Enthoprotin) (Epsin-4) (Epsin-related protein) (EpsinR) | Binds to membranes enriched in phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2). May have a role in transport via clathrin-coated vesicles from the trans-Golgi network to endosomes. Stimulates clathrin assembly. {ECO:0000269|PubMed:12429846, ECO:0000269|PubMed:12538641}. |
Q14692 | BMS1 | S403 | ochoa | Ribosome biogenesis protein BMS1 homolog (EC 3.6.5.-) (Ribosome assembly protein BMS1 homolog) | GTPase required for the synthesis of 40S ribosomal subunits and for processing of pre-ribosomal RNA (pre-rRNA) at sites A0, A1, and A2. Controls access of pre-rRNA intermediates to RCL1 during ribosome biogenesis by binding RCL1 in a GTP-dependent manner, and delivering it to pre-ribosomes. GTP-binding and/or GTP hydrolysis may induce conformational rearrangements within the BMS1-RCL1 complex allowing the interaction of RCL1 with its RNA substrate. Required for RCL1 import into the nucleus. {ECO:0000250|UniProtKB:Q08965}. |
Q14978 | NOLC1 | S643 | ochoa | Nucleolar and coiled-body phosphoprotein 1 (140 kDa nucleolar phosphoprotein) (Nopp140) (Hepatitis C virus NS5A-transactivated protein 13) (HCV NS5A-transactivated protein 13) (Nucleolar 130 kDa protein) (Nucleolar phosphoprotein p130) | Nucleolar protein that acts as a regulator of RNA polymerase I by connecting RNA polymerase I with enzymes responsible for ribosomal processing and modification (PubMed:10567578, PubMed:26399832). Required for neural crest specification: following monoubiquitination by the BCR(KBTBD8) complex, associates with TCOF1 and acts as a platform to connect RNA polymerase I with enzymes responsible for ribosomal processing and modification, leading to remodel the translational program of differentiating cells in favor of neural crest specification (PubMed:26399832). Involved in nucleologenesis, possibly by playing a role in the maintenance of the fundamental structure of the fibrillar center and dense fibrillar component in the nucleolus (PubMed:9016786). It has intrinsic GTPase and ATPase activities (PubMed:9016786). {ECO:0000269|PubMed:10567578, ECO:0000269|PubMed:26399832, ECO:0000269|PubMed:9016786}. |
Q15233 | NONO | S212 | ochoa | Non-POU domain-containing octamer-binding protein (NonO protein) (54 kDa nuclear RNA- and DNA-binding protein) (p54(nrb)) (p54nrb) (55 kDa nuclear protein) (NMT55) (DNA-binding p52/p100 complex, 52 kDa subunit) | DNA- and RNA binding protein, involved in several nuclear processes (PubMed:11525732, PubMed:12403470, PubMed:26571461). Binds the conventional octamer sequence in double-stranded DNA (PubMed:11525732, PubMed:12403470, PubMed:26571461). Also binds single-stranded DNA and RNA at a site independent of the duplex site (PubMed:11525732, PubMed:12403470, PubMed:26571461). Involved in pre-mRNA splicing, probably as a heterodimer with SFPQ (PubMed:11525732, PubMed:12403470, PubMed:26571461). Interacts with U5 snRNA, probably by binding to a purine-rich sequence located on the 3' side of U5 snRNA stem 1b (PubMed:12403470). Together with PSPC1, required for the formation of nuclear paraspeckles (PubMed:22416126). The SFPQ-NONO heteromer associated with MATR3 may play a role in nuclear retention of defective RNAs (PubMed:11525732). The SFPQ-NONO heteromer may be involved in DNA unwinding by modulating the function of topoisomerase I/TOP1 (PubMed:10858305). The SFPQ-NONO heteromer may be involved in DNA non-homologous end joining (NHEJ) required for double-strand break repair and V(D)J recombination and may stabilize paired DNA ends (PubMed:15590677). In vitro, the complex strongly stimulates DNA end joining, binds directly to the DNA substrates and cooperates with the Ku70/G22P1-Ku80/XRCC5 (Ku) dimer to establish a functional preligation complex (PubMed:15590677). NONO is involved in transcriptional regulation. The SFPQ-NONO-NR5A1 complex binds to the CYP17 promoter and regulates basal and cAMP-dependent transcriptional activity (PubMed:11897684). NONO binds to an enhancer element in long terminal repeats of endogenous intracisternal A particles (IAPs) and activates transcription (By similarity). Regulates the circadian clock by repressing the transcriptional activator activity of the CLOCK-BMAL1 heterodimer (By similarity). Important for the functional organization of GABAergic synapses (By similarity). Plays a specific and important role in the regulation of synaptic RNAs and GPHN/gephyrin scaffold structure, through the regulation of GABRA2 transcript (By similarity). Plays a key role during neuronal differentiation by recruiting TET1 to genomic loci and thereby regulating 5-hydroxymethylcytosine levels (By similarity). Plays a role in the regulation of DNA virus-mediated innate immune response by assembling into the HDP-RNP complex, a complex that serves as a platform for IRF3 phosphorylation and subsequent innate immune response activation through the cGAS-STING pathway (PubMed:28712728, PubMed:30270045). Promotes activation of the cGAS-STING pathway in response to HIV-2 infection: acts by interacting with HIV-2 Capsid protein p24, thereby promoting detection of viral DNA by CGAS, leading to CGAS-mediated inmmune activation (PubMed:30270045). In contrast, the weak interaction with HIV-1 Capsid protein p24 does not allow activation of the cGAS-STING pathway (PubMed:30270045). {ECO:0000250|UniProtKB:Q99K48, ECO:0000269|PubMed:10858305, ECO:0000269|PubMed:11525732, ECO:0000269|PubMed:11897684, ECO:0000269|PubMed:12403470, ECO:0000269|PubMed:15590677, ECO:0000269|PubMed:22416126, ECO:0000269|PubMed:26571461, ECO:0000269|PubMed:28712728, ECO:0000269|PubMed:30270045}. |
Q15276 | RABEP1 | S377 | ochoa | Rab GTPase-binding effector protein 1 (Rabaptin-4) (Rabaptin-5) (Rabaptin-5alpha) (Renal carcinoma antigen NY-REN-17) | Rab effector protein acting as linker between gamma-adaptin, RAB4A and RAB5A. Involved in endocytic membrane fusion and membrane trafficking of recycling endosomes. Involved in KCNH1 channels trafficking to and from the cell membrane (PubMed:22841712). Stimulates RABGEF1 mediated nucleotide exchange on RAB5A. Mediates the traffic of PKD1:PKD2 complex from the endoplasmic reticulum through the Golgi to the cilium (By similarity). {ECO:0000250|UniProtKB:O35551, ECO:0000269|PubMed:10698684, ECO:0000269|PubMed:11452015, ECO:0000269|PubMed:12773381, ECO:0000269|PubMed:22841712, ECO:0000269|PubMed:8521472}. |
Q15424 | SAFB | S761 | ochoa | Scaffold attachment factor B1 (SAF-B) (SAF-B1) (HSP27 estrogen response element-TATA box-binding protein) (HSP27 ERE-TATA-binding protein) | Binds to scaffold/matrix attachment region (S/MAR) DNA and forms a molecular assembly point to allow the formation of a 'transcriptosomal' complex (consisting of SR proteins and RNA polymerase II) coupling transcription and RNA processing (PubMed:9671816). Functions as an estrogen receptor corepressor and can also bind to the HSP27 promoter and decrease its transcription (PubMed:12660241). Thereby acts as a negative regulator of cell proliferation (PubMed:12660241). When associated with RBMX, binds to and stimulates transcription from the SREBF1 promoter (By similarity). {ECO:0000250|UniProtKB:D3YXK2, ECO:0000269|PubMed:12660241, ECO:0000269|PubMed:9671816}. |
Q15545 | TAF7 | S34 | ochoa | Transcription initiation factor TFIID subunit 7 (RNA polymerase II TBP-associated factor subunit F) (Transcription initiation factor TFIID 55 kDa subunit) (TAF(II)55) (TAFII-55) (TAFII55) | The TFIID basal transcription factor complex plays a major role in the initiation of RNA polymerase II (Pol II)-dependent transcription (PubMed:33795473). TFIID recognizes and binds promoters with or without a TATA box via its subunit TBP, a TATA-box-binding protein, and promotes assembly of the pre-initiation complex (PIC) (PubMed:33795473). The TFIID complex consists of TBP and TBP-associated factors (TAFs), including TAF1, TAF2, TAF3, TAF4, TAF5, TAF6, TAF7, TAF8, TAF9, TAF10, TAF11, TAF12 and TAF13 (PubMed:10438527, PubMed:33795473). TAF7 forms a promoter DNA binding subcomplex of TFIID, together with TAF1 and TAF2 (PubMed:33795473). Part of a TFIID complex containing TAF10 (TFIID alpha) and a TFIID complex lacking TAF10 (TFIID beta) (PubMed:10438527). {ECO:0000269|PubMed:10438527, ECO:0000269|PubMed:33795473}. |
Q15637 | SF1 | S268 | ochoa | Splicing factor 1 (Mammalian branch point-binding protein) (BBP) (mBBP) (Transcription factor ZFM1) (Zinc finger gene in MEN1 locus) (Zinc finger protein 162) | Necessary for the ATP-dependent first step of spliceosome assembly. Binds to the intron branch point sequence (BPS) 5'-UACUAAC-3' of the pre-mRNA. May act as transcription repressor. {ECO:0000269|PubMed:10449420, ECO:0000269|PubMed:8752089, ECO:0000269|PubMed:9660765}. |
Q17RH5 | RAPGEF2 | S921 | psp | Rap guanine nucleotide exchange factor 2 (Cyclic nucleotide ras GEF) (Neural RAP guanine nucleotide exchange protein) (PDZ domain-containing guanine nucleotide exchange factor 1) (RA-GEF-1) (Ras/Rap1-associating GEF-1) | None |
Q5JSZ5 | PRRC2B | S1153 | ochoa | Protein PRRC2B (HLA-B-associated transcript 2-like 1) (Proline-rich coiled-coil protein 2B) | None |
Q5T035 | FAM120A2P | S68 | ochoa | Putative uncharacterized protein FAM120A2P (FAM120A2P pseudogene) | None |
Q6DN90 | IQSEC1 | S253 | ochoa | IQ motif and SEC7 domain-containing protein 1 (ADP-ribosylation factors guanine nucleotide-exchange protein 100) (ADP-ribosylation factors guanine nucleotide-exchange protein 2) (Brefeldin-resistant Arf-GEF 2 protein) (BRAG2) | Guanine nucleotide exchange factor for ARF1 and ARF6 (PubMed:11226253, PubMed:24058294). Guanine nucleotide exchange factor activity is enhanced by lipid binding (PubMed:24058294). Accelerates GTP binding by ARFs of all three classes. Guanine nucleotide exchange protein for ARF6, mediating internalization of beta-1 integrin (PubMed:16461286). Involved in neuronal development (Probable). In neurons, plays a role in the control of vesicle formation by endocytoc cargo. Upon long term depression, interacts with GRIA2 and mediates the activation of ARF6 to internalize synaptic AMPAR receptors (By similarity). {ECO:0000250|UniProtKB:A0A0G2JUG7, ECO:0000269|PubMed:11226253, ECO:0000269|PubMed:16461286, ECO:0000269|PubMed:24058294, ECO:0000305|PubMed:31607425}. |
Q6ZU80 | CEP128 | S298 | ochoa | Centrosomal protein of 128 kDa (Cep128) | None |
Q6ZV73 | FGD6 | S1195 | ochoa | FYVE, RhoGEF and PH domain-containing protein 6 (Zinc finger FYVE domain-containing protein 24) | May activate CDC42, a member of the Ras-like family of Rho- and Rac proteins, by exchanging bound GDP for free GTP. May play a role in regulating the actin cytoskeleton and cell shape (By similarity). {ECO:0000250}. |
Q711Q0 | CEFIP | S816 | ochoa | Cardiac-enriched FHL2-interacting protein | Plays an important role in cardiomyocyte hypertrophy via activation of the calcineurin/NFAT signaling pathway. {ECO:0000250|UniProtKB:M0RD54}. |
Q7Z417 | NUFIP2 | S607 | ochoa | FMR1-interacting protein NUFIP2 (82 kDa FMRP-interacting protein) (82-FIP) (Cell proliferation-inducing gene 1 protein) (FMRP-interacting protein 2) (Nuclear FMR1-interacting protein 2) | Binds RNA. {ECO:0000269|PubMed:12837692}. |
Q86UU1 | PHLDB1 | S47 | ochoa | Pleckstrin homology-like domain family B member 1 (Protein LL5-alpha) | None |
Q86VP1 | TAX1BP1 | S683 | ochoa | Tax1-binding protein 1 (TRAF6-binding protein) | Ubiquitin-binding adapter that participates in inflammatory, antiviral and innate immune processes as well as selective autophagy regulation (PubMed:29940186, PubMed:30459273, PubMed:30909570). Plays a key role in the negative regulation of NF-kappa-B and IRF3 signalings by acting as an adapter for the ubiquitin-editing enzyme A20/TNFAIP3 to bind and inactivate its substrates (PubMed:17703191). Disrupts the interactions between the E3 ubiquitin ligase TRAF3 and TBK1/IKBKE to attenuate 'Lys63'-linked polyubiquitination of TBK1 and thereby IFN-beta production (PubMed:21885437). Also recruits A20/TNFAIP3 to ubiquitinated signaling proteins TRAF6 and RIPK1, leading to their deubiquitination and disruption of IL-1 and TNF-induced NF-kappa-B signaling pathways (PubMed:17703191). Inhibits virus-induced apoptosis by inducing the 'Lys-48'-linked polyubiquitination and degradation of MAVS via recruitment of the E3 ligase ITCH, thereby attenuating MAVS-mediated apoptosis signaling (PubMed:27736772). As a macroautophagy/autophagy receptor, facilitates the xenophagic clearance of pathogenic bacteria such as Salmonella typhimurium and Mycobacterium tuberculosis (PubMed:26451915). Upon NBR1 recruitment to the SQSTM1-ubiquitin condensates, acts as the major recruiter of RB1CC1 to these ubiquitin condensates to promote their autophagic degradation (PubMed:33226137, PubMed:34471133). Mediates the autophagic degradation of other substrates including TICAM1 (PubMed:28898289). {ECO:0000269|PubMed:10435631, ECO:0000269|PubMed:10920205, ECO:0000269|PubMed:17703191, ECO:0000269|PubMed:21885437, ECO:0000269|PubMed:26451915, ECO:0000269|PubMed:27736772, ECO:0000269|PubMed:28898289, ECO:0000269|PubMed:29940186, ECO:0000269|PubMed:30459273, ECO:0000269|PubMed:30909570, ECO:0000269|PubMed:33226137, ECO:0000269|PubMed:34471133}. |
Q8IUD2 | ERC1 | S251 | ochoa | ELKS/Rab6-interacting/CAST family member 1 (ERC-1) (Rab6-interacting protein 2) | Regulatory subunit of the IKK complex. Probably recruits IkappaBalpha/NFKBIA to the complex. May be involved in the organization of the cytomatrix at the nerve terminals active zone (CAZ) which regulates neurotransmitter release. May be involved in vesicle trafficking at the CAZ. May be involved in Rab-6 regulated endosomes to Golgi transport. {ECO:0000269|PubMed:15218148}. |
Q8N392 | ARHGAP18 | S209 | ochoa | Rho GTPase-activating protein 18 (MacGAP) (Rho-type GTPase-activating protein 18) | Rho GTPase activating protein that suppresses F-actin polymerization by inhibiting Rho. Rho GTPase activating proteins act by converting Rho-type GTPases to an inactive GDP-bound state (PubMed:21865595). Plays a key role in tissue tension and 3D tissue shape by regulating cortical actomyosin network formation. Acts downstream of YAP1 and inhibits actin polymerization, which in turn reduces nuclear localization of YAP1 (PubMed:25778702). Regulates cell shape, spreading, and migration (PubMed:21865595). {ECO:0000269|PubMed:21865595, ECO:0000269|PubMed:25778702}. |
Q8N4C8 | MINK1 | S1088 | ochoa | Misshapen-like kinase 1 (EC 2.7.11.1) (GCK family kinase MiNK) (MAPK/ERK kinase kinase kinase 6) (MEK kinase kinase 6) (MEKKK 6) (Misshapen/NIK-related kinase) (Mitogen-activated protein kinase kinase kinase kinase 6) | Serine/threonine kinase which acts as a negative regulator of Ras-related Rap2-mediated signal transduction to control neuronal structure and AMPA receptor trafficking (PubMed:10708748, PubMed:16337592). Required for normal synaptic density, dendrite complexity, as well as surface AMPA receptor expression in hippocampal neurons (By similarity). Can activate the JNK and MAPK14/p38 pathways and mediates stimulation of the stress-activated protein kinase MAPK14/p38 MAPK downstream of the Raf/ERK pathway. Phosphorylates TANC1 upon stimulation by RAP2A, MBP and SMAD1 (PubMed:18930710, PubMed:21690388). Has an essential function in negative selection of thymocytes, perhaps by coupling NCK1 to activation of JNK1 (By similarity). Activator of the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. MAP4Ks act in parallel to and are partially redundant with STK3/MST2 and STK4/MST2 in the phosphorylation and activation of LATS1/2, and establish MAP4Ks as components of the expanded Hippo pathway (PubMed:26437443). {ECO:0000250|UniProtKB:F1LP90, ECO:0000250|UniProtKB:Q9JM52, ECO:0000269|PubMed:10708748, ECO:0000269|PubMed:16337592, ECO:0000269|PubMed:18930710, ECO:0000269|PubMed:21690388, ECO:0000269|PubMed:26437443}.; FUNCTION: Isoform 4 can activate the JNK pathway. Involved in the regulation of actin cytoskeleton reorganization, cell-matrix adhesion, cell-cell adhesion and cell migration. |
Q8N6F7 | GCSAM | S102 | ochoa | Germinal center-associated signaling and motility protein (Germinal center B-cell-expressed transcript 2 protein) (Germinal center-associated lymphoma protein) (hGAL) | Involved in the negative regulation of lymphocyte motility. It mediates the migration-inhibitory effects of IL6. Serves as a positive regulator of the RhoA signaling pathway. Enhancement of RhoA activation results in inhibition of lymphocyte and lymphoma cell motility by activation of its downstream effector ROCK. Is a regulator of B-cell receptor signaling, that acts through SYK kinase activation. {ECO:0000269|PubMed:17823310, ECO:0000269|PubMed:20844236, ECO:0000269|PubMed:23299888}. |
Q8N6R0 | METTL13 | S269 | ochoa | eEF1A lysine and N-terminal methyltransferase (eEF1A-KNMT) (Methyltransferase-like protein 13) [Includes: eEF1A lysine methyltransferase (EC 2.1.1.-); eEF1A N-terminal methyltransferase (EC 2.1.1.-)] | Dual methyltransferase that catalyzes methylation of elongation factor 1-alpha (EEF1A1 and EEF1A2) at two different positions, and is therefore involved in the regulation of mRNA translation (PubMed:30143613, PubMed:30612740). Via its C-terminus, methylates EEF1A1 and EEF1A2 at the N-terminal residue 'Gly-2' (PubMed:30143613). Via its N-terminus dimethylates EEF1A1 and EEF1A2 at residue 'Lys-55' (PubMed:30143613, PubMed:30612740). Has no activity towards core histones H2A, H2B, H3 and H4 (PubMed:30612740). {ECO:0000269|PubMed:30143613, ECO:0000269|PubMed:30612740}. |
Q8NCN2 | ZBTB34 | S207 | ochoa | Zinc finger and BTB domain-containing protein 34 | May be a transcriptional repressor. {ECO:0000269|PubMed:16718364}. |
Q8NDX1 | PSD4 | S413 | ochoa | PH and SEC7 domain-containing protein 4 (Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6 B) (Exchange factor for ARF6 B) (Pleckstrin homology and SEC7 domain-containing protein 4) (Telomeric of interleukin-1 cluster protein) | Guanine nucleotide exchange factor for ARF6 and ARL14/ARF7. Through ARL14 activation, controls the movement of MHC class II-containing vesicles along the actin cytoskeleton in dendritic cells. Involved in membrane recycling. Interacts with several phosphatidylinositol phosphate species, including phosphatidylinositol 3,4-bisphosphate, phosphatidylinositol 3,5-bisphosphate and phosphatidylinositol 4,5-bisphosphate. {ECO:0000269|PubMed:12082148, ECO:0000269|PubMed:21458045}. |
Q8TB24 | RIN3 | S875 | ochoa | Ras and Rab interactor 3 (Ras interaction/interference protein 3) | Ras effector protein that functions as a guanine nucleotide exchange (GEF) for RAB5B and RAB31, by exchanging bound GDP for free GTP. Required for normal RAB31 function. {ECO:0000269|PubMed:12972505, ECO:0000269|PubMed:21586568}. |
Q8TEW0 | PARD3 | S962 | ochoa|psp | Partitioning defective 3 homolog (PAR-3) (PARD-3) (Atypical PKC isotype-specific-interacting protein) (ASIP) (CTCL tumor antigen se2-5) (PAR3-alpha) | Adapter protein involved in asymmetrical cell division and cell polarization processes (PubMed:10954424, PubMed:27925688). Seems to play a central role in the formation of epithelial tight junctions (PubMed:27925688). Targets the phosphatase PTEN to cell junctions (By similarity). Involved in Schwann cell peripheral myelination (By similarity). Association with PARD6B may prevent the interaction of PARD3 with F11R/JAM1, thereby preventing tight junction assembly (By similarity). The PARD6-PARD3 complex links GTP-bound Rho small GTPases to atypical protein kinase C proteins (PubMed:10934474). Required for establishment of neuronal polarity and normal axon formation in cultured hippocampal neurons (PubMed:19812038, PubMed:27925688). {ECO:0000250|UniProtKB:Q99NH2, ECO:0000250|UniProtKB:Q9Z340, ECO:0000269|PubMed:10934474, ECO:0000269|PubMed:10954424, ECO:0000269|PubMed:19812038, ECO:0000269|PubMed:27925688}. |
Q8TEW8 | PARD3B | S780 | ochoa | Partitioning defective 3 homolog B (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 19 protein) (PAR3-beta) (Partitioning defective 3-like protein) (PAR3-L protein) | Putative adapter protein involved in asymmetrical cell division and cell polarization processes. May play a role in the formation of epithelial tight junctions. |
Q8TF76 | HASPIN | S243 | psp | Serine/threonine-protein kinase haspin (EC 2.7.11.1) (Germ cell-specific gene 2 protein) (H-haspin) (Haploid germ cell-specific nuclear protein kinase) | Serine/threonine-protein kinase that phosphorylates histone H3 at 'Thr-3' (H3T3ph) during mitosis. May act through H3T3ph to both position and modulate activation of AURKB and other components of the chromosomal passenger complex (CPC) at centromeres to ensure proper chromatid cohesion, metaphase alignment and normal progression through the cell cycle. {ECO:0000269|PubMed:11228240, ECO:0000269|PubMed:15681610, ECO:0000269|PubMed:17084365, ECO:0000269|PubMed:20705812, ECO:0000269|PubMed:20929775}. |
Q92575 | UBXN4 | S330 | ochoa | UBX domain-containing protein 4 (Erasin) (UBX domain-containing protein 2) | Involved in endoplasmic reticulum-associated protein degradation (ERAD). Acts as a platform to recruit both UBQLN1 and VCP to the ER during ERAD (PubMed:19822669). {ECO:0000269|PubMed:16968747, ECO:0000269|PubMed:19822669}. |
Q92736 | RYR2 | S2814 | psp | Ryanodine receptor 2 (RYR-2) (RyR2) (hRYR-2) (Cardiac muscle ryanodine receptor) (Cardiac muscle ryanodine receptor-calcium release channel) (Type 2 ryanodine receptor) | Cytosolic calcium-activated calcium channel that mediates the release of Ca(2+) from the sarcoplasmic reticulum into the cytosol and thereby plays a key role in triggering cardiac muscle contraction. Aberrant channel activation can lead to cardiac arrhythmia. In cardiac myocytes, calcium release is triggered by increased Ca(2+) cytosolic levels due to activation of the L-type calcium channel CACNA1C. The calcium channel activity is modulated by formation of heterotetramers with RYR3. Required for cellular calcium ion homeostasis. Required for embryonic heart development. {ECO:0000269|PubMed:10830164, ECO:0000269|PubMed:17984046, ECO:0000269|PubMed:20056922, ECO:0000269|PubMed:27733687, ECO:0000269|PubMed:33536282}. |
Q92966 | SNAPC3 | S69 | ochoa | snRNA-activating protein complex subunit 3 (SNAPc subunit 3) (Proximal sequence element-binding transcription factor subunit beta) (PSE-binding factor subunit beta) (PTF subunit beta) (Small nuclear RNA-activating complex polypeptide 3) (snRNA-activating protein complex 50 kDa subunit) (SNAPc 50 kDa subunit) | Part of the SNAPc complex required for the transcription of both RNA polymerase II and III small-nuclear RNA genes. Binds to the proximal sequence element (PSE), a non-TATA-box basal promoter element common to these 2 types of genes. Recruits TBP and BRF2 to the U6 snRNA TATA box. {ECO:0000269|PubMed:12621023}. |
Q96B97 | SH3KBP1 | S181 | ochoa | SH3 domain-containing kinase-binding protein 1 (CD2-binding protein 3) (CD2BP3) (Cbl-interacting protein of 85 kDa) (Human Src family kinase-binding protein 1) (HSB-1) | Adapter protein involved in regulating diverse signal transduction pathways. Involved in the regulation of endocytosis and lysosomal degradation of ligand-induced receptor tyrosine kinases, including EGFR and MET/hepatocyte growth factor receptor, through an association with CBL and endophilins. The association with CBL, and thus the receptor internalization, may be inhibited by an interaction with PDCD6IP and/or SPRY2. Involved in regulation of ligand-dependent endocytosis of the IgE receptor. Attenuates phosphatidylinositol 3-kinase activity by interaction with its regulatory subunit (By similarity). May be involved in regulation of cell adhesion; promotes the interaction between TTK2B and PDCD6IP. May be involved in the regulation of cellular stress response via the MAPK pathways through its interaction with MAP3K4. Is involved in modulation of tumor necrosis factor mediated apoptosis. Plays a role in the regulation of cell morphology and cytoskeletal organization. Required in the control of cell shape and migration. Has an essential role in the stimulation of B cell activation (PubMed:29636373). {ECO:0000250, ECO:0000269|PubMed:11894095, ECO:0000269|PubMed:11894096, ECO:0000269|PubMed:12177062, ECO:0000269|PubMed:12734385, ECO:0000269|PubMed:12771190, ECO:0000269|PubMed:15090612, ECO:0000269|PubMed:15707590, ECO:0000269|PubMed:16177060, ECO:0000269|PubMed:16256071, ECO:0000269|PubMed:21275903, ECO:0000269|PubMed:21834987, ECO:0000269|PubMed:29636373}. |
Q96HB5 | CCDC120 | S331 | ochoa | Coiled-coil domain-containing protein 120 | Centriolar protein required for centriole subdistal appendage assembly and microtubule anchoring in interphase cells (PubMed:28422092). Together with CCDC68, cooperate with subdistal appendage components ODF2, NIN and CEP170 for hierarchical subdistal appendage assembly (PubMed:28422092). Recruits NIN and CEP170 to centrosomes (PubMed:28422092). Also required for neurite growth. Localizes CYTH2 to vesicles to allow its transport along neurites, and subsequent ARF6 activation and neurite growth. {ECO:0000269|PubMed:25326380}. |
Q96KM6 | ZNF512B | S686 | ochoa | Zinc finger protein 512B | Involved in transcriptional regulation by repressing gene expression (PubMed:39460621). Associates with the nucleosome remodeling and histone deacetylase (NuRD) complex, which promotes transcriptional repression by histone deacetylation and nucleosome remodeling (PubMed:39460621). {ECO:0000269|PubMed:39460621}. |
Q99683 | MAP3K5 | S1072 | ochoa | Mitogen-activated protein kinase kinase kinase 5 (EC 2.7.11.25) (Apoptosis signal-regulating kinase 1) (ASK-1) (MAPK/ERK kinase kinase 5) (MEK kinase 5) (MEKK 5) | Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. Plays an important role in the cascades of cellular responses evoked by changes in the environment. Mediates signaling for determination of cell fate such as differentiation and survival. Plays a crucial role in the apoptosis signal transduction pathway through mitochondria-dependent caspase activation. MAP3K5/ASK1 is required for the innate immune response, which is essential for host defense against a wide range of pathogens. Mediates signal transduction of various stressors like oxidative stress as well as by receptor-mediated inflammatory signals, such as the tumor necrosis factor (TNF) or lipopolysaccharide (LPS). Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade and the p38 MAPK signal transduction cascade through the phosphorylation and activation of several MAP kinase kinases like MAP2K4/SEK1, MAP2K3/MKK3, MAP2K6/MKK6 and MAP2K7/MKK7. These MAP2Ks in turn activate p38 MAPKs and c-jun N-terminal kinases (JNKs). Both p38 MAPK and JNKs control the transcription factors activator protein-1 (AP-1). {ECO:0000269|PubMed:10411906, ECO:0000269|PubMed:10688666, ECO:0000269|PubMed:10849426, ECO:0000269|PubMed:11029458, ECO:0000269|PubMed:11154276, ECO:0000269|PubMed:11689443, ECO:0000269|PubMed:11920685, ECO:0000269|PubMed:14688258, ECO:0000269|PubMed:14749717, ECO:0000269|PubMed:15023544, ECO:0000269|PubMed:16129676, ECO:0000269|PubMed:17220297, ECO:0000269|PubMed:23102700, ECO:0000269|PubMed:26095851, ECO:0000269|PubMed:8940179, ECO:0000269|PubMed:8974401, ECO:0000269|PubMed:9564042, ECO:0000269|PubMed:9774977}. |
Q9BXL7 | CARD11 | S655 | psp | Caspase recruitment domain-containing protein 11 (CARD-containing MAGUK protein 1) (Carma 1) | Adapter protein that plays a key role in adaptive immune response by transducing the activation of NF-kappa-B downstream of T-cell receptor (TCR) and B-cell receptor (BCR) engagement (PubMed:11278692, PubMed:11356195, PubMed:12356734). Transduces signals downstream TCR or BCR activation via the formation of a multiprotein complex together with BCL10 and MALT1 that induces NF-kappa-B and MAP kinase p38 (MAPK11, MAPK12, MAPK13 and/or MAPK14) pathways (PubMed:11356195). Upon activation in response to TCR or BCR triggering, CARD11 homooligomerizes to form a nucleating helical template that recruits BCL10 via CARD-CARD interaction, thereby promoting polymerization of BCL10 and subsequent recruitment of MALT1: this leads to I-kappa-B kinase (IKK) phosphorylation and degradation, and release of NF-kappa-B proteins for nuclear translocation (PubMed:24074955). Its binding to DPP4 induces T-cell proliferation and NF-kappa-B activation in a T-cell receptor/CD3-dependent manner (PubMed:17287217). Promotes linear ubiquitination of BCL10 by promoting the targeting of BCL10 to RNF31/HOIP (PubMed:27777308). Stimulates the phosphorylation of BCL10 (PubMed:11356195). Also activates the TORC1 signaling pathway (PubMed:28628108). {ECO:0000269|PubMed:11278692, ECO:0000269|PubMed:11356195, ECO:0000269|PubMed:12356734, ECO:0000269|PubMed:17287217, ECO:0000269|PubMed:24074955, ECO:0000269|PubMed:27777308, ECO:0000269|PubMed:28628108}. |
Q9H223 | EHD4 | S352 | ochoa | EH domain-containing protein 4 (Hepatocellular carcinoma-associated protein 10/11) (PAST homolog 4) | ATP- and membrane-binding protein that probably controls membrane reorganization/tubulation upon ATP hydrolysis. Plays a role in early endosomal transport (PubMed:17233914, PubMed:18331452). During sprouting angiogenesis, in complex with PACSIN2 and MICALL1, forms recycling endosome-like tubular structure at asymmetric adherens junctions to control CDH5 trafficking (By similarity). {ECO:0000250|UniProtKB:Q9EQP2, ECO:0000269|PubMed:17233914, ECO:0000269|PubMed:18331452}. |
Q9H4L5 | OSBPL3 | S303 | ochoa | Oxysterol-binding protein-related protein 3 (ORP-3) (OSBP-related protein 3) | Phosphoinositide-binding protein which associates with both cell and endoplasmic reticulum (ER) membranes (PubMed:16143324). Can bind to the ER membrane protein VAPA and recruit VAPA to plasma membrane sites, thus linking these intracellular compartments (PubMed:25447204). The ORP3-VAPA complex stimulates RRAS signaling which in turn attenuates integrin beta-1 (ITGB1) activation at the cell surface (PubMed:18270267, PubMed:25447204). With VAPA, may regulate ER morphology (PubMed:16143324). Has a role in regulation of the actin cytoskeleton, cell polarity and cell adhesion (PubMed:18270267). Binds to phosphoinositides with preference for PI(3,4)P2 and PI(3,4,5)P3 (PubMed:16143324). Also binds 25-hydroxycholesterol and cholesterol (PubMed:17428193). {ECO:0000269|PubMed:16143324, ECO:0000269|PubMed:17428193, ECO:0000269|PubMed:18270267, ECO:0000269|PubMed:25447204}. |
Q9HBI1 | PARVB | S39 | ochoa | Beta-parvin (Affixin) | Adapter protein that plays a role in integrin signaling via ILK and in activation of the GTPases CDC42 and RAC1 by guanine exchange factors, such as ARHGEF6. Is involved in the reorganization of the actin cytoskeleton and formation of lamellipodia. Plays a role in cell adhesion, cell spreading, establishment or maintenance of cell polarity, and cell migration. {ECO:0000269|PubMed:11402068, ECO:0000269|PubMed:15005707, ECO:0000269|PubMed:15159419, ECO:0000269|PubMed:15284246, ECO:0000269|PubMed:18325335}. |
Q9NQ55 | PPAN | S228 | ochoa | Suppressor of SWI4 1 homolog (Ssf-1) (Brix domain-containing protein 3) (Peter Pan homolog) | May have a role in cell growth. |
Q9NVF7 | FBXO28 | S330 | ochoa | F-box only protein 28 | Probably recognizes and binds to some phosphorylated proteins and promotes their ubiquitination and degradation. {ECO:0000250}. |
Q9NZB2 | FAM120A | S419 | ochoa | Constitutive coactivator of PPAR-gamma-like protein 1 (Oxidative stress-associated SRC activator) (Protein FAM120A) | Component of the oxidative stress-induced survival signaling. May regulate the activation of SRC family protein kinases (PubMed:19015244). May act as a scaffolding protein enabling SRC family protein kinases to phosphorylate and activate PI3-kinase (PubMed:19015244). Binds IGF2 RNA and promotes the production of IGF2 protein (PubMed:19015244). {ECO:0000269|PubMed:19015244}. |
Q9P2E9 | RRBP1 | S978 | ochoa | Ribosome-binding protein 1 (180 kDa ribosome receptor homolog) (RRp) (ES/130-related protein) (Ribosome receptor protein) | Acts as a ribosome receptor and mediates interaction between the ribosome and the endoplasmic reticulum membrane. {ECO:0000250}. |
Q9P2G1 | ANKIB1 | S782 | ochoa | Ankyrin repeat and IBR domain-containing protein 1 (EC 2.3.2.31) | Might act as an E3 ubiquitin-protein ligase, or as part of E3 complex, which accepts ubiquitin from specific E2 ubiquitin-conjugating enzymes and then transfers it to substrates. {ECO:0000250}. |
Q9UBZ4 | APEX2 | S227 | ochoa | DNA-(apurinic or apyrimidinic site) endonuclease 2 (EC 3.1.11.2) (AP endonuclease XTH2) (APEX nuclease 2) (APEX nuclease-like 2) (Apurinic-apyrimidinic endonuclease 2) (AP endonuclease 2) | Functions as a weak apurinic/apyrimidinic (AP) endodeoxyribonuclease in the DNA base excision repair (BER) pathway of DNA lesions induced by oxidative and alkylating agents (PubMed:16687656). Initiates repair of AP sites in DNA by catalyzing hydrolytic incision of the phosphodiester backbone immediately adjacent to the damage, generating a single-strand break with 5'-deoxyribose phosphate and 3'-hydroxyl ends. Also displays double-stranded DNA 3'-5' exonuclease, 3'-phosphodiesterase activities (PubMed:16687656, PubMed:19443450, PubMed:32516598). Shows robust 3'-5' exonuclease activity on 3'-recessed heteroduplex DNA and is able to remove mismatched nucleotides preferentially (PubMed:16687656, PubMed:19443450). Also exhibits 3'-5' exonuclease activity on a single nucleotide gap containing heteroduplex DNA and on blunt-ended substrates (PubMed:16687656). Shows fairly strong 3'-phosphodiesterase activity involved in the removal of 3'-damaged termini formed in DNA by oxidative agents (PubMed:16687656, PubMed:19443450). In the nucleus functions in the PCNA-dependent BER pathway (PubMed:11376153). Plays a role in reversing blocked 3' DNA ends, problematic lesions that preclude DNA synthesis (PubMed:32516598). Required for somatic hypermutation (SHM) and DNA cleavage step of class switch recombination (CSR) of immunoglobulin genes (By similarity). Required for proper cell cycle progression during proliferation of peripheral lymphocytes (By similarity). {ECO:0000250|UniProtKB:Q68G58, ECO:0000269|PubMed:11376153, ECO:0000269|PubMed:16687656, ECO:0000269|PubMed:19443450, ECO:0000269|PubMed:32516598}. |
Q9UIF8 | BAZ2B | S1269 | ochoa | Bromodomain adjacent to zinc finger domain protein 2B (hWALp4) | Regulatory subunit of the ATP-dependent BRF-1 and BRF-5 ISWI chromatin remodeling complexes, which form ordered nucleosome arrays on chromatin and facilitate access to DNA during DNA-templated processes such as DNA replication, transcription, and repair (PubMed:28801535). Both complexes regulate the spacing of nucleosomes along the chromatin and have the ability to slide mononucleosomes to the center of a DNA template (PubMed:28801535). The BRF-1 ISWI chromatin remodeling complex has a lower ATP hydrolysis rate than the BRF-5 ISWI chromatin remodeling complex (PubMed:28801535). Chromatin reader protein, which may play a role in transcriptional regulation via interaction with ISWI (By similarity) (PubMed:10662543). Involved in positively modulating the rate of age-related behavioral deterioration (By similarity). Represses the expression of mitochondrial function-related genes, perhaps by occupying their promoter regions, working in concert with histone methyltransferase EHMT1 (By similarity). {ECO:0000250|UniProtKB:A2AUY4, ECO:0000269|PubMed:28801535, ECO:0000303|PubMed:10662543}. |
Q9UIF9 | BAZ2A | S611 | ochoa | Bromodomain adjacent to zinc finger domain protein 2A (Transcription termination factor I-interacting protein 5) (TTF-I-interacting protein 5) (Tip5) (hWALp3) | Regulatory subunit of the ATP-dependent NoRC-1 and NoRC-5 ISWI chromatin remodeling complexes, which form ordered nucleosome arrays on chromatin and facilitate access to DNA during DNA-templated processes such as DNA replication, transcription, and repair (PubMed:28801535). Both complexes regulate the spacing of nucleosomes along the chromatin and have the ability to slide mononucleosomes to the center of a DNA template (PubMed:28801535). Directly stimulates the ATPase activity of SMARCA5 in the NoRC-5 ISWI chromatin remodeling complex (PubMed:28801535). The NoRC-1 ISWI chromatin remodeling complex has a lower ATP hydrolysis rate than the NoRC-5 ISWI chromatin remodeling complex (PubMed:28801535). Within the NoRC-5 ISWI chromatin remodeling complex, mediates silencing of a fraction of rDNA by recruiting histone-modifying enzymes and DNA methyltransferases, leading to heterochromatin formation and transcriptional silencing (By similarity). In the complex, it plays a central role by being recruited to rDNA and by targeting chromatin modifying enzymes such as HDAC1, leading to repress RNA polymerase I transcription (By similarity). Recruited to rDNA via its interaction with TTF1 and its ability to recognize and bind histone H4 acetylated on 'Lys-16' (H4K16ac), leading to deacetylation of H4K5ac, H4K8ac, H4K12ac but not H4K16ac (By similarity). Specifically binds pRNAs, 150-250 nucleotide RNAs that are complementary in sequence to the rDNA promoter; pRNA-binding is required for heterochromatin formation and rDNA silencing (By similarity). {ECO:0000250|UniProtKB:Q91YE5, ECO:0000269|PubMed:28801535}. |
Q9UKX2 | MYH2 | S670 | ochoa | Myosin-2 (Myosin heavy chain 2) (Myosin heavy chain 2a) (MyHC-2a) (Myosin heavy chain IIa) (MyHC-IIa) (Myosin heavy chain, skeletal muscle, adult 2) | Myosins are actin-based motor molecules with ATPase activity essential for muscle contraction. {ECO:0000250|UniProtKB:P12883}. |
Q9UKX3 | MYH13 | S668 | ochoa | Myosin-13 (Myosin heavy chain 13) (Myosin heavy chain, skeletal muscle, extraocular) (MyHC-EO) (Myosin heavy chain, skeletal muscle, laryngeal) (MyHC-IIL) (Superfast myosin) | Fast twitching myosin mediating the high-velocity and low-tension contractions of specific striated muscles. {ECO:0000269|PubMed:23908353}. |
Q9ULD9 | ZNF608 | S440 | ochoa | Zinc finger protein 608 (Renal carcinoma antigen NY-REN-36) | Transcription factor, which represses ZNF609 transcription. {ECO:0000250|UniProtKB:Q56A10}. |
Q9ULJ8 | PPP1R9A | S460 | psp | Neurabin-1 (Neurabin-I) (Neural tissue-specific F-actin-binding protein I) (Protein phosphatase 1 regulatory subunit 9A) | Binds to actin filaments (F-actin) and shows cross-linking activity. Binds along the sides of the F-actin. May be involved in neurite formation. Inhibits protein phosphatase 1-alpha activity (By similarity). {ECO:0000250}. |
Q9Y289 | SLC5A6 | S585 | ochoa | Sodium-dependent multivitamin transporter (Na(+)-dependent multivitamin transporter) (hSMVT) (Solute carrier family 5 member 6) | Sodium-dependent multivitamin transporter that mediates the electrogenic transport of pantothenate, biotin, lipoate and iodide (PubMed:10329687, PubMed:15561972, PubMed:19211916, PubMed:20980265, PubMed:21570947, PubMed:22015582, PubMed:25809983, PubMed:25971966, PubMed:27904971, PubMed:28052864, PubMed:31754459). Functions as a Na(+)-coupled substrate symporter where the stoichiometry of Na(+):substrate is 2:1, creating an electrochemical Na(+) gradient used as driving force for substrate uptake (PubMed:10329687, PubMed:20980265). Required for biotin and pantothenate uptake in the intestine across the brush border membrane (PubMed:19211916). Plays a role in the maintenance of intestinal mucosa integrity, by providing the gut mucosa with biotin (By similarity). Contributes to the luminal uptake of biotin and pantothenate into the brain across the blood-brain barrier (PubMed:25809983). {ECO:0000250|UniProtKB:Q5U4D8, ECO:0000269|PubMed:10329687, ECO:0000269|PubMed:15561972, ECO:0000269|PubMed:19211916, ECO:0000269|PubMed:20980265, ECO:0000269|PubMed:21570947, ECO:0000269|PubMed:22015582, ECO:0000269|PubMed:25809983, ECO:0000269|PubMed:25971966, ECO:0000269|PubMed:27904971, ECO:0000269|PubMed:28052864, ECO:0000269|PubMed:31754459}. |
Q9Y2X9 | ZNF281 | S198 | ochoa | Zinc finger protein 281 (GC-box-binding zinc finger protein 1) (Transcription factor ZBP-99) (Zinc finger DNA-binding protein 99) | Transcription repressor that plays a role in regulation of embryonic stem cells (ESCs) differentiation. Required for ESCs differentiation and acts by mediating autorepression of NANOG in ESCs: binds to the NANOG promoter and promotes association of NANOG protein to its own promoter and recruits the NuRD complex, which deacetylates histones. Not required for establishement and maintenance of ESCs (By similarity). Represses the transcription of a number of genes including GAST, ODC1 and VIM. Binds to the G-rich box in the enhancer region of these genes. {ECO:0000250, ECO:0000269|PubMed:10448078, ECO:0000269|PubMed:12771217}. |
Q9Y4G8 | RAPGEF2 | S933 | ochoa | Rap guanine nucleotide exchange factor 2 (Cyclic nucleotide ras GEF) (CNrasGEF) (Neural RAP guanine nucleotide exchange protein) (nRap GEP) (PDZ domain-containing guanine nucleotide exchange factor 1) (PDZ-GEF1) (RA-GEF-1) (Ras/Rap1-associating GEF-1) | Functions as a guanine nucleotide exchange factor (GEF), which activates Rap and Ras family of small GTPases by exchanging bound GDP for free GTP in a cAMP-dependent manner. Serves as a link between cell surface receptors and Rap/Ras GTPases in intracellular signaling cascades. Also acts as an effector for Rap1 by direct association with Rap1-GTP thereby leading to the amplification of Rap1-mediated signaling. Shows weak activity on HRAS. It is controversial whether RAPGEF2 binds cAMP and cGMP (PubMed:23800469, PubMed:10801446) or not (PubMed:10548487, PubMed:10608844, PubMed:11359771). Its binding to ligand-activated beta-1 adrenergic receptor ADRB1 leads to the Ras activation through the G(s)-alpha signaling pathway. Involved in the cAMP-induced Ras and Erk1/2 signaling pathway that leads to sustained inhibition of long term melanogenesis by reducing dendrite extension and melanin synthesis. Also provides inhibitory signals for cell proliferation of melanoma cells and promotes their apoptosis in a cAMP-independent nanner. Regulates cAMP-induced neuritogenesis by mediating the Rap1/B-Raf/ERK signaling through a pathway that is independent on both PKA and RAPGEF3/RAPGEF4. Involved in neuron migration and in the formation of the major forebrain fiber connections forming the corpus callosum, the anterior commissure and the hippocampal commissure during brain development. Involved in neuronal growth factor (NGF)-induced sustained activation of Rap1 at late endosomes and in brain-derived neurotrophic factor (BDNF)-induced axon outgrowth of hippocampal neurons. Plays a role in the regulation of embryonic blood vessel formation and in the establishment of basal junction integrity and endothelial barrier function. May be involved in the regulation of the vascular endothelial growth factor receptor KDR and cadherin CDH5 expression at allantois endothelial cell-cell junctions. {ECO:0000269|PubMed:10548487, ECO:0000269|PubMed:10608844, ECO:0000269|PubMed:10608883, ECO:0000269|PubMed:10801446, ECO:0000269|PubMed:10934204, ECO:0000269|PubMed:11359771, ECO:0000269|PubMed:12391161, ECO:0000269|PubMed:16272156, ECO:0000269|PubMed:17724123, ECO:0000269|PubMed:21840392, ECO:0000269|PubMed:23800469}. |
Q9Y4W6 | AFG3L2 | S53 | ochoa | Mitochondrial inner membrane m-AAA protease component AFG3L2 (EC 3.4.24.-) (EC 3.6.-.-) (AFG3-like protein 2) (Paraplegin-like protein) | Catalytic component of the m-AAA protease, a protease that plays a key role in proteostasis of inner mitochondrial membrane proteins, and which is essential for axonal and neuron development (PubMed:19748354, PubMed:28396416, PubMed:29932645, PubMed:30683687, PubMed:31327635, PubMed:37917749, PubMed:38157846). AFG3L2 possesses both ATPase and protease activities: the ATPase activity is required to unfold substrates, threading them into the internal proteolytic cavity for hydrolysis into small peptide fragments (PubMed:19748354, PubMed:31327635). The m-AAA protease carries out quality control in the inner membrane of the mitochondria by mediating degradation of mistranslated or misfolded polypeptides (PubMed:26504172, PubMed:30683687, PubMed:34718584). The m-AAA protease complex also promotes the processing and maturation of mitochondrial proteins, such as MRPL32/bL32m, PINK1 and SP7 (PubMed:22354088, PubMed:29932645, PubMed:30252181). Mediates protein maturation of the mitochondrial ribosomal subunit MRPL32/bL32m by catalyzing the cleavage of the presequence of MRPL32/bL32m prior to assembly into the mitochondrial ribosome (PubMed:29932645). Required for SPG7 maturation into its active mature form after SPG7 cleavage by mitochondrial-processing peptidase (MPP) (PubMed:30252181). Required for the maturation of PINK1 into its 52kDa mature form after its cleavage by mitochondrial-processing peptidase (MPP) (PubMed:22354088). Acts as a regulator of calcium in neurons by mediating degradation of SMDT1/EMRE before its assembly with the uniporter complex, limiting the availability of SMDT1/EMRE for MCU assembly and promoting efficient assembly of gatekeeper subunits with MCU (PubMed:27642048, PubMed:28396416). Promotes the proteolytic degradation of GHITM upon hyperpolarization of mitochondria: progressive GHITM degradation leads to respiratory complex I degradation and broad reshaping of the mitochondrial proteome by AFG3L2 (PubMed:35912435). Also acts as a regulator of mitochondrial glutathione homeostasis by mediating cleavage and degradation of SLC25A39 (PubMed:37917749, PubMed:38157846). SLC25A39 cleavage is prevented when SLC25A39 binds iron-sulfur (PubMed:37917749, PubMed:38157846). Involved in the regulation of OMA1-dependent processing of OPA1 (PubMed:17615298, PubMed:29545505, PubMed:30252181, PubMed:30683687, PubMed:32600459). May act by mediating processing of OMA1 precursor, participating in OMA1 maturation (PubMed:29545505). {ECO:0000269|PubMed:17615298, ECO:0000269|PubMed:19748354, ECO:0000269|PubMed:22354088, ECO:0000269|PubMed:26504172, ECO:0000269|PubMed:27642048, ECO:0000269|PubMed:28396416, ECO:0000269|PubMed:29545505, ECO:0000269|PubMed:29932645, ECO:0000269|PubMed:30252181, ECO:0000269|PubMed:30683687, ECO:0000269|PubMed:31327635, ECO:0000269|PubMed:32600459, ECO:0000269|PubMed:34718584, ECO:0000269|PubMed:35912435, ECO:0000269|PubMed:37917749, ECO:0000269|PubMed:38157846}. |
Q9Y623 | MYH4 | S668 | ochoa | Myosin-4 (Myosin heavy chain 2b) (MyHC-2b) (Myosin heavy chain 4) (Myosin heavy chain IIb) (MyHC-IIb) (Myosin heavy chain, skeletal muscle, fetal) | Muscle contraction. |
Q9NYB9 | ABI2 | S22 | Sugiyama | Abl interactor 2 (Abelson interactor 2) (Abi-2) (Abl-binding protein 3) (AblBP3) (Arg-binding protein 1) (ArgBP1) | Regulator of actin cytoskeleton dynamics underlying cell motility and adhesion. Functions as a component of the WAVE complex, which activates actin nucleating machinery Arp2/3 to drive lamellipodia formation (PubMed:21107423). Acts as a regulator and substrate of nonreceptor tyrosine kinases ABL1 and ABL2 involved in processes linked to cell growth and differentiation. Positively regulates ABL1-mediated phosphorylation of ENAH, which is required for proper polymerization of nucleated actin filaments at the leading edge (PubMed:10498863, PubMed:7590236, PubMed:8649853). Contributes to the regulation of actin assembly at the tips of neuron projections. In particular, controls dendritic spine morphogenesis and may promote dendritic spine specification toward large mushroom-type spines known as repositories of memory in the brain (By similarity). In hippocampal neurons, may mediate actin-dependent BDNF-NTRK2 early endocytic trafficking that triggers dendrite outgrowth (By similarity). Participates in ocular lens morphogenesis, likely by regulating lamellipodia-driven adherens junction formation at the epithelial cell-secondary lens fiber interface (By similarity). Also required for nascent adherens junction assembly in epithelial cells (PubMed:15572692). {ECO:0000250|UniProtKB:P62484, ECO:0000269|PubMed:10498863, ECO:0000269|PubMed:15572692, ECO:0000269|PubMed:21107423, ECO:0000269|PubMed:7590236, ECO:0000269|PubMed:8649853}. |
P30626 | SRI | S111 | Sugiyama | Sorcin (22 kDa protein) (CP-22) (CP22) (V19) | Calcium-binding protein that modulates excitation-contraction coupling in the heart. Contributes to calcium homeostasis in the heart sarcoplasmic reticulum. Modulates the activity of RYR2 calcium channels. {ECO:0000269|PubMed:17699613}. |
P04629 | NTRK1 | S732 | Sugiyama | High affinity nerve growth factor receptor (EC 2.7.10.1) (Neurotrophic tyrosine kinase receptor type 1) (TRK1-transforming tyrosine kinase protein) (Tropomyosin-related kinase A) (Tyrosine kinase receptor) (Tyrosine kinase receptor A) (Trk-A) (gp140trk) (p140-TrkA) | Receptor tyrosine kinase involved in the development and the maturation of the central and peripheral nervous systems through regulation of proliferation, differentiation and survival of sympathetic and nervous neurons. High affinity receptor for NGF which is its primary ligand (PubMed:1281417, PubMed:15488758, PubMed:17196528, PubMed:1849459, PubMed:1850821, PubMed:22649032, PubMed:27445338, PubMed:8325889). Can also bind and be activated by NTF3/neurotrophin-3. However, NTF3 only supports axonal extension through NTRK1 but has no effect on neuron survival (By similarity). Upon dimeric NGF ligand-binding, undergoes homodimerization, autophosphorylation and activation (PubMed:1281417). Recruits, phosphorylates and/or activates several downstream effectors including SHC1, FRS2, SH2B1, SH2B2 and PLCG1 that regulate distinct overlapping signaling cascades driving cell survival and differentiation. Through SHC1 and FRS2 activates a GRB2-Ras-MAPK cascade that regulates cell differentiation and survival. Through PLCG1 controls NF-Kappa-B activation and the transcription of genes involved in cell survival. Through SHC1 and SH2B1 controls a Ras-PI3 kinase-AKT1 signaling cascade that is also regulating survival. In absence of ligand and activation, may promote cell death, making the survival of neurons dependent on trophic factors. {ECO:0000250|UniProtKB:P35739, ECO:0000250|UniProtKB:Q3UFB7, ECO:0000269|PubMed:11244088, ECO:0000269|PubMed:1281417, ECO:0000269|PubMed:15488758, ECO:0000269|PubMed:17196528, ECO:0000269|PubMed:1849459, ECO:0000269|PubMed:1850821, ECO:0000269|PubMed:22649032, ECO:0000269|PubMed:27445338, ECO:0000269|PubMed:27676246, ECO:0000269|PubMed:8155326, ECO:0000269|PubMed:8325889}.; FUNCTION: [Isoform TrkA-III]: Resistant to NGF, it constitutively activates AKT1 and NF-kappa-B and is unable to activate the Ras-MAPK signaling cascade. Antagonizes the anti-proliferative NGF-NTRK1 signaling that promotes neuronal precursors differentiation. Isoform TrkA-III promotes angiogenesis and has oncogenic activity when overexpressed. {ECO:0000269|PubMed:15488758}. |
Q8IZP0 | ABI1 | S22 | Sugiyama | Abl interactor 1 (Abelson interactor 1) (Abi-1) (Abl-binding protein 4) (AblBP4) (Eps8 SH3 domain-binding protein) (Eps8-binding protein) (Nap1-binding protein) (Nap1BP) (Spectrin SH3 domain-binding protein 1) (e3B1) | May act in negative regulation of cell growth and transformation by interacting with nonreceptor tyrosine kinases ABL1 and/or ABL2. May play a role in regulation of EGF-induced Erk pathway activation. Involved in cytoskeletal reorganization and EGFR signaling. Together with EPS8 participates in transduction of signals from Ras to Rac. In vitro, a trimeric complex of ABI1, EPS8 and SOS1 exhibits Rac specific guanine nucleotide exchange factor (GEF) activity and ABI1 seems to act as an adapter in the complex. Regulates ABL1/c-Abl-mediated phosphorylation of ENAH. Recruits WASF1 to lamellipodia and there seems to regulate WASF1 protein level. In brain, seems to regulate the dendritic outgrowth and branching as well as to determine the shape and number of synaptic contacts of developing neurons. {ECO:0000269|PubMed:11003655, ECO:0000269|PubMed:18328268}. |
Q9UHX1 | PUF60 | S232 | Sugiyama | Poly(U)-binding-splicing factor PUF60 (60 kDa poly(U)-binding-splicing factor) (FUSE-binding protein-interacting repressor) (FBP-interacting repressor) (Ro-binding protein 1) (RoBP1) (Siah-binding protein 1) (Siah-BP1) | DNA- and RNA-binding protein, involved in several nuclear processes such as pre-mRNA splicing, apoptosis and transcription regulation. In association with FUBP1 regulates MYC transcription at the P2 promoter through the core-TFIIH basal transcription factor. Acts as a transcriptional repressor through the core-TFIIH basal transcription factor. Represses FUBP1-induced transcriptional activation but not basal transcription. Decreases ERCC3 helicase activity. Does not repress TFIIH-mediated transcription in xeroderma pigmentosum complementation group B (XPB) cells. Is also involved in pre-mRNA splicing. Promotes splicing of an intron with weak 3'-splice site and pyrimidine tract in a cooperative manner with U2AF2. Involved in apoptosis induction when overexpressed in HeLa cells. Isoform 6 failed to repress MYC transcription and inhibited FIR-induced apoptosis in colorectal cancer. Isoform 6 may contribute to tumor progression by enabling increased MYC expression and greater resistance to apoptosis in tumors than in normal cells. Modulates alternative splicing of several mRNAs. Binds to relaxed DNA of active promoter regions. Binds to the pyrimidine tract and 3'-splice site regions of pre-mRNA; binding is enhanced in presence of U2AF2. Binds to Y5 RNA in association with RO60. Binds to poly(U) RNA. {ECO:0000269|PubMed:10606266, ECO:0000269|PubMed:10882074, ECO:0000269|PubMed:11239393, ECO:0000269|PubMed:16452196, ECO:0000269|PubMed:16628215, ECO:0000269|PubMed:17579712}. |
O14974 | PPP1R12A | S187 | Sugiyama | Protein phosphatase 1 regulatory subunit 12A (Myosin phosphatase-targeting subunit 1) (Myosin phosphatase target subunit 1) (Protein phosphatase myosin-binding subunit) | Key regulator of protein phosphatase 1C (PPP1C). Mediates binding to myosin. As part of the PPP1C complex, involved in dephosphorylation of PLK1. Capable of inhibiting HIF1AN-dependent suppression of HIF1A activity. {ECO:0000269|PubMed:18477460, ECO:0000269|PubMed:19245366, ECO:0000269|PubMed:20354225}. |
P31327 | CPS1 | S819 | Sugiyama | Carbamoyl-phosphate synthase [ammonia], mitochondrial (EC 6.3.4.16) (Carbamoyl-phosphate synthetase I) (CPSase I) | Involved in the urea cycle of ureotelic animals where the enzyme plays an important role in removing excess ammonia from the cell. |
Q14697 | GANAB | S190 | Sugiyama | Neutral alpha-glucosidase AB (EC 3.2.1.207) (Alpha-glucosidase 2) (Glucosidase II subunit alpha) | Catalytic subunit of glucosidase II that cleaves sequentially the 2 innermost alpha-1,3-linked glucose residues from the Glc(2)Man(9)GlcNAc(2) oligosaccharide precursor of immature glycoproteins (PubMed:10929008). Required for PKD1/Polycystin-1 and PKD2/Polycystin-2 maturation and localization to the cell surface and cilia (PubMed:27259053). {ECO:0000269|PubMed:10929008, ECO:0000269|PubMed:27259053}. |
Q9UBS4 | DNAJB11 | Y222 | Sugiyama | DnaJ homolog subfamily B member 11 (APOBEC1-binding protein 2) (ABBP-2) (DnaJ protein homolog 9) (ER-associated DNAJ) (ER-associated Hsp40 co-chaperone) (Endoplasmic reticulum DNA J domain-containing protein 3) (ER-resident protein ERdj3) (ERdj3) (ERj3p) (HEDJ) (Human DnaJ protein 9) (hDj-9) (PWP1-interacting protein 4) | As a co-chaperone for HSPA5 it is required for proper folding, trafficking or degradation of proteins (PubMed:10827079, PubMed:15525676, PubMed:29706351). Binds directly to both unfolded proteins that are substrates for ERAD and nascent unfolded peptide chains, but dissociates from the HSPA5-unfolded protein complex before folding is completed (PubMed:15525676). May help recruiting HSPA5 and other chaperones to the substrate. Stimulates HSPA5 ATPase activity (PubMed:10827079). It is necessary for maturation and correct trafficking of PKD1 (PubMed:29706351). {ECO:0000269|PubMed:10827079, ECO:0000269|PubMed:15525676, ECO:0000269|PubMed:29706351}. |
P31327 | CPS1 | S808 | Sugiyama | Carbamoyl-phosphate synthase [ammonia], mitochondrial (EC 6.3.4.16) (Carbamoyl-phosphate synthetase I) (CPSase I) | Involved in the urea cycle of ureotelic animals where the enzyme plays an important role in removing excess ammonia from the cell. |
P16234 | PDGFRA | S984 | Sugiyama | Platelet-derived growth factor receptor alpha (PDGF-R-alpha) (PDGFR-alpha) (EC 2.7.10.1) (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor) (CD140 antigen-like family member A) (CD140a antigen) (Platelet-derived growth factor alpha receptor) (Platelet-derived growth factor receptor 2) (PDGFR-2) (CD antigen CD140a) | Tyrosine-protein kinase that acts as a cell-surface receptor for PDGFA, PDGFB and PDGFC and plays an essential role in the regulation of embryonic development, cell proliferation, survival and chemotaxis. Depending on the context, promotes or inhibits cell proliferation and cell migration. Plays an important role in the differentiation of bone marrow-derived mesenchymal stem cells. Required for normal skeleton development and cephalic closure during embryonic development. Required for normal development of the mucosa lining the gastrointestinal tract, and for recruitment of mesenchymal cells and normal development of intestinal villi. Plays a role in cell migration and chemotaxis in wound healing. Plays a role in platelet activation, secretion of agonists from platelet granules, and in thrombin-induced platelet aggregation. Binding of its cognate ligands - homodimeric PDGFA, homodimeric PDGFB, heterodimers formed by PDGFA and PDGFB or homodimeric PDGFC -leads to the activation of several signaling cascades; the response depends on the nature of the bound ligand and is modulated by the formation of heterodimers between PDGFRA and PDGFRB. Phosphorylates PIK3R1, PLCG1, and PTPN11. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate, mobilization of cytosolic Ca(2+) and the activation of protein kinase C. Phosphorylates PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase, and thereby mediates activation of the AKT1 signaling pathway. Mediates activation of HRAS and of the MAP kinases MAPK1/ERK2 and/or MAPK3/ERK1. Promotes activation of STAT family members STAT1, STAT3 and STAT5A and/or STAT5B. Receptor signaling is down-regulated by protein phosphatases that dephosphorylate the receptor and its down-stream effectors, and by rapid internalization of the activated receptor. {ECO:0000269|PubMed:10734113, ECO:0000269|PubMed:10947961, ECO:0000269|PubMed:11297552, ECO:0000269|PubMed:12522257, ECO:0000269|PubMed:1646396, ECO:0000269|PubMed:17087943, ECO:0000269|PubMed:1709159, ECO:0000269|PubMed:17141222, ECO:0000269|PubMed:20972453, ECO:0000269|PubMed:21224473, ECO:0000269|PubMed:21596750, ECO:0000269|PubMed:2554309, ECO:0000269|PubMed:8188664, ECO:0000269|PubMed:8760137, ECO:0000269|PubMed:8943348}. |
P43405 | SYK | S54 | Sugiyama | Tyrosine-protein kinase SYK (EC 2.7.10.2) (Spleen tyrosine kinase) (p72-Syk) | Non-receptor tyrosine kinase which mediates signal transduction downstream of a variety of transmembrane receptors including classical immunoreceptors like the B-cell receptor (BCR). Regulates several biological processes including innate and adaptive immunity, cell adhesion, osteoclast maturation, platelet activation and vascular development (PubMed:12387735, PubMed:33782605). Assembles into signaling complexes with activated receptors at the plasma membrane via interaction between its SH2 domains and the receptor tyrosine-phosphorylated ITAM domains. The association with the receptor can also be indirect and mediated by adapter proteins containing ITAM or partial hemITAM domains. The phosphorylation of the ITAM domains is generally mediated by SRC subfamily kinases upon engagement of the receptor. More rarely signal transduction via SYK could be ITAM-independent. Direct downstream effectors phosphorylated by SYK include DEPTOR, VAV1, PLCG1, PI-3-kinase, LCP2 and BLNK (PubMed:12456653, PubMed:15388330, PubMed:34634301, PubMed:8657103). Initially identified as essential in B-cell receptor (BCR) signaling, it is necessary for the maturation of B-cells most probably at the pro-B to pre-B transition (PubMed:12456653). Activated upon BCR engagement, it phosphorylates and activates BLNK an adapter linking the activated BCR to downstream signaling adapters and effectors. It also phosphorylates and activates PLCG1 and the PKC signaling pathway. It also phosphorylates BTK and regulates its activity in B-cell antigen receptor (BCR)-coupled signaling. In addition to its function downstream of BCR also plays a role in T-cell receptor signaling. Also plays a crucial role in the innate immune response to fungal, bacterial and viral pathogens. It is for instance activated by the membrane lectin CLEC7A. Upon stimulation by fungal proteins, CLEC7A together with SYK activates immune cells inducing the production of ROS. Also activates the inflammasome and NF-kappa-B-mediated transcription of chemokines and cytokines in presence of pathogens. Regulates neutrophil degranulation and phagocytosis through activation of the MAPK signaling cascade (By similarity). Required for the stimulation of neutrophil phagocytosis by IL15 (PubMed:15123770). Also mediates the activation of dendritic cells by cell necrosis stimuli. Also involved in mast cells activation. Involved in interleukin-3/IL3-mediated signaling pathway in basophils (By similarity). Also functions downstream of receptors mediating cell adhesion (PubMed:12387735). Relays for instance, integrin-mediated neutrophils and macrophages activation and P-selectin receptor/SELPG-mediated recruitment of leukocytes to inflammatory loci. Also plays a role in non-immune processes. It is for instance involved in vascular development where it may regulate blood and lymphatic vascular separation. It is also required for osteoclast development and function. Functions in the activation of platelets by collagen, mediating PLCG2 phosphorylation and activation. May be coupled to the collagen receptor by the ITAM domain-containing FCER1G. Also activated by the membrane lectin CLEC1B that is required for activation of platelets by PDPN/podoplanin. Involved in platelet adhesion being activated by ITGB3 engaged by fibrinogen. Together with CEACAM20, enhances production of the cytokine CXCL8/IL-8 via the NFKB pathway and may thus have a role in the intestinal immune response (By similarity). {ECO:0000250|UniProtKB:P48025, ECO:0000269|PubMed:12387735, ECO:0000269|PubMed:12456653, ECO:0000269|PubMed:15123770, ECO:0000269|PubMed:15388330, ECO:0000269|PubMed:19909739, ECO:0000269|PubMed:33782605, ECO:0000269|PubMed:34634301, ECO:0000269|PubMed:8657103, ECO:0000269|PubMed:9535867}. |
P20020 | ATP2B1 | S52 | Sugiyama | Plasma membrane calcium-transporting ATPase 1 (EC 7.2.2.10) (Plasma membrane calcium ATPase isoform 1) (PMCA1) (Plasma membrane calcium pump isoform 1) | Catalyzes the hydrolysis of ATP coupled with the transport of calcium from the cytoplasm to the extracellular space thereby maintaining intracellular calcium homeostasis (PubMed:35358416). Plays a role in blood pressure regulation through regulation of intracellular calcium concentration and nitric oxide production leading to regulation of vascular smooth muscle cells vasoconstriction. Positively regulates bone mineralization through absorption of calcium from the intestine. Plays dual roles in osteoclast differentiation and survival by regulating RANKL-induced calcium oscillations in preosteoclasts and mediating calcium extrusion in mature osteoclasts (By similarity). Regulates insulin sensitivity through calcium/calmodulin signaling pathway by regulating AKT1 activation and NOS3 activation in endothelial cells (PubMed:29104511). May play a role in synaptic transmission by modulating calcium and proton dynamics at the synaptic vesicles. {ECO:0000250|UniProtKB:G5E829, ECO:0000269|PubMed:29104511, ECO:0000269|PubMed:35358416}. |
Q14432 | PDE3A | S273 | Sugiyama | cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A (EC 3.1.4.17) (Cyclic GMP-inhibited phosphodiesterase A) (CGI-PDE A) (cGMP-inhibited cAMP phosphodiesterase) (cGI-PDE) | Cyclic nucleotide phosphodiesterase with specificity for the second messengers cAMP and cGMP, which are key regulators of many important physiological processes (PubMed:1315035, PubMed:25961942, PubMed:8155697, PubMed:8695850). Also has activity toward cUMP (PubMed:27975297). Independently of its catalytic activity it is part of an E2/17beta-estradiol-induced pro-apoptotic signaling pathway. E2 stabilizes the PDE3A/SLFN12 complex in the cytosol, promoting the dephosphorylation of SLFN12 and activating its pro-apoptotic ribosomal RNA/rRNA ribonuclease activity. This apoptotic pathway might be relevant in tissues with high concentration of E2 and be for instance involved in placenta remodeling (PubMed:31420216, PubMed:34707099). {ECO:0000269|PubMed:1315035, ECO:0000269|PubMed:25961942, ECO:0000269|PubMed:27975297, ECO:0000269|PubMed:31420216, ECO:0000269|PubMed:34707099, ECO:0000269|PubMed:8155697, ECO:0000269|PubMed:8695850}. |
Q12802 | AKAP13 | S1294 | Sugiyama | A-kinase anchor protein 13 (AKAP-13) (AKAP-Lbc) (Breast cancer nuclear receptor-binding auxiliary protein) (Guanine nucleotide exchange factor Lbc) (Human thyroid-anchoring protein 31) (Lymphoid blast crisis oncogene) (LBC oncogene) (Non-oncogenic Rho GTPase-specific GTP exchange factor) (Protein kinase A-anchoring protein 13) (PRKA13) (p47) | Scaffold protein that plays an important role in assembling signaling complexes downstream of several types of G protein-coupled receptors. Activates RHOA in response to signaling via G protein-coupled receptors via its function as Rho guanine nucleotide exchange factor (PubMed:11546812, PubMed:15229649, PubMed:23090968, PubMed:24993829, PubMed:25186459). May also activate other Rho family members (PubMed:11546812). Part of a kinase signaling complex that links ADRA1A and ADRA1B adrenergic receptor signaling to the activation of downstream p38 MAP kinases, such as MAPK11 and MAPK14 (PubMed:17537920, PubMed:21224381, PubMed:23716597). Part of a signaling complex that links ADRA1B signaling to the activation of RHOA and IKBKB/IKKB, leading to increased NF-kappa-B transcriptional activity (PubMed:23090968). Part of a RHOA-dependent signaling cascade that mediates responses to lysophosphatidic acid (LPA), a signaling molecule that activates G-protein coupled receptors and potentiates transcriptional activation of the glucocorticoid receptor NR3C1 (PubMed:16469733). Part of a signaling cascade that stimulates MEF2C-dependent gene expression in response to lysophosphatidic acid (LPA) (By similarity). Part of a signaling pathway that activates MAPK11 and/or MAPK14 and leads to increased transcription activation of the estrogen receptors ESR1 and ESR2 (PubMed:11579095, PubMed:9627117). Part of a signaling cascade that links cAMP and EGFR signaling to BRAF signaling and to PKA-mediated phosphorylation of KSR1, leading to the activation of downstream MAP kinases, such as MAPK1 or MAPK3 (PubMed:21102438). Functions as a scaffold protein that anchors cAMP-dependent protein kinase (PKA) and PRKD1. This promotes activation of PRKD1, leading to increased phosphorylation of HDAC5 and ultimately cardiomyocyte hypertrophy (By similarity). Has no guanine nucleotide exchange activity on CDC42, Ras or Rac (PubMed:11546812). Required for normal embryonic heart development, and in particular for normal sarcomere formation in the developing cardiomyocytes (By similarity). Plays a role in cardiomyocyte growth and cardiac hypertrophy in response to activation of the beta-adrenergic receptor by phenylephrine or isoproterenol (PubMed:17537920, PubMed:23090968). Required for normal adaptive cardiac hypertrophy in response to pressure overload (PubMed:23716597). Plays a role in osteogenesis (By similarity). {ECO:0000250|UniProtKB:E9Q394, ECO:0000269|PubMed:11546812, ECO:0000269|PubMed:11579095, ECO:0000269|PubMed:17537920, ECO:0000269|PubMed:21224381, ECO:0000269|PubMed:23716597, ECO:0000269|PubMed:24993829, ECO:0000269|PubMed:25186459, ECO:0000269|PubMed:9627117, ECO:0000269|PubMed:9891067}. |
Q14164 | IKBKE | S603 | Sugiyama | Inhibitor of nuclear factor kappa-B kinase subunit epsilon (I-kappa-B kinase epsilon) (IKK-E) (IKK-epsilon) (IkBKE) (EC 2.7.11.10) (Inducible I kappa-B kinase) (IKK-i) | Serine/threonine kinase that plays an essential role in regulating inflammatory responses to viral infection, through the activation of the type I IFN, NF-kappa-B and STAT signaling. Also involved in TNFA and inflammatory cytokines, like Interleukin-1, signaling. Following activation of viral RNA sensors, such as RIG-I-like receptors, associates with DDX3X and phosphorylates interferon regulatory factors (IRFs), IRF3 and IRF7, as well as DDX3X. This activity allows subsequent homodimerization and nuclear translocation of the IRF3 leading to transcriptional activation of pro-inflammatory and antiviral genes including IFNB. In order to establish such an antiviral state, IKBKE forms several different complexes whose composition depends on the type of cell and cellular stimuli. Thus, several scaffolding molecules including IPS1/MAVS, TANK, AZI2/NAP1 or TBKBP1/SINTBAD can be recruited to the IKBKE-containing-complexes. Activated by polyubiquitination in response to TNFA and interleukin-1, regulates the NF-kappa-B signaling pathway through, at least, the phosphorylation of CYLD. Phosphorylates inhibitors of NF-kappa-B thus leading to the dissociation of the inhibitor/NF-kappa-B complex and ultimately the degradation of the inhibitor. In addition, is also required for the induction of a subset of ISGs which displays antiviral activity, may be through the phosphorylation of STAT1 at 'Ser-708'. Phosphorylation of STAT1 at 'Ser-708' also seems to promote the assembly and DNA binding of ISGF3 (STAT1:STAT2:IRF9) complexes compared to GAF (STAT1:STAT1) complexes, in this way regulating the balance between type I and type II IFN responses. Protects cells against DNA damage-induced cell death. Also plays an important role in energy balance regulation by sustaining a state of chronic, low-grade inflammation in obesity, wich leads to a negative impact on insulin sensitivity. Phosphorylates AKT1. {ECO:0000269|PubMed:17568778, ECO:0000269|PubMed:18583960, ECO:0000269|PubMed:19153231, ECO:0000269|PubMed:20188669, ECO:0000269|PubMed:21138416, ECO:0000269|PubMed:21464307, ECO:0000269|PubMed:22532683, ECO:0000269|PubMed:23453969, ECO:0000269|PubMed:23478265}. |
Q8WYL5 | SSH1 | S99 | SIGNOR | Protein phosphatase Slingshot homolog 1 (EC 3.1.3.16) (EC 3.1.3.48) (SSH-like protein 1) (SSH-1L) (hSSH-1L) | Protein phosphatase which regulates actin filament dynamics. Dephosphorylates and activates the actin binding/depolymerizing factor cofilin, which subsequently binds to actin filaments and stimulates their disassembly. Inhibitory phosphorylation of cofilin is mediated by LIMK1, which may also be dephosphorylated and inactivated by this protein. {ECO:0000269|PubMed:11832213, ECO:0000269|PubMed:12684437, ECO:0000269|PubMed:12807904, ECO:0000269|PubMed:14531860, ECO:0000269|PubMed:14645219, ECO:0000269|PubMed:15056216, ECO:0000269|PubMed:15159416, ECO:0000269|PubMed:15660133, ECO:0000269|PubMed:15671020, ECO:0000269|PubMed:16230460}. |
P50851 | LRBA | S1725 | Sugiyama | Lipopolysaccharide-responsive and beige-like anchor protein (Beige-like protein) (CDC4-like protein) | Involved in coupling signal transduction and vesicle trafficking to enable polarized secretion and/or membrane deposition of immune effector molecules (By similarity). Involved in phagophore growth during mitophagy by regulating ATG9A trafficking to mitochondria (PubMed:33773106). {ECO:0000250|UniProtKB:Q9ESE1, ECO:0000269|PubMed:33773106}. |
Q06124 | PTPN11 | S28 | Sugiyama | Tyrosine-protein phosphatase non-receptor type 11 (EC 3.1.3.48) (Protein-tyrosine phosphatase 1D) (PTP-1D) (Protein-tyrosine phosphatase 2C) (PTP-2C) (SH-PTP2) (SHP-2) (Shp2) (SH-PTP3) | Acts downstream of various receptor and cytoplasmic protein tyrosine kinases to participate in the signal transduction from the cell surface to the nucleus (PubMed:10655584, PubMed:14739280, PubMed:18559669, PubMed:18829466, PubMed:26742426, PubMed:28074573). Positively regulates MAPK signal transduction pathway (PubMed:28074573). Dephosphorylates GAB1, ARHGAP35 and EGFR (PubMed:28074573). Dephosphorylates ROCK2 at 'Tyr-722' resulting in stimulation of its RhoA binding activity (PubMed:18559669). Dephosphorylates CDC73 (PubMed:26742426). Dephosphorylates SOX9 on tyrosine residues, leading to inactivate SOX9 and promote ossification (By similarity). Dephosphorylates tyrosine-phosphorylated NEDD9/CAS-L (PubMed:19275884). {ECO:0000250|UniProtKB:P35235, ECO:0000269|PubMed:10655584, ECO:0000269|PubMed:14739280, ECO:0000269|PubMed:18559669, ECO:0000269|PubMed:18829466, ECO:0000269|PubMed:19275884, ECO:0000269|PubMed:26742426, ECO:0000269|PubMed:28074573}. |
Q9H093 | NUAK2 | S573 | Sugiyama | NUAK family SNF1-like kinase 2 (EC 2.7.11.1) (Omphalocele kinase 2) (SNF1/AMP kinase-related kinase) (SNARK) | Stress-activated kinase involved in tolerance to glucose starvation. Induces cell-cell detachment by increasing F-actin conversion to G-actin. Expression is induced by CD95 or TNF-alpha, via NF-kappa-B. Protects cells from CD95-mediated apoptosis and is required for the increased motility and invasiveness of CD95-activated tumor cells. Phosphorylates LATS1 and LATS2. Plays a key role in neural tube closure during embryonic development through LATS2 phosphorylation and regulation of the nuclear localization of YAP1 a critical downstream regulatory target in the Hippo signaling pathway (PubMed:32845958). {ECO:0000269|PubMed:14575707, ECO:0000269|PubMed:14976552, ECO:0000269|PubMed:15345718, ECO:0000269|PubMed:19927127, ECO:0000269|PubMed:32845958}. |
O14893 | GEMIN2 | S126 | Sugiyama | Gem-associated protein 2 (Gemin-2) (Component of gems 2) (Survival of motor neuron protein-interacting protein 1) (SMN-interacting protein 1) | The SMN complex catalyzes the assembly of small nuclear ribonucleoproteins (snRNPs), the building blocks of the spliceosome, and thereby plays an important role in the splicing of cellular pre-mRNAs (PubMed:18984161, PubMed:9323129). Most spliceosomal snRNPs contain a common set of Sm proteins SNRPB, SNRPD1, SNRPD2, SNRPD3, SNRPE, SNRPF and SNRPG that assemble in a heptameric protein ring on the Sm site of the small nuclear RNA to form the core snRNP (Sm core) (PubMed:18984161). In the cytosol, the Sm proteins SNRPD1, SNRPD2, SNRPE, SNRPF and SNRPG (5Sm) are trapped in an inactive 6S pICln-Sm complex by the chaperone CLNS1A that controls the assembly of the core snRNP (PubMed:18984161). To assemble core snRNPs, the SMN complex accepts the trapped 5Sm proteins from CLNS1A (PubMed:18984161, PubMed:9323129). Binding of snRNA inside 5Sm ultimately triggers eviction of the SMN complex, thereby allowing binding of SNRPD3 and SNRPB to complete assembly of the core snRNP (PubMed:31799625). Within the SMN complex, GEMIN2 constrains the conformation of 5Sm, thereby promoting 5Sm binding to snRNA containing the snRNP code (a nonameric Sm site and a 3'-adjacent stem-loop), thus preventing progression of assembly until a cognate substrate is bound (PubMed:16314521, PubMed:21816274, PubMed:31799625). {ECO:0000269|PubMed:16314521, ECO:0000269|PubMed:18984161, ECO:0000269|PubMed:21816274, ECO:0000269|PubMed:31799625, ECO:0000269|PubMed:9323129}. |
Download
reactome_id | name | p | -log10_p |
---|---|---|---|
R-HSA-9860927 | Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZ... | 0.000429 | 3.368 |
R-HSA-391160 | Signal regulatory protein family interactions | 0.000470 | 3.328 |
R-HSA-9768919 | NPAS4 regulates expression of target genes | 0.000392 | 3.407 |
R-HSA-9008059 | Interleukin-37 signaling | 0.000240 | 3.619 |
R-HSA-187042 | TRKA activation by NGF | 0.000811 | 3.091 |
R-HSA-512988 | Interleukin-3, Interleukin-5 and GM-CSF signaling | 0.000819 | 3.087 |
R-HSA-9927353 | Co-inhibition by BTLA | 0.001574 | 2.803 |
R-HSA-9634815 | Transcriptional Regulation by NPAS4 | 0.001594 | 2.797 |
R-HSA-9634638 | Estrogen-dependent nuclear events downstream of ESR-membrane signaling | 0.001840 | 2.735 |
R-HSA-187015 | Activation of TRKA receptors | 0.003160 | 2.500 |
R-HSA-9925563 | Developmental Lineage of Pancreatic Ductal Cells | 0.003888 | 2.410 |
R-HSA-9674415 | Drug resistance of PDGFR mutants | 0.008164 | 2.088 |
R-HSA-9674428 | PDGFR mutants bind TKIs | 0.008164 | 2.088 |
R-HSA-9674396 | Imatinib-resistant PDGFR mutants | 0.008164 | 2.088 |
R-HSA-9674403 | Regorafenib-resistant PDGFR mutants | 0.008164 | 2.088 |
R-HSA-9674401 | Sunitinib-resistant PDGFR mutants | 0.008164 | 2.088 |
R-HSA-9674404 | Sorafenib-resistant PDGFR mutants | 0.008164 | 2.088 |
R-HSA-418359 | Reduction of cytosolic Ca++ levels | 0.006923 | 2.160 |
R-HSA-114604 | GPVI-mediated activation cascade | 0.005521 | 2.258 |
R-HSA-210990 | PECAM1 interactions | 0.006063 | 2.217 |
R-HSA-877312 | Regulation of IFNG signaling | 0.007835 | 2.106 |
R-HSA-451927 | Interleukin-2 family signaling | 0.007041 | 2.152 |
R-HSA-9664417 | Leishmania phagocytosis | 0.009830 | 2.007 |
R-HSA-9664407 | Parasite infection | 0.009830 | 2.007 |
R-HSA-9664422 | FCGR3A-mediated phagocytosis | 0.009830 | 2.007 |
R-HSA-2029482 | Regulation of actin dynamics for phagocytic cup formation | 0.010082 | 1.996 |
R-HSA-5357905 | Regulation of TNFR1 signaling | 0.010246 | 1.989 |
R-HSA-5602636 | IKBKB deficiency causes SCID | 0.024294 | 1.615 |
R-HSA-5603027 | IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (E... | 0.024294 | 1.615 |
R-HSA-167021 | PLC-gamma1 signalling | 0.040164 | 1.396 |
R-HSA-198745 | Signalling to STAT3 | 0.040164 | 1.396 |
R-HSA-8865999 | MET activates PTPN11 | 0.040164 | 1.396 |
R-HSA-187024 | NGF-independant TRKA activation | 0.063489 | 1.197 |
R-HSA-187706 | Signalling to p38 via RIT and RIN | 0.063489 | 1.197 |
R-HSA-9645135 | STAT5 Activation | 0.071139 | 1.148 |
R-HSA-177539 | Autointegration results in viral DNA circles | 0.071139 | 1.148 |
R-HSA-170984 | ARMS-mediated activation | 0.093717 | 1.028 |
R-HSA-3656237 | Defective EXT2 causes exostoses 2 | 0.122976 | 0.910 |
R-HSA-3656253 | Defective EXT1 causes exostoses 1, TRPS2 and CHDS | 0.122976 | 0.910 |
R-HSA-177504 | Retrograde neurotrophin signalling | 0.137252 | 0.862 |
R-HSA-9673767 | Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | 0.144303 | 0.841 |
R-HSA-9673770 | Signaling by PDGFRA extracellular domain mutants | 0.144303 | 0.841 |
R-HSA-2173791 | TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | 0.144303 | 0.841 |
R-HSA-354194 | GRB2:SOS provides linkage to MAPK signaling for Integrins | 0.151297 | 0.820 |
R-HSA-3560783 | Defective B4GALT7 causes EDS, progeroid type | 0.158235 | 0.801 |
R-HSA-4420332 | Defective B3GALT6 causes EDSP2 and SEMDJL1 | 0.158235 | 0.801 |
R-HSA-372708 | p130Cas linkage to MAPK signaling for integrins | 0.165116 | 0.782 |
R-HSA-3560801 | Defective B3GAT3 causes JDSSDHD | 0.165116 | 0.782 |
R-HSA-73779 | RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | 0.057411 | 1.241 |
R-HSA-167161 | HIV Transcription Initiation | 0.061753 | 1.209 |
R-HSA-75953 | RNA Polymerase II Transcription Initiation | 0.061753 | 1.209 |
R-HSA-76071 | RNA Polymerase III Transcription Initiation From Type 3 Promoter | 0.205246 | 0.688 |
R-HSA-8874081 | MET activates PTK2 signaling | 0.230929 | 0.637 |
R-HSA-186763 | Downstream signal transduction | 0.037492 | 1.426 |
R-HSA-5620916 | VxPx cargo-targeting to cilium | 0.185426 | 0.732 |
R-HSA-162658 | Golgi Cisternae Pericentriolar Stack Reorganization | 0.130143 | 0.886 |
R-HSA-418885 | DCC mediated attractive signaling | 0.144303 | 0.841 |
R-HSA-9671555 | Signaling by PDGFR in disease | 0.198693 | 0.702 |
R-HSA-76042 | RNA Polymerase II Transcription Initiation And Promoter Clearance | 0.070758 | 1.150 |
R-HSA-198203 | PI3K/AKT activation | 0.101121 | 0.995 |
R-HSA-162592 | Integration of provirus | 0.115750 | 0.936 |
R-HSA-9609523 | Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | 0.185426 | 0.732 |
R-HSA-73776 | RNA Polymerase II Promoter Escape | 0.066204 | 1.179 |
R-HSA-432722 | Golgi Associated Vesicle Biogenesis | 0.089925 | 1.046 |
R-HSA-186797 | Signaling by PDGF | 0.113052 | 0.947 |
R-HSA-167162 | RNA Polymerase II HIV Promoter Escape | 0.061753 | 1.209 |
R-HSA-8949664 | Processing of SMDT1 | 0.130143 | 0.886 |
R-HSA-169893 | Prolonged ERK activation events | 0.011984 | 1.921 |
R-HSA-9705462 | Inactivation of CSF3 (G-CSF) signaling | 0.198693 | 0.702 |
R-HSA-9758274 | Regulation of NF-kappa B signaling | 0.151297 | 0.820 |
R-HSA-202424 | Downstream TCR signaling | 0.195146 | 0.710 |
R-HSA-187687 | Signalling to ERKs | 0.047059 | 1.327 |
R-HSA-9674555 | Signaling by CSF3 (G-CSF) | 0.033903 | 1.470 |
R-HSA-8866376 | Reelin signalling pathway | 0.055777 | 1.254 |
R-HSA-5603029 | IkBA variant leads to EDA-ID | 0.063489 | 1.197 |
R-HSA-209560 | NF-kB is activated and signals survival | 0.115750 | 0.936 |
R-HSA-1810476 | RIP-mediated NFkB activation via ZBP1 | 0.144303 | 0.841 |
R-HSA-9702518 | STAT5 activation downstream of FLT3 ITD mutants | 0.158235 | 0.801 |
R-HSA-350054 | Notch-HLH transcription pathway | 0.205246 | 0.688 |
R-HSA-1169091 | Activation of NF-kappaB in B cells | 0.084999 | 1.071 |
R-HSA-933542 | TRAF6 mediated NF-kB activation | 0.218192 | 0.661 |
R-HSA-2219530 | Constitutive Signaling by Aberrant PI3K in Cancer | 0.210020 | 0.678 |
R-HSA-2029480 | Fcgamma receptor (FCGR) dependent phagocytosis | 0.021928 | 1.659 |
R-HSA-918233 | TRAF3-dependent IRF activation pathway | 0.158235 | 0.801 |
R-HSA-180292 | GAB1 signalosome | 0.171941 | 0.765 |
R-HSA-9694614 | Attachment and Entry | 0.198693 | 0.702 |
R-HSA-5654710 | PI-3K cascade:FGFR3 | 0.178711 | 0.748 |
R-HSA-912631 | Regulation of signaling by CBL | 0.178711 | 0.748 |
R-HSA-5654720 | PI-3K cascade:FGFR4 | 0.185426 | 0.732 |
R-HSA-5654689 | PI-3K cascade:FGFR1 | 0.205246 | 0.688 |
R-HSA-5654695 | PI-3K cascade:FGFR2 | 0.224587 | 0.649 |
R-HSA-354192 | Integrin signaling | 0.041220 | 1.385 |
R-HSA-446388 | Regulation of cytoskeletal remodeling and cell spreading by IPP complex componen... | 0.063489 | 1.197 |
R-HSA-450341 | Activation of the AP-1 family of transcription factors | 0.093717 | 1.028 |
R-HSA-912694 | Regulation of IFNA/IFNB signaling | 0.022514 | 1.648 |
R-HSA-3000170 | Syndecan interactions | 0.211745 | 0.674 |
R-HSA-9690406 | Transcriptional regulation of testis differentiation | 0.158235 | 0.801 |
R-HSA-170968 | Frs2-mediated activation | 0.130143 | 0.886 |
R-HSA-983695 | Antigen activates B Cell Receptor (BCR) leading to generation of second messenge... | 0.053435 | 1.272 |
R-HSA-187037 | Signaling by NTRK1 (TRKA) | 0.113753 | 0.944 |
R-HSA-76009 | Platelet Aggregation (Plug Formation) | 0.070758 | 1.150 |
R-HSA-983705 | Signaling by the B Cell Receptor (BCR) | 0.015411 | 1.812 |
R-HSA-2454202 | Fc epsilon receptor (FCERI) signaling | 0.110568 | 0.956 |
R-HSA-175567 | Integration of viral DNA into host genomic DNA | 0.071139 | 1.148 |
R-HSA-936964 | Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | 0.013143 | 1.881 |
R-HSA-9828211 | Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | 0.086252 | 1.064 |
R-HSA-112411 | MAPK1 (ERK2) activation | 0.093717 | 1.028 |
R-HSA-164843 | 2-LTR circle formation | 0.101121 | 0.995 |
R-HSA-912526 | Interleukin receptor SHC signaling | 0.024024 | 1.619 |
R-HSA-9013973 | TICAM1-dependent activation of IRF3/IRF7 | 0.115750 | 0.936 |
R-HSA-9824878 | Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | 0.115750 | 0.936 |
R-HSA-180689 | APOBEC3G mediated resistance to HIV-1 infection | 0.115750 | 0.936 |
R-HSA-168927 | TICAM1, RIP1-mediated IKK complex recruitment | 0.144303 | 0.841 |
R-HSA-937041 | IKK complex recruitment mediated by RIP1 | 0.178711 | 0.748 |
R-HSA-5357786 | TNFR1-induced proapoptotic signaling | 0.192086 | 0.717 |
R-HSA-5654706 | FRS-mediated FGFR3 signaling | 0.198693 | 0.702 |
R-HSA-5654712 | FRS-mediated FGFR4 signaling | 0.205246 | 0.688 |
R-HSA-9703648 | Signaling by FLT3 ITD and TKD mutants | 0.218192 | 0.661 |
R-HSA-5654693 | FRS-mediated FGFR1 signaling | 0.224587 | 0.649 |
R-HSA-420029 | Tight junction interactions | 0.224587 | 0.649 |
R-HSA-1168372 | Downstream signaling events of B Cell Receptor (BCR) | 0.134736 | 0.871 |
R-HSA-373752 | Netrin-1 signaling | 0.068468 | 1.165 |
R-HSA-446353 | Cell-extracellular matrix interactions | 0.144303 | 0.841 |
R-HSA-167044 | Signalling to RAS | 0.192086 | 0.717 |
R-HSA-8949215 | Mitochondrial calcium ion transport | 0.198693 | 0.702 |
R-HSA-9860931 | Response of endothelial cells to shear stress | 0.015273 | 1.816 |
R-HSA-9028731 | Activated NTRK2 signals through FRS2 and FRS3 | 0.122976 | 0.910 |
R-HSA-177929 | Signaling by EGFR | 0.097466 | 1.011 |
R-HSA-416482 | G alpha (12/13) signalling events | 0.157255 | 0.803 |
R-HSA-168928 | DDX58/IFIH1-mediated induction of interferon-alpha/beta | 0.055959 | 1.252 |
R-HSA-937061 | TRIF (TICAM1)-mediated TLR4 signaling | 0.018527 | 1.732 |
R-HSA-199992 | trans-Golgi Network Vesicle Budding | 0.140295 | 0.853 |
R-HSA-162594 | Early Phase of HIV Life Cycle | 0.192086 | 0.717 |
R-HSA-166166 | MyD88-independent TLR4 cascade | 0.018527 | 1.732 |
R-HSA-167172 | Transcription of the HIV genome | 0.129229 | 0.889 |
R-HSA-168164 | Toll Like Receptor 3 (TLR3) Cascade | 0.072259 | 1.141 |
R-HSA-9706374 | FLT3 signaling through SRC family kinases | 0.048002 | 1.319 |
R-HSA-8941284 | RUNX2 regulates chondrocyte maturation | 0.055777 | 1.254 |
R-HSA-418886 | Netrin mediated repulsion signals | 0.078726 | 1.104 |
R-HSA-390696 | Adrenoceptors | 0.086252 | 1.064 |
R-HSA-425986 | Sodium/Proton exchangers | 0.086252 | 1.064 |
R-HSA-9683686 | Maturation of spike protein | 0.101121 | 0.995 |
R-HSA-110056 | MAPK3 (ERK1) activation | 0.101121 | 0.995 |
R-HSA-425561 | Sodium/Calcium exchangers | 0.115750 | 0.936 |
R-HSA-8951936 | RUNX3 regulates p14-ARF | 0.122976 | 0.910 |
R-HSA-975144 | IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | 0.122976 | 0.910 |
R-HSA-937039 | IRAK1 recruits IKK complex | 0.122976 | 0.910 |
R-HSA-418360 | Platelet calcium homeostasis | 0.033903 | 1.470 |
R-HSA-5684264 | MAP3K8 (TPL2)-dependent MAPK1/3 activation | 0.137252 | 0.862 |
R-HSA-8875360 | InlB-mediated entry of Listeria monocytogenes into host cell | 0.144303 | 0.841 |
R-HSA-432047 | Passive transport by Aquaporins | 0.158235 | 0.801 |
R-HSA-1482801 | Acyl chain remodelling of PS | 0.224587 | 0.649 |
R-HSA-9855142 | Cellular responses to mechanical stimuli | 0.020565 | 1.687 |
R-HSA-166520 | Signaling by NTRKs | 0.048482 | 1.314 |
R-HSA-5578775 | Ion homeostasis | 0.016084 | 1.794 |
R-HSA-193639 | p75NTR signals via NF-kB | 0.144303 | 0.841 |
R-HSA-4420097 | VEGFA-VEGFR2 Pathway | 0.090426 | 1.044 |
R-HSA-432142 | Platelet sensitization by LDL | 0.015599 | 1.807 |
R-HSA-9680350 | Signaling by CSF1 (M-CSF) in myeloid cells | 0.045081 | 1.346 |
R-HSA-975871 | MyD88 cascade initiated on plasma membrane | 0.225005 | 0.648 |
R-HSA-168176 | Toll Like Receptor 5 (TLR5) Cascade | 0.225005 | 0.648 |
R-HSA-168142 | Toll Like Receptor 10 (TLR10) Cascade | 0.225005 | 0.648 |
R-HSA-194138 | Signaling by VEGF | 0.108574 | 0.964 |
R-HSA-68875 | Mitotic Prophase | 0.098507 | 1.007 |
R-HSA-1433557 | Signaling by SCF-KIT | 0.066204 | 1.179 |
R-HSA-8964011 | HDL clearance | 0.071139 | 1.148 |
R-HSA-933543 | NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | 0.108465 | 0.965 |
R-HSA-389513 | Co-inhibition by CTLA4 | 0.185426 | 0.732 |
R-HSA-2559580 | Oxidative Stress Induced Senescence | 0.014416 | 1.841 |
R-HSA-5357956 | TNFR1-induced NF-kappa-B signaling pathway | 0.237220 | 0.625 |
R-HSA-9820448 | Developmental Cell Lineages of the Exocrine Pancreas | 0.013464 | 1.871 |
R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases | 0.036370 | 1.439 |
R-HSA-9658195 | Leishmania infection | 0.102603 | 0.989 |
R-HSA-9824443 | Parasitic Infection Pathways | 0.102603 | 0.989 |
R-HSA-162587 | HIV Life Cycle | 0.174141 | 0.759 |
R-HSA-166016 | Toll Like Receptor 4 (TLR4) Cascade | 0.048482 | 1.314 |
R-HSA-76002 | Platelet activation, signaling and aggregation | 0.095268 | 1.021 |
R-HSA-1606322 | ZBP1(DAI) mediated induction of type I IFNs | 0.171941 | 0.765 |
R-HSA-674695 | RNA Polymerase II Pre-transcription Events | 0.145903 | 0.836 |
R-HSA-877300 | Interferon gamma signaling | 0.058610 | 1.232 |
R-HSA-397014 | Muscle contraction | 0.042987 | 1.367 |
R-HSA-9860276 | SLC15A4:TASL-dependent IRF5 activation | 0.063489 | 1.197 |
R-HSA-4419969 | Depolymerization of the Nuclear Lamina | 0.015599 | 1.807 |
R-HSA-1247673 | Erythrocytes take up oxygen and release carbon dioxide | 0.122976 | 0.910 |
R-HSA-9909505 | Modulation of host responses by IFN-stimulated genes | 0.165116 | 0.782 |
R-HSA-6807004 | Negative regulation of MET activity | 0.185426 | 0.732 |
R-HSA-112409 | RAF-independent MAPK1/3 activation | 0.205246 | 0.688 |
R-HSA-2160916 | Hyaluronan degradation | 0.224587 | 0.649 |
R-HSA-446652 | Interleukin-1 family signaling | 0.013464 | 1.871 |
R-HSA-6806834 | Signaling by MET | 0.036348 | 1.440 |
R-HSA-75893 | TNF signaling | 0.016084 | 1.794 |
R-HSA-8876384 | Listeria monocytogenes entry into host cells | 0.198693 | 0.702 |
R-HSA-2980766 | Nuclear Envelope Breakdown | 0.100019 | 1.000 |
R-HSA-1059683 | Interleukin-6 signaling | 0.130143 | 0.886 |
R-HSA-5621481 | C-type lectin receptors (CLRs) | 0.205036 | 0.688 |
R-HSA-2995383 | Initiation of Nuclear Envelope (NE) Reformation | 0.021046 | 1.677 |
R-HSA-1170546 | Prolactin receptor signaling | 0.137252 | 0.862 |
R-HSA-9856872 | Malate-aspartate shuttle | 0.137252 | 0.862 |
R-HSA-1480926 | O2/CO2 exchange in erythrocytes | 0.178711 | 0.748 |
R-HSA-9607240 | FLT3 Signaling | 0.059568 | 1.225 |
R-HSA-168898 | Toll-like Receptor Cascades | 0.095139 | 1.022 |
R-HSA-2559583 | Cellular Senescence | 0.081970 | 1.086 |
R-HSA-418346 | Platelet homeostasis | 0.016620 | 1.779 |
R-HSA-9009391 | Extra-nuclear estrogen signaling | 0.065231 | 1.186 |
R-HSA-9705671 | SARS-CoV-2 activates/modulates innate and adaptive immune responses | 0.043403 | 1.362 |
R-HSA-1433559 | Regulation of KIT signaling | 0.137252 | 0.862 |
R-HSA-1237044 | Erythrocytes take up carbon dioxide and release oxygen | 0.178711 | 0.748 |
R-HSA-70635 | Urea cycle | 0.230929 | 0.637 |
R-HSA-450294 | MAP kinase activation | 0.110411 | 0.957 |
R-HSA-5576891 | Cardiac conduction | 0.120800 | 0.918 |
R-HSA-936837 | Ion transport by P-type ATPases | 0.118384 | 0.927 |
R-HSA-448424 | Interleukin-17 signaling | 0.134736 | 0.871 |
R-HSA-209543 | p75NTR recruits signalling complexes | 0.122976 | 0.910 |
R-HSA-1368108 | BMAL1:CLOCK,NPAS2 activates circadian expression | 0.045081 | 1.346 |
R-HSA-5607764 | CLEC7A (Dectin-1) signaling | 0.058540 | 1.233 |
R-HSA-73887 | Death Receptor Signaling | 0.053876 | 1.269 |
R-HSA-2586552 | Signaling by Leptin | 0.101121 | 0.995 |
R-HSA-9020558 | Interleukin-2 signaling | 0.108465 | 0.965 |
R-HSA-8934593 | Regulation of RUNX1 Expression and Activity | 0.230929 | 0.637 |
R-HSA-9705683 | SARS-CoV-2-host interactions | 0.054248 | 1.266 |
R-HSA-1295596 | Spry regulation of FGF signaling | 0.144303 | 0.841 |
R-HSA-9734767 | Developmental Cell Lineages | 0.084312 | 1.074 |
R-HSA-6783589 | Interleukin-6 family signaling | 0.218192 | 0.661 |
R-HSA-1280215 | Cytokine Signaling in Immune system | 0.114751 | 0.940 |
R-HSA-109582 | Hemostasis | 0.215854 | 0.666 |
R-HSA-983712 | Ion channel transport | 0.092674 | 1.033 |
R-HSA-193704 | p75 NTR receptor-mediated signalling | 0.228013 | 0.642 |
R-HSA-936440 | Negative regulators of DDX58/IFIH1 signaling | 0.037492 | 1.426 |
R-HSA-196780 | Biotin transport and metabolism | 0.144303 | 0.841 |
R-HSA-210993 | Tie2 Signaling | 0.171941 | 0.765 |
R-HSA-425410 | Metal ion SLC transporters | 0.077775 | 1.109 |
R-HSA-8854691 | Interleukin-20 family signaling | 0.211745 | 0.674 |
R-HSA-982772 | Growth hormone receptor signaling | 0.211745 | 0.674 |
R-HSA-449147 | Signaling by Interleukins | 0.017645 | 1.753 |
R-HSA-9694516 | SARS-CoV-2 Infection | 0.033004 | 1.481 |
R-HSA-9725370 | Signaling by ALK fusions and activated point mutants | 0.075162 | 1.124 |
R-HSA-9725371 | Nuclear events stimulated by ALK signaling in cancer | 0.077775 | 1.109 |
R-HSA-2672351 | Stimuli-sensing channels | 0.076632 | 1.116 |
R-HSA-9824446 | Viral Infection Pathways | 0.232200 | 0.634 |
R-HSA-9700206 | Signaling by ALK in cancer | 0.075162 | 1.124 |
R-HSA-9006115 | Signaling by NTRK2 (TRKB) | 0.237220 | 0.625 |
R-HSA-75205 | Dissolution of Fibrin Clot | 0.108465 | 0.965 |
R-HSA-8862803 | Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's dis... | 0.218192 | 0.661 |
R-HSA-8863678 | Neurodegenerative Diseases | 0.218192 | 0.661 |
R-HSA-1500931 | Cell-Cell communication | 0.059203 | 1.228 |
R-HSA-9679506 | SARS-CoV Infections | 0.048191 | 1.317 |
R-HSA-9734009 | Defective Intrinsic Pathway for Apoptosis | 0.237220 | 0.625 |
R-HSA-2995410 | Nuclear Envelope (NE) Reassembly | 0.162992 | 0.788 |
R-HSA-6804756 | Regulation of TP53 Activity through Phosphorylation | 0.183350 | 0.737 |
R-HSA-8950505 | Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulati... | 0.121073 | 0.917 |
R-HSA-381038 | XBP1(S) activates chaperone genes | 0.183350 | 0.737 |
R-HSA-381070 | IRE1alpha activates chaperones | 0.201080 | 0.697 |
R-HSA-9020591 | Interleukin-12 signaling | 0.151558 | 0.819 |
R-HSA-447115 | Interleukin-12 family signaling | 0.186289 | 0.730 |
R-HSA-913531 | Interferon Signaling | 0.237922 | 0.624 |
R-HSA-8856825 | Cargo recognition for clathrin-mediated endocytosis | 0.243089 | 0.614 |
R-HSA-5654700 | FRS-mediated FGFR2 signaling | 0.243460 | 0.614 |
R-HSA-5654732 | Negative regulation of FGFR3 signaling | 0.243460 | 0.614 |
R-HSA-5654708 | Downstream signaling of activated FGFR3 | 0.249650 | 0.603 |
R-HSA-5654733 | Negative regulation of FGFR4 signaling | 0.249650 | 0.603 |
R-HSA-450282 | MAPK targets/ Nuclear events mediated by MAP kinases | 0.249650 | 0.603 |
R-HSA-72163 | mRNA Splicing - Major Pathway | 0.254513 | 0.594 |
R-HSA-2424491 | DAP12 signaling | 0.255789 | 0.592 |
R-HSA-76046 | RNA Polymerase III Transcription Initiation | 0.255789 | 0.592 |
R-HSA-5654716 | Downstream signaling of activated FGFR4 | 0.255789 | 0.592 |
R-HSA-975138 | TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | 0.258209 | 0.588 |
R-HSA-5684996 | MAPK1/MAPK3 signaling | 0.261000 | 0.583 |
R-HSA-975155 | MyD88 dependent cascade initiated on endosome | 0.261235 | 0.583 |
R-HSA-182971 | EGFR downregulation | 0.261878 | 0.582 |
R-HSA-9820960 | Respiratory syncytial virus (RSV) attachment and entry | 0.261878 | 0.582 |
R-HSA-2129379 | Molecules associated with elastic fibres | 0.261878 | 0.582 |
R-HSA-162710 | Synthesis of glycosylphosphatidylinositol (GPI) | 0.261878 | 0.582 |
R-HSA-8963693 | Aspartate and asparagine metabolism | 0.261878 | 0.582 |
R-HSA-202403 | TCR signaling | 0.264262 | 0.578 |
R-HSA-389948 | Co-inhibition by PD-1 | 0.267711 | 0.572 |
R-HSA-2024096 | HS-GAG degradation | 0.267918 | 0.572 |
R-HSA-111465 | Apoptotic cleavage of cellular proteins | 0.267918 | 0.572 |
R-HSA-2871796 | FCERI mediated MAPK activation | 0.270317 | 0.568 |
R-HSA-168181 | Toll Like Receptor 7/8 (TLR7/8) Cascade | 0.273343 | 0.563 |
R-HSA-5654726 | Negative regulation of FGFR1 signaling | 0.273909 | 0.562 |
R-HSA-1855204 | Synthesis of IP3 and IP4 in the cytosol | 0.273909 | 0.562 |
R-HSA-5663202 | Diseases of signal transduction by growth factor receptors and second messengers | 0.277266 | 0.557 |
R-HSA-72172 | mRNA Splicing | 0.278771 | 0.555 |
R-HSA-390522 | Striated Muscle Contraction | 0.279851 | 0.553 |
R-HSA-1482788 | Acyl chain remodelling of PC | 0.279851 | 0.553 |
R-HSA-9768727 | Regulation of CDH1 posttranslational processing and trafficking to plasma membra... | 0.279851 | 0.553 |
R-HSA-8964539 | Glutamate and glutamine metabolism | 0.279851 | 0.553 |
R-HSA-199220 | Vitamin B5 (pantothenate) metabolism | 0.279851 | 0.553 |
R-HSA-168138 | Toll Like Receptor 9 (TLR9) Cascade | 0.282421 | 0.549 |
R-HSA-162582 | Signal Transduction | 0.283471 | 0.547 |
R-HSA-909733 | Interferon alpha/beta signaling | 0.285445 | 0.544 |
R-HSA-1971475 | Glycosaminoglycan-protein linkage region biosynthesis | 0.285745 | 0.544 |
R-HSA-5654727 | Negative regulation of FGFR2 signaling | 0.285745 | 0.544 |
R-HSA-2142845 | Hyaluronan metabolism | 0.285745 | 0.544 |
R-HSA-901042 | Calnexin/calreticulin cycle | 0.285745 | 0.544 |
R-HSA-168638 | NOD1/2 Signaling Pathway | 0.285745 | 0.544 |
R-HSA-9007101 | Rab regulation of trafficking | 0.291489 | 0.535 |
R-HSA-5654696 | Downstream signaling of activated FGFR2 | 0.291591 | 0.535 |
R-HSA-5654687 | Downstream signaling of activated FGFR1 | 0.291591 | 0.535 |
R-HSA-1482839 | Acyl chain remodelling of PE | 0.291591 | 0.535 |
R-HSA-9772755 | Formation of WDR5-containing histone-modifying complexes | 0.291591 | 0.535 |
R-HSA-2219528 | PI3K/AKT Signaling in Cancer | 0.294510 | 0.531 |
R-HSA-2022928 | HS-GAG biosynthesis | 0.297389 | 0.527 |
R-HSA-74158 | RNA Polymerase III Transcription | 0.297389 | 0.527 |
R-HSA-749476 | RNA Polymerase III Abortive And Retractive Initiation | 0.297389 | 0.527 |
R-HSA-9682385 | FLT3 signaling in disease | 0.297389 | 0.527 |
R-HSA-8853659 | RET signaling | 0.297389 | 0.527 |
R-HSA-8941326 | RUNX2 regulates bone development | 0.297389 | 0.527 |
R-HSA-166058 | MyD88:MAL(TIRAP) cascade initiated on plasma membrane | 0.297528 | 0.526 |
R-HSA-168188 | Toll Like Receptor TLR6:TLR2 Cascade | 0.297528 | 0.526 |
R-HSA-180910 | Vpr-mediated nuclear import of PICs | 0.303141 | 0.518 |
R-HSA-933541 | TRAF6 mediated IRF7 activation | 0.303141 | 0.518 |
R-HSA-549127 | SLC-mediated transport of organic cations | 0.303141 | 0.518 |
R-HSA-168179 | Toll Like Receptor TLR1:TLR2 Cascade | 0.306571 | 0.513 |
R-HSA-181438 | Toll Like Receptor 2 (TLR2) Cascade | 0.306571 | 0.513 |
R-HSA-382551 | Transport of small molecules | 0.306904 | 0.513 |
R-HSA-8875878 | MET promotes cell motility | 0.308845 | 0.510 |
R-HSA-1566948 | Elastic fibre formation | 0.308845 | 0.510 |
R-HSA-452723 | Transcriptional regulation of pluripotent stem cells | 0.308845 | 0.510 |
R-HSA-6811558 | PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | 0.309581 | 0.509 |
R-HSA-168249 | Innate Immune System | 0.313905 | 0.503 |
R-HSA-8964043 | Plasma lipoprotein clearance | 0.314504 | 0.502 |
R-HSA-201556 | Signaling by ALK | 0.314504 | 0.502 |
R-HSA-176033 | Interactions of Vpr with host cellular proteins | 0.320116 | 0.495 |
R-HSA-5602358 | Diseases associated with the TLR signaling cascade | 0.320116 | 0.495 |
R-HSA-5260271 | Diseases of Immune System | 0.320116 | 0.495 |
R-HSA-9694548 | Maturation of spike protein | 0.325683 | 0.487 |
R-HSA-5663205 | Infectious disease | 0.328330 | 0.484 |
R-HSA-162906 | HIV Infection | 0.330060 | 0.481 |
R-HSA-9683701 | Translation of Structural Proteins | 0.331204 | 0.480 |
R-HSA-199418 | Negative regulation of the PI3K/AKT network | 0.333555 | 0.477 |
R-HSA-5654743 | Signaling by FGFR4 | 0.342113 | 0.466 |
R-HSA-8854214 | TBC/RABGAPs | 0.342113 | 0.466 |
R-HSA-9909396 | Circadian clock | 0.342488 | 0.465 |
R-HSA-2172127 | DAP12 interactions | 0.347501 | 0.459 |
R-HSA-3928662 | EPHB-mediated forward signaling | 0.347501 | 0.459 |
R-HSA-375280 | Amine ligand-binding receptors | 0.347501 | 0.459 |
R-HSA-202733 | Cell surface interactions at the vascular wall | 0.352401 | 0.453 |
R-HSA-8939211 | ESR-mediated signaling | 0.352401 | 0.453 |
R-HSA-3560782 | Diseases associated with glycosaminoglycan metabolism | 0.352845 | 0.452 |
R-HSA-5654741 | Signaling by FGFR3 | 0.352845 | 0.452 |
R-HSA-432040 | Vasopressin regulates renal water homeostasis via Aquaporins | 0.352845 | 0.452 |
R-HSA-1614558 | Degradation of cysteine and homocysteine | 0.352845 | 0.452 |
R-HSA-5683057 | MAPK family signaling cascades | 0.354658 | 0.450 |
R-HSA-75153 | Apoptotic execution phase | 0.358146 | 0.446 |
R-HSA-445989 | TAK1-dependent IKK and NF-kappa-B activation | 0.363404 | 0.440 |
R-HSA-381119 | Unfolded Protein Response (UPR) | 0.366118 | 0.436 |
R-HSA-9031628 | NGF-stimulated transcription | 0.368618 | 0.433 |
R-HSA-532668 | N-glycan trimming in the ER and Calnexin/Calreticulin cycle | 0.373791 | 0.427 |
R-HSA-2122947 | NOTCH1 Intracellular Domain Regulates Transcription | 0.373791 | 0.427 |
R-HSA-389661 | Glyoxylate metabolism and glycine degradation | 0.373791 | 0.427 |
R-HSA-162599 | Late Phase of HIV Life Cycle | 0.377814 | 0.423 |
R-HSA-109704 | PI3K Cascade | 0.378921 | 0.421 |
R-HSA-8856828 | Clathrin-mediated endocytosis | 0.380725 | 0.419 |
R-HSA-2871837 | FCERI mediated NF-kB activation | 0.383630 | 0.416 |
R-HSA-6794361 | Neurexins and neuroligins | 0.389057 | 0.410 |
R-HSA-9692916 | SARS-CoV-1 activates/modulates innate immune responses | 0.389057 | 0.410 |
R-HSA-445355 | Smooth Muscle Contraction | 0.394064 | 0.404 |
R-HSA-388841 | Regulation of T cell activation by CD28 family | 0.394577 | 0.404 |
R-HSA-9754678 | SARS-CoV-2 modulates host translation machinery | 0.399029 | 0.399 |
R-HSA-9679191 | Potential therapeutics for SARS | 0.400934 | 0.397 |
R-HSA-5654736 | Signaling by FGFR1 | 0.408840 | 0.388 |
R-HSA-193648 | NRAGE signals death through JNK | 0.408840 | 0.388 |
R-HSA-5621480 | Dectin-2 family | 0.413685 | 0.383 |
R-HSA-112399 | IRS-mediated signalling | 0.413685 | 0.383 |
R-HSA-9772572 | Early SARS-CoV-2 Infection Events | 0.418491 | 0.378 |
R-HSA-194441 | Metabolism of non-coding RNA | 0.423258 | 0.373 |
R-HSA-191859 | snRNP Assembly | 0.423258 | 0.373 |
R-HSA-1638091 | Heparan sulfate/heparin (HS-GAG) metabolism | 0.423258 | 0.373 |
R-HSA-1660661 | Sphingolipid de novo biosynthesis | 0.427986 | 0.369 |
R-HSA-2644606 | Constitutive Signaling by NOTCH1 PEST Domain Mutants | 0.427986 | 0.369 |
R-HSA-2894862 | Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | 0.427986 | 0.369 |
R-HSA-2894858 | Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | 0.427986 | 0.369 |
R-HSA-2644602 | Signaling by NOTCH1 PEST Domain Mutants in Cancer | 0.427986 | 0.369 |
R-HSA-2644603 | Signaling by NOTCH1 in Cancer | 0.427986 | 0.369 |
R-HSA-5633007 | Regulation of TP53 Activity | 0.429261 | 0.367 |
R-HSA-445717 | Aquaporin-mediated transport | 0.432676 | 0.364 |
R-HSA-2428928 | IRS-related events triggered by IGF1R | 0.432676 | 0.364 |
R-HSA-375165 | NCAM signaling for neurite out-growth | 0.437327 | 0.359 |
R-HSA-1660499 | Synthesis of PIPs at the plasma membrane | 0.437327 | 0.359 |
R-HSA-6790901 | rRNA modification in the nucleus and cytosol | 0.441941 | 0.355 |
R-HSA-446728 | Cell junction organization | 0.442497 | 0.354 |
R-HSA-72203 | Processing of Capped Intron-Containing Pre-mRNA | 0.444643 | 0.352 |
R-HSA-5690714 | CD22 mediated BCR regulation | 0.446517 | 0.350 |
R-HSA-2428924 | IGF1R signaling cascade | 0.446517 | 0.350 |
R-HSA-74751 | Insulin receptor signalling cascade | 0.446517 | 0.350 |
R-HSA-168643 | Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signali... | 0.446517 | 0.350 |
R-HSA-425407 | SLC-mediated transmembrane transport | 0.448633 | 0.348 |
R-HSA-2404192 | Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | 0.451056 | 0.346 |
R-HSA-9909649 | Regulation of PD-L1(CD274) transcription | 0.455558 | 0.341 |
R-HSA-196807 | Nicotinate metabolism | 0.460023 | 0.337 |
R-HSA-9662360 | Sensory processing of sound by inner hair cells of the cochlea | 0.464452 | 0.333 |
R-HSA-5673001 | RAF/MAP kinase cascade | 0.465924 | 0.332 |
R-HSA-199991 | Membrane Trafficking | 0.470084 | 0.328 |
R-HSA-9678108 | SARS-CoV-1 Infection | 0.473077 | 0.325 |
R-HSA-204005 | COPII-mediated vesicle transport | 0.473202 | 0.325 |
R-HSA-1834949 | Cytosolic sensors of pathogen-associated DNA | 0.473202 | 0.325 |
R-HSA-427413 | NoRC negatively regulates rRNA expression | 0.477523 | 0.321 |
R-HSA-5620920 | Cargo trafficking to the periciliary membrane | 0.477523 | 0.321 |
R-HSA-975634 | Retinoid metabolism and transport | 0.477523 | 0.321 |
R-HSA-198725 | Nuclear Events (kinase and transcription factor activation) | 0.481810 | 0.317 |
R-HSA-204998 | Cell death signalling via NRAGE, NRIF and NADE | 0.486061 | 0.313 |
R-HSA-8953897 | Cellular responses to stimuli | 0.488407 | 0.311 |
R-HSA-425397 | Transport of vitamins, nucleosides, and related molecules | 0.490278 | 0.310 |
R-HSA-3000171 | Non-integrin membrane-ECM interactions | 0.494461 | 0.306 |
R-HSA-1980143 | Signaling by NOTCH1 | 0.498609 | 0.302 |
R-HSA-9694635 | Translation of Structural Proteins | 0.502724 | 0.299 |
R-HSA-383280 | Nuclear Receptor transcription pathway | 0.506805 | 0.295 |
R-HSA-6796648 | TP53 Regulates Transcription of DNA Repair Genes | 0.506805 | 0.295 |
R-HSA-9925561 | Developmental Lineage of Pancreatic Acinar Cells | 0.510853 | 0.292 |
R-HSA-9659379 | Sensory processing of sound | 0.510853 | 0.292 |
R-HSA-5250941 | Negative epigenetic regulation of rRNA expression | 0.514868 | 0.288 |
R-HSA-5654738 | Signaling by FGFR2 | 0.514868 | 0.288 |
R-HSA-9833482 | PKR-mediated signaling | 0.514868 | 0.288 |
R-HSA-6785807 | Interleukin-4 and Interleukin-13 signaling | 0.517372 | 0.286 |
R-HSA-6806667 | Metabolism of fat-soluble vitamins | 0.518850 | 0.285 |
R-HSA-1630316 | Glycosaminoglycan metabolism | 0.519900 | 0.284 |
R-HSA-2559582 | Senescence-Associated Secretory Phenotype (SASP) | 0.522800 | 0.282 |
R-HSA-2565942 | Regulation of PLK1 Activity at G2/M Transition | 0.530604 | 0.275 |
R-HSA-6794362 | Protein-protein interactions at synapses | 0.534458 | 0.272 |
R-HSA-8876198 | RAB GEFs exchange GTP for GDP on RABs | 0.538280 | 0.269 |
R-HSA-6807505 | RNA polymerase II transcribes snRNA genes | 0.542072 | 0.266 |
R-HSA-1614635 | Sulfur amino acid metabolism | 0.542072 | 0.266 |
R-HSA-9645723 | Diseases of programmed cell death | 0.549562 | 0.260 |
R-HSA-1236974 | ER-Phagosome pathway | 0.553262 | 0.257 |
R-HSA-2682334 | EPH-Ephrin signaling | 0.567761 | 0.246 |
R-HSA-74752 | Signaling by Insulin receptor | 0.567761 | 0.246 |
R-HSA-9772573 | Late SARS-CoV-2 Infection Events | 0.567761 | 0.246 |
R-HSA-174824 | Plasma lipoprotein assembly, remodeling, and clearance | 0.567761 | 0.246 |
R-HSA-2029481 | FCGR activation | 0.571312 | 0.243 |
R-HSA-9837999 | Mitochondrial protein degradation | 0.574835 | 0.240 |
R-HSA-68882 | Mitotic Anaphase | 0.577917 | 0.238 |
R-HSA-2555396 | Mitotic Metaphase and Anaphase | 0.580221 | 0.236 |
R-HSA-2730905 | Role of LAT2/NTAL/LAB on calcium mobilization | 0.585230 | 0.233 |
R-HSA-6807878 | COPI-mediated anterograde transport | 0.585230 | 0.233 |
R-HSA-170834 | Signaling by TGF-beta Receptor Complex | 0.588639 | 0.230 |
R-HSA-8878159 | Transcriptional regulation by RUNX3 | 0.588639 | 0.230 |
R-HSA-190236 | Signaling by FGFR | 0.592019 | 0.228 |
R-HSA-3214847 | HATs acetylate histones | 0.595373 | 0.225 |
R-HSA-192105 | Synthesis of bile acids and bile salts | 0.595373 | 0.225 |
R-HSA-9020702 | Interleukin-1 signaling | 0.601998 | 0.220 |
R-HSA-1483255 | PI Metabolism | 0.605270 | 0.218 |
R-HSA-196849 | Metabolism of water-soluble vitamins and cofactors | 0.609343 | 0.215 |
R-HSA-9006931 | Signaling by Nuclear Receptors | 0.610264 | 0.214 |
R-HSA-196854 | Metabolism of vitamins and cofactors | 0.612031 | 0.213 |
R-HSA-5619507 | Activation of HOX genes during differentiation | 0.614926 | 0.211 |
R-HSA-5617472 | Activation of anterior HOX genes in hindbrain development during early embryogen... | 0.614926 | 0.211 |
R-HSA-9833110 | RSV-host interactions | 0.614926 | 0.211 |
R-HSA-163125 | Post-translational modification: synthesis of GPI-anchored proteins | 0.614926 | 0.211 |
R-HSA-9692914 | SARS-CoV-1-host interactions | 0.621233 | 0.207 |
R-HSA-1236975 | Antigen processing-Cross presentation | 0.627438 | 0.202 |
R-HSA-194068 | Bile acid and bile salt metabolism | 0.633541 | 0.198 |
R-HSA-1483249 | Inositol phosphate metabolism | 0.639546 | 0.194 |
R-HSA-68886 | M Phase | 0.644586 | 0.191 |
R-HSA-421270 | Cell-cell junction organization | 0.653124 | 0.185 |
R-HSA-2029485 | Role of phospholipids in phagocytosis | 0.654133 | 0.184 |
R-HSA-2871809 | FCERI mediated Ca+2 mobilization | 0.654133 | 0.184 |
R-HSA-8878166 | Transcriptional regulation by RUNX2 | 0.665380 | 0.177 |
R-HSA-5653656 | Vesicle-mediated transport | 0.678840 | 0.168 |
R-HSA-162909 | Host Interactions of HIV factors | 0.678929 | 0.168 |
R-HSA-9664323 | FCGR3A-mediated IL10 synthesis | 0.686796 | 0.163 |
R-HSA-114608 | Platelet degranulation | 0.689375 | 0.162 |
R-HSA-168256 | Immune System | 0.702836 | 0.153 |
R-HSA-76005 | Response to elevated platelet cytosolic Ca2+ | 0.706851 | 0.151 |
R-HSA-69278 | Cell Cycle, Mitotic | 0.712630 | 0.147 |
R-HSA-9018519 | Estrogen-dependent gene expression | 0.716395 | 0.145 |
R-HSA-9820952 | Respiratory Syncytial Virus Infection Pathway | 0.718732 | 0.143 |
R-HSA-1483257 | Phospholipid metabolism | 0.732191 | 0.135 |
R-HSA-1257604 | PIP3 activates AKT signaling | 0.732191 | 0.135 |
R-HSA-1643685 | Disease | 0.740736 | 0.130 |
R-HSA-199977 | ER to Golgi Anterograde Transport | 0.743216 | 0.129 |
R-HSA-2187338 | Visual phototransduction | 0.743216 | 0.129 |
R-HSA-9609507 | Protein localization | 0.755667 | 0.122 |
R-HSA-9917777 | Epigenetic regulation by WDR5-containing histone modifying complexes | 0.757683 | 0.121 |
R-HSA-1169410 | Antiviral mechanism by IFN-stimulated genes | 0.757683 | 0.121 |
R-HSA-3700989 | Transcriptional Regulation by TP53 | 0.764000 | 0.117 |
R-HSA-9006936 | Signaling by TGFB family members | 0.769437 | 0.114 |
R-HSA-109581 | Apoptosis | 0.773228 | 0.112 |
R-HSA-212165 | Epigenetic regulation of gene expression | 0.774185 | 0.111 |
R-HSA-1280218 | Adaptive Immune System | 0.778425 | 0.109 |
R-HSA-1474244 | Extracellular matrix organization | 0.785088 | 0.105 |
R-HSA-6791226 | Major pathway of rRNA processing in the nucleolus and cytosol | 0.789536 | 0.103 |
R-HSA-418555 | G alpha (s) signalling events | 0.791274 | 0.102 |
R-HSA-9909648 | Regulation of PD-L1(CD274) expression | 0.792999 | 0.101 |
R-HSA-9664433 | Leishmania parasite growth and survival | 0.794709 | 0.100 |
R-HSA-9662851 | Anti-inflammatory response favouring Leishmania parasite infection | 0.794709 | 0.100 |
R-HSA-5689880 | Ub-specific processing proteases | 0.794709 | 0.100 |
R-HSA-9764265 | Regulation of CDH1 Expression and Function | 0.794709 | 0.100 |
R-HSA-9764274 | Regulation of Expression and Function of Type I Classical Cadherins | 0.794709 | 0.100 |
R-HSA-9006925 | Intracellular signaling by second messengers | 0.799330 | 0.097 |
R-HSA-611105 | Respiratory electron transport | 0.803052 | 0.095 |
R-HSA-3781865 | Diseases of glycosylation | 0.812620 | 0.090 |
R-HSA-69275 | G2/M Transition | 0.815706 | 0.088 |
R-HSA-8868773 | rRNA processing in the nucleus and cytosol | 0.818741 | 0.087 |
R-HSA-453274 | Mitotic G2-G2/M phases | 0.818741 | 0.087 |
R-HSA-5617833 | Cilium Assembly | 0.821726 | 0.085 |
R-HSA-9759476 | Regulation of Homotypic Cell-Cell Adhesion | 0.830394 | 0.081 |
R-HSA-8953854 | Metabolism of RNA | 0.835941 | 0.078 |
R-HSA-428157 | Sphingolipid metabolism | 0.837296 | 0.077 |
R-HSA-948021 | Transport to the Golgi and subsequent modification | 0.838643 | 0.076 |
R-HSA-1483206 | Glycerophospholipid biosynthesis | 0.839978 | 0.076 |
R-HSA-5357801 | Programmed Cell Death | 0.843920 | 0.074 |
R-HSA-422475 | Axon guidance | 0.846404 | 0.072 |
R-HSA-1640170 | Cell Cycle | 0.852792 | 0.069 |
R-HSA-418990 | Adherens junctions interactions | 0.859914 | 0.066 |
R-HSA-2262752 | Cellular responses to stress | 0.860329 | 0.065 |
R-HSA-8878171 | Transcriptional regulation by RUNX1 | 0.868937 | 0.061 |
R-HSA-9675108 | Nervous system development | 0.875303 | 0.058 |
R-HSA-72312 | rRNA processing | 0.875324 | 0.058 |
R-HSA-3247509 | Chromatin modifying enzymes | 0.877383 | 0.057 |
R-HSA-446203 | Asparagine N-linked glycosylation | 0.880861 | 0.055 |
R-HSA-157118 | Signaling by NOTCH | 0.883361 | 0.054 |
R-HSA-4839726 | Chromatin organization | 0.891790 | 0.050 |
R-HSA-5688426 | Deubiquitination | 0.897070 | 0.047 |
R-HSA-74160 | Gene expression (Transcription) | 0.902992 | 0.044 |
R-HSA-71387 | Metabolism of carbohydrates and carbohydrate derivatives | 0.904357 | 0.044 |
R-HSA-416476 | G alpha (q) signalling events | 0.904515 | 0.044 |
R-HSA-6798695 | Neutrophil degranulation | 0.905634 | 0.043 |
R-HSA-73857 | RNA Polymerase II Transcription | 0.906143 | 0.043 |
R-HSA-212436 | Generic Transcription Pathway | 0.906947 | 0.042 |
R-HSA-1852241 | Organelle biogenesis and maintenance | 0.940209 | 0.027 |
R-HSA-597592 | Post-translational protein modification | 0.940816 | 0.026 |
R-HSA-8957322 | Metabolism of steroids | 0.942179 | 0.026 |
R-HSA-1428517 | Aerobic respiration and respiratory electron transport | 0.949857 | 0.022 |
R-HSA-388396 | GPCR downstream signalling | 0.960976 | 0.017 |
R-HSA-983169 | Class I MHC mediated antigen processing & presentation | 0.965053 | 0.015 |
R-HSA-9824439 | Bacterial Infection Pathways | 0.967051 | 0.015 |
R-HSA-1266738 | Developmental Biology | 0.968076 | 0.014 |
R-HSA-373076 | Class A/1 (Rhodopsin-like receptors) | 0.968142 | 0.014 |
R-HSA-71291 | Metabolism of amino acids and derivatives | 0.969193 | 0.014 |
R-HSA-5668914 | Diseases of metabolism | 0.975873 | 0.011 |
R-HSA-372790 | Signaling by GPCR | 0.977179 | 0.010 |
R-HSA-112316 | Neuronal System | 0.982932 | 0.007 |
R-HSA-500792 | GPCR ligand binding | 0.993888 | 0.003 |
R-HSA-392499 | Metabolism of proteins | 0.996959 | 0.001 |
R-HSA-556833 | Metabolism of lipids | 0.998808 | 0.001 |
R-HSA-9709957 | Sensory Perception | 0.999735 | 0.000 |
R-HSA-1430728 | Metabolism | 1.000000 | 0.000 |
Download
kinase | JSD_mean | pearson_surrounding | kinase_max_IC_position | max_position_JSD |
---|---|---|---|---|
PRKD1 |
0.829 | 0.175 | -3 | 0.880 |
PIM3 |
0.827 | 0.225 | -3 | 0.877 |
COT |
0.826 | 0.064 | 2 | 0.833 |
NDR2 |
0.824 | 0.150 | -3 | 0.884 |
MAPKAPK2 |
0.824 | 0.180 | -3 | 0.796 |
RSK3 |
0.823 | 0.273 | -3 | 0.817 |
PRKD2 |
0.823 | 0.184 | -3 | 0.819 |
RSK2 |
0.823 | 0.238 | -3 | 0.826 |
MAPKAPK3 |
0.823 | 0.162 | -3 | 0.839 |
P70S6KB |
0.822 | 0.299 | -3 | 0.851 |
LATS2 |
0.821 | 0.121 | -5 | 0.577 |
P90RSK |
0.821 | 0.233 | -3 | 0.827 |
CDC7 |
0.820 | 0.058 | 1 | 0.831 |
NDR1 |
0.820 | 0.196 | -3 | 0.879 |
GCN2 |
0.820 | 0.032 | 2 | 0.805 |
PIM1 |
0.819 | 0.248 | -3 | 0.835 |
PRPK |
0.818 | 0.033 | -1 | 0.814 |
PKN3 |
0.815 | 0.140 | -3 | 0.869 |
DSTYK |
0.815 | 0.013 | 2 | 0.840 |
CAMK1B |
0.815 | 0.118 | -3 | 0.896 |
CDKL1 |
0.815 | 0.148 | -3 | 0.865 |
MTOR |
0.813 | 0.017 | 1 | 0.786 |
ULK2 |
0.813 | -0.006 | 2 | 0.778 |
CAMK2D |
0.813 | 0.093 | -3 | 0.898 |
CDKL5 |
0.812 | 0.136 | -3 | 0.862 |
NUAK2 |
0.812 | 0.122 | -3 | 0.865 |
P70S6K |
0.812 | 0.349 | -3 | 0.786 |
AMPKA1 |
0.812 | 0.137 | -3 | 0.890 |
RAF1 |
0.812 | -0.012 | 1 | 0.841 |
CLK3 |
0.811 | 0.131 | 1 | 0.783 |
IKKB |
0.811 | -0.068 | -2 | 0.765 |
PIM2 |
0.811 | 0.308 | -3 | 0.805 |
RSK4 |
0.811 | 0.268 | -3 | 0.793 |
TGFBR2 |
0.810 | 0.052 | -2 | 0.826 |
TBK1 |
0.810 | -0.014 | 1 | 0.762 |
ERK5 |
0.810 | 0.083 | 1 | 0.780 |
AMPKA2 |
0.810 | 0.151 | -3 | 0.864 |
PKN2 |
0.809 | 0.135 | -3 | 0.879 |
BMPR2 |
0.809 | -0.029 | -2 | 0.878 |
PDHK1 |
0.809 | -0.058 | 1 | 0.839 |
SRPK2 |
0.809 | 0.165 | -3 | 0.748 |
MST4 |
0.808 | 0.099 | 2 | 0.808 |
CAMK2G |
0.808 | -0.011 | 2 | 0.788 |
NLK |
0.808 | 0.036 | 1 | 0.777 |
NEK6 |
0.808 | -0.018 | -2 | 0.850 |
BCKDK |
0.808 | -0.005 | -1 | 0.780 |
NIK |
0.808 | 0.118 | -3 | 0.908 |
PDHK4 |
0.808 | -0.139 | 1 | 0.849 |
PRKD3 |
0.807 | 0.144 | -3 | 0.792 |
MARK4 |
0.807 | 0.060 | 4 | 0.751 |
MOS |
0.807 | -0.036 | 1 | 0.856 |
DAPK2 |
0.807 | 0.116 | -3 | 0.907 |
PKACG |
0.807 | 0.133 | -2 | 0.671 |
PKCD |
0.807 | 0.128 | 2 | 0.764 |
HUNK |
0.807 | 0.017 | 2 | 0.782 |
SRPK1 |
0.807 | 0.115 | -3 | 0.809 |
TSSK1 |
0.806 | 0.080 | -3 | 0.898 |
CAMLCK |
0.806 | 0.113 | -2 | 0.805 |
TSSK2 |
0.806 | 0.051 | -5 | 0.580 |
IKKE |
0.806 | -0.043 | 1 | 0.747 |
SGK3 |
0.806 | 0.232 | -3 | 0.825 |
WNK1 |
0.806 | 0.071 | -2 | 0.795 |
MSK2 |
0.805 | 0.120 | -3 | 0.824 |
CAMK2B |
0.805 | 0.099 | 2 | 0.761 |
NIM1 |
0.805 | 0.111 | 3 | 0.740 |
ATR |
0.805 | -0.019 | 1 | 0.810 |
NEK7 |
0.805 | -0.063 | -3 | 0.871 |
HIPK4 |
0.805 | 0.092 | 1 | 0.725 |
MELK |
0.804 | 0.121 | -3 | 0.854 |
SRPK3 |
0.804 | 0.149 | -3 | 0.791 |
CAMK4 |
0.803 | 0.065 | -3 | 0.862 |
CHK1 |
0.802 | 0.069 | -3 | 0.863 |
CAMK2A |
0.802 | 0.095 | 2 | 0.776 |
NUAK1 |
0.802 | 0.074 | -3 | 0.830 |
ULK1 |
0.802 | -0.062 | -3 | 0.827 |
NEK9 |
0.802 | 0.001 | 2 | 0.818 |
AURC |
0.801 | 0.075 | -2 | 0.590 |
PAK3 |
0.801 | 0.109 | -2 | 0.736 |
RIPK3 |
0.801 | -0.018 | 3 | 0.708 |
ICK |
0.801 | 0.076 | -3 | 0.888 |
MSK1 |
0.800 | 0.131 | -3 | 0.823 |
PHKG1 |
0.800 | 0.093 | -3 | 0.874 |
WNK3 |
0.800 | -0.003 | 1 | 0.822 |
PKACB |
0.799 | 0.131 | -2 | 0.611 |
LATS1 |
0.799 | 0.093 | -3 | 0.888 |
SIK |
0.799 | 0.106 | -3 | 0.822 |
SKMLCK |
0.799 | -0.001 | -2 | 0.779 |
QSK |
0.798 | 0.087 | 4 | 0.730 |
IKKA |
0.798 | -0.069 | -2 | 0.748 |
PKCA |
0.798 | 0.119 | 2 | 0.703 |
AKT2 |
0.798 | 0.166 | -3 | 0.745 |
MLK1 |
0.798 | -0.071 | 2 | 0.790 |
PAK1 |
0.798 | 0.087 | -2 | 0.721 |
MLK2 |
0.797 | -0.020 | 2 | 0.811 |
MASTL |
0.797 | -0.106 | -2 | 0.799 |
PKCG |
0.796 | 0.091 | 2 | 0.699 |
QIK |
0.796 | 0.050 | -3 | 0.884 |
PLK1 |
0.796 | 0.021 | -2 | 0.850 |
DLK |
0.795 | -0.036 | 1 | 0.833 |
CHAK2 |
0.795 | -0.061 | -1 | 0.755 |
BRSK1 |
0.795 | 0.083 | -3 | 0.839 |
AURB |
0.795 | 0.078 | -2 | 0.595 |
PKCB |
0.795 | 0.074 | 2 | 0.714 |
GRK6 |
0.795 | -0.039 | 1 | 0.842 |
GRK5 |
0.795 | -0.140 | -3 | 0.883 |
GRK1 |
0.795 | -0.029 | -2 | 0.751 |
DYRK2 |
0.795 | 0.069 | 1 | 0.629 |
MNK2 |
0.794 | 0.038 | -2 | 0.728 |
ANKRD3 |
0.794 | -0.049 | 1 | 0.855 |
PKR |
0.794 | 0.100 | 1 | 0.821 |
ALK4 |
0.794 | 0.024 | -2 | 0.828 |
MAPKAPK5 |
0.794 | 0.058 | -3 | 0.810 |
RIPK1 |
0.794 | -0.031 | 1 | 0.814 |
ATM |
0.793 | -0.014 | 1 | 0.758 |
BRSK2 |
0.793 | 0.043 | -3 | 0.864 |
IRE1 |
0.793 | -0.003 | 1 | 0.776 |
TGFBR1 |
0.792 | 0.017 | -2 | 0.811 |
DCAMKL1 |
0.792 | 0.127 | -3 | 0.817 |
NEK2 |
0.792 | 0.016 | 2 | 0.799 |
PKG2 |
0.792 | 0.088 | -2 | 0.604 |
AKT1 |
0.792 | 0.171 | -3 | 0.763 |
PAK2 |
0.792 | 0.082 | -2 | 0.716 |
IRE2 |
0.791 | 0.053 | 2 | 0.727 |
PKCH |
0.791 | 0.080 | 2 | 0.700 |
TTBK2 |
0.790 | -0.060 | 2 | 0.680 |
FAM20C |
0.790 | -0.006 | 2 | 0.534 |
BMPR1B |
0.790 | 0.030 | 1 | 0.778 |
PAK6 |
0.789 | 0.054 | -2 | 0.675 |
DNAPK |
0.789 | 0.051 | 1 | 0.698 |
MARK2 |
0.789 | 0.038 | 4 | 0.650 |
MNK1 |
0.789 | 0.055 | -2 | 0.740 |
CLK4 |
0.789 | 0.093 | -3 | 0.810 |
PRKX |
0.788 | 0.120 | -3 | 0.726 |
CAMK1G |
0.788 | 0.101 | -3 | 0.816 |
HIPK1 |
0.788 | 0.117 | 1 | 0.645 |
MEK1 |
0.788 | -0.035 | 2 | 0.842 |
CAMK1D |
0.788 | 0.126 | -3 | 0.743 |
MYLK4 |
0.788 | 0.064 | -2 | 0.722 |
MARK3 |
0.788 | 0.044 | 4 | 0.680 |
KIS |
0.787 | -0.021 | 1 | 0.619 |
PKCT |
0.787 | 0.116 | 2 | 0.714 |
CLK2 |
0.787 | 0.147 | -3 | 0.784 |
PLK4 |
0.787 | 0.037 | 2 | 0.636 |
CDK8 |
0.787 | -0.032 | 1 | 0.598 |
CLK1 |
0.787 | 0.101 | -3 | 0.782 |
VRK2 |
0.787 | -0.028 | 1 | 0.859 |
ALK2 |
0.787 | 0.023 | -2 | 0.825 |
PKACA |
0.787 | 0.111 | -2 | 0.561 |
YSK4 |
0.787 | -0.048 | 1 | 0.775 |
BRAF |
0.787 | 0.038 | -4 | 0.779 |
GRK4 |
0.786 | -0.128 | -2 | 0.798 |
SNRK |
0.786 | -0.006 | 2 | 0.695 |
PKCZ |
0.786 | 0.021 | 2 | 0.761 |
CDK18 |
0.786 | 0.019 | 1 | 0.522 |
HRI |
0.786 | -0.010 | -2 | 0.866 |
PERK |
0.786 | -0.003 | -2 | 0.871 |
MARK1 |
0.785 | 0.041 | 4 | 0.705 |
SSTK |
0.785 | 0.091 | 4 | 0.725 |
CDK7 |
0.785 | -0.016 | 1 | 0.596 |
ACVR2A |
0.785 | -0.003 | -2 | 0.833 |
AURA |
0.785 | 0.039 | -2 | 0.572 |
PLK3 |
0.785 | -0.019 | 2 | 0.740 |
CDK19 |
0.785 | -0.022 | 1 | 0.556 |
ACVR2B |
0.784 | -0.004 | -2 | 0.840 |
SGK1 |
0.784 | 0.219 | -3 | 0.682 |
SMMLCK |
0.784 | 0.109 | -3 | 0.869 |
DYRK1A |
0.784 | 0.074 | 1 | 0.669 |
PHKG2 |
0.783 | 0.078 | -3 | 0.826 |
MEKK1 |
0.783 | 0.011 | 1 | 0.814 |
AKT3 |
0.783 | 0.176 | -3 | 0.693 |
WNK4 |
0.783 | 0.058 | -2 | 0.786 |
MLK4 |
0.782 | -0.043 | 2 | 0.721 |
HIPK3 |
0.782 | 0.080 | 1 | 0.651 |
CHAK1 |
0.782 | -0.067 | 2 | 0.745 |
CDK13 |
0.781 | -0.026 | 1 | 0.570 |
DAPK3 |
0.781 | 0.152 | -3 | 0.841 |
CRIK |
0.781 | 0.365 | -3 | 0.769 |
ZAK |
0.781 | 0.001 | 1 | 0.791 |
DCAMKL2 |
0.780 | 0.062 | -3 | 0.831 |
IRAK4 |
0.780 | 0.045 | 1 | 0.798 |
GRK7 |
0.780 | -0.003 | 1 | 0.782 |
DYRK1B |
0.780 | 0.085 | 1 | 0.572 |
SMG1 |
0.780 | -0.068 | 1 | 0.760 |
TLK1 |
0.780 | 0.004 | -2 | 0.828 |
TLK2 |
0.780 | -0.065 | 1 | 0.794 |
CDK5 |
0.780 | 0.000 | 1 | 0.616 |
NEK5 |
0.780 | 0.011 | 1 | 0.835 |
P38A |
0.779 | -0.004 | 1 | 0.640 |
CAMKK1 |
0.779 | 0.048 | -2 | 0.826 |
MLK3 |
0.779 | -0.087 | 2 | 0.714 |
DYRK3 |
0.779 | 0.110 | 1 | 0.649 |
CAMKK2 |
0.779 | 0.073 | -2 | 0.813 |
CAMK1A |
0.779 | 0.124 | -3 | 0.709 |
JNK2 |
0.779 | 0.007 | 1 | 0.540 |
MPSK1 |
0.779 | 0.103 | 1 | 0.767 |
CDK9 |
0.779 | -0.014 | 1 | 0.581 |
DRAK1 |
0.778 | -0.026 | 1 | 0.757 |
HIPK2 |
0.778 | 0.057 | 1 | 0.527 |
JNK3 |
0.778 | -0.007 | 1 | 0.586 |
CHK2 |
0.777 | 0.107 | -3 | 0.691 |
PRP4 |
0.777 | 0.033 | -3 | 0.789 |
PKCI |
0.777 | 0.077 | 2 | 0.726 |
PKN1 |
0.777 | 0.104 | -3 | 0.790 |
DYRK4 |
0.777 | 0.058 | 1 | 0.545 |
CDK12 |
0.776 | -0.015 | 1 | 0.543 |
MEK5 |
0.776 | -0.073 | 2 | 0.820 |
MST3 |
0.775 | 0.048 | 2 | 0.795 |
P38B |
0.775 | -0.011 | 1 | 0.570 |
LKB1 |
0.775 | 0.071 | -3 | 0.877 |
CDK10 |
0.775 | 0.071 | 1 | 0.551 |
SBK |
0.775 | 0.109 | -3 | 0.633 |
CDK14 |
0.774 | 0.021 | 1 | 0.569 |
BMPR1A |
0.774 | 0.018 | 1 | 0.766 |
CDK17 |
0.774 | -0.009 | 1 | 0.468 |
MRCKA |
0.774 | 0.170 | -3 | 0.811 |
PAK5 |
0.773 | 0.037 | -2 | 0.608 |
MEKK6 |
0.772 | 0.102 | 1 | 0.795 |
CDK2 |
0.772 | -0.045 | 1 | 0.645 |
MEKK3 |
0.772 | -0.101 | 1 | 0.798 |
MRCKB |
0.772 | 0.157 | -3 | 0.796 |
CDK16 |
0.772 | 0.015 | 1 | 0.491 |
ERK2 |
0.772 | -0.031 | 1 | 0.601 |
PKCE |
0.771 | 0.084 | 2 | 0.679 |
ERK1 |
0.771 | -0.032 | 1 | 0.558 |
ROCK2 |
0.771 | 0.188 | -3 | 0.838 |
MEKK2 |
0.771 | -0.057 | 2 | 0.800 |
PASK |
0.770 | 0.016 | -3 | 0.894 |
DAPK1 |
0.770 | 0.108 | -3 | 0.832 |
TAO3 |
0.770 | -0.013 | 1 | 0.785 |
P38G |
0.769 | -0.017 | 1 | 0.459 |
CDK1 |
0.769 | -0.045 | 1 | 0.547 |
NEK4 |
0.769 | 0.040 | 1 | 0.788 |
IRAK1 |
0.769 | -0.079 | -1 | 0.683 |
PINK1 |
0.768 | -0.145 | 1 | 0.776 |
BUB1 |
0.768 | 0.094 | -5 | 0.593 |
TNIK |
0.768 | 0.076 | 3 | 0.813 |
TAO2 |
0.768 | 0.009 | 2 | 0.810 |
HGK |
0.767 | 0.043 | 3 | 0.813 |
NEK1 |
0.767 | 0.069 | 1 | 0.807 |
PDK1 |
0.766 | 0.019 | 1 | 0.824 |
PBK |
0.766 | 0.128 | 1 | 0.759 |
MINK |
0.766 | 0.050 | 1 | 0.790 |
NEK11 |
0.766 | -0.052 | 1 | 0.791 |
PAK4 |
0.766 | 0.029 | -2 | 0.611 |
GRK2 |
0.765 | -0.099 | -2 | 0.677 |
NEK3 |
0.765 | 0.096 | 1 | 0.773 |
EEF2K |
0.765 | 0.020 | 3 | 0.769 |
DMPK1 |
0.765 | 0.173 | -3 | 0.795 |
GAK |
0.765 | 0.009 | 1 | 0.826 |
NEK8 |
0.765 | -0.095 | 2 | 0.791 |
TTBK1 |
0.764 | -0.094 | 2 | 0.588 |
ERK7 |
0.764 | 0.027 | 2 | 0.546 |
MAP3K15 |
0.764 | 0.017 | 1 | 0.777 |
MOK |
0.764 | 0.128 | 1 | 0.667 |
MST2 |
0.764 | -0.057 | 1 | 0.805 |
P38D |
0.764 | -0.006 | 1 | 0.481 |
LOK |
0.763 | 0.056 | -2 | 0.755 |
CDK3 |
0.763 | -0.013 | 1 | 0.487 |
GCK |
0.762 | 0.015 | 1 | 0.783 |
ROCK1 |
0.762 | 0.184 | -3 | 0.810 |
LRRK2 |
0.762 | 0.011 | 2 | 0.819 |
MAK |
0.761 | 0.082 | -2 | 0.640 |
MEK2 |
0.761 | -0.030 | 2 | 0.822 |
YSK1 |
0.760 | 0.059 | 2 | 0.788 |
PKG1 |
0.760 | 0.059 | -2 | 0.534 |
TAK1 |
0.759 | -0.057 | 1 | 0.835 |
HPK1 |
0.759 | 0.027 | 1 | 0.760 |
CK1E |
0.759 | -0.045 | -3 | 0.554 |
KHS1 |
0.759 | 0.059 | 1 | 0.772 |
CK2A2 |
0.759 | 0.004 | 1 | 0.675 |
CDK4 |
0.758 | 0.013 | 1 | 0.528 |
MST1 |
0.758 | -0.030 | 1 | 0.787 |
GSK3B |
0.757 | -0.073 | 4 | 0.328 |
VRK1 |
0.756 | -0.051 | 2 | 0.800 |
KHS2 |
0.756 | 0.070 | 1 | 0.773 |
CDK6 |
0.755 | -0.005 | 1 | 0.549 |
RIPK2 |
0.753 | -0.123 | 1 | 0.755 |
BIKE |
0.753 | 0.087 | 1 | 0.711 |
PLK2 |
0.753 | -0.059 | -3 | 0.740 |
CK1G1 |
0.753 | -0.053 | -3 | 0.537 |
TTK |
0.752 | 0.051 | -2 | 0.845 |
CK1D |
0.751 | -0.048 | -3 | 0.508 |
GSK3A |
0.751 | -0.066 | 4 | 0.337 |
OSR1 |
0.751 | 0.014 | 2 | 0.813 |
JNK1 |
0.750 | -0.041 | 1 | 0.530 |
STK33 |
0.750 | -0.087 | 2 | 0.589 |
GRK3 |
0.749 | -0.106 | -2 | 0.626 |
SLK |
0.748 | -0.058 | -2 | 0.692 |
CK1A2 |
0.748 | -0.045 | -3 | 0.508 |
PDHK3_TYR |
0.748 | 0.092 | 4 | 0.821 |
HASPIN |
0.745 | 0.037 | -1 | 0.686 |
MYO3B |
0.745 | 0.018 | 2 | 0.794 |
CK2A1 |
0.745 | -0.026 | 1 | 0.645 |
AAK1 |
0.744 | 0.117 | 1 | 0.602 |
LIMK2_TYR |
0.743 | 0.154 | -3 | 0.923 |
PKMYT1_TYR |
0.743 | 0.123 | 3 | 0.811 |
ASK1 |
0.742 | -0.017 | 1 | 0.767 |
TESK1_TYR |
0.742 | 0.055 | 3 | 0.835 |
EPHA6 |
0.741 | 0.114 | -1 | 0.795 |
MAP2K4_TYR |
0.741 | 0.019 | -1 | 0.833 |
TAO1 |
0.739 | -0.020 | 1 | 0.728 |
PINK1_TYR |
0.738 | 0.032 | 1 | 0.835 |
MYO3A |
0.737 | -0.020 | 1 | 0.759 |
MAP2K7_TYR |
0.737 | -0.043 | 2 | 0.831 |
MAP2K6_TYR |
0.736 | -0.043 | -1 | 0.826 |
PDHK4_TYR |
0.736 | -0.033 | 2 | 0.852 |
STLK3 |
0.735 | -0.040 | 1 | 0.752 |
RET |
0.735 | 0.046 | 1 | 0.815 |
ALPHAK3 |
0.735 | -0.024 | -1 | 0.732 |
EPHB4 |
0.734 | 0.039 | -1 | 0.776 |
MST1R |
0.734 | 0.024 | 3 | 0.799 |
TYK2 |
0.734 | -0.008 | 1 | 0.822 |
LIMK1_TYR |
0.734 | 0.022 | 2 | 0.823 |
ABL2 |
0.733 | 0.062 | -1 | 0.771 |
ROS1 |
0.733 | 0.018 | 3 | 0.746 |
BMPR2_TYR |
0.733 | -0.050 | -1 | 0.817 |
DDR1 |
0.732 | 0.031 | 4 | 0.761 |
PDHK1_TYR |
0.731 | -0.096 | -1 | 0.830 |
YANK3 |
0.730 | -0.047 | 2 | 0.362 |
JAK2 |
0.729 | -0.032 | 1 | 0.818 |
TNK2 |
0.729 | 0.066 | 3 | 0.766 |
JAK3 |
0.729 | 0.005 | 1 | 0.806 |
TYRO3 |
0.729 | -0.013 | 3 | 0.775 |
ABL1 |
0.729 | 0.054 | -1 | 0.762 |
TNNI3K_TYR |
0.729 | 0.075 | 1 | 0.832 |
CSF1R |
0.728 | -0.035 | 3 | 0.782 |
PDGFRB |
0.725 | 0.022 | 3 | 0.788 |
EPHB3 |
0.725 | 0.003 | -1 | 0.759 |
JAK1 |
0.725 | 0.025 | 1 | 0.772 |
FGR |
0.725 | -0.041 | 1 | 0.864 |
FER |
0.724 | -0.071 | 1 | 0.885 |
INSRR |
0.724 | -0.016 | 3 | 0.719 |
FLT3 |
0.723 | 0.010 | 3 | 0.775 |
AXL |
0.722 | 0.013 | 3 | 0.769 |
EPHA4 |
0.722 | -0.028 | 2 | 0.725 |
YES1 |
0.722 | -0.038 | -1 | 0.759 |
EPHB1 |
0.722 | -0.035 | 1 | 0.859 |
EPHB2 |
0.721 | -0.015 | -1 | 0.756 |
NEK10_TYR |
0.721 | 0.013 | 1 | 0.679 |
TNK1 |
0.721 | 0.014 | 3 | 0.751 |
TXK |
0.721 | -0.015 | 1 | 0.828 |
TEK |
0.721 | -0.010 | 3 | 0.710 |
SRMS |
0.720 | -0.053 | 1 | 0.864 |
FGFR1 |
0.720 | -0.012 | 3 | 0.756 |
FGFR2 |
0.720 | -0.030 | 3 | 0.768 |
PDGFRA |
0.720 | -0.027 | 3 | 0.784 |
LCK |
0.720 | -0.018 | -1 | 0.743 |
KDR |
0.719 | -0.005 | 3 | 0.743 |
KIT |
0.719 | -0.061 | 3 | 0.781 |
EPHA1 |
0.719 | 0.019 | 3 | 0.770 |
HCK |
0.719 | -0.082 | -1 | 0.739 |
BLK |
0.718 | 0.001 | -1 | 0.749 |
TEC |
0.718 | -0.016 | -1 | 0.671 |
DDR2 |
0.718 | 0.080 | 3 | 0.723 |
ITK |
0.717 | -0.048 | -1 | 0.717 |
MERTK |
0.717 | -0.028 | 3 | 0.761 |
LTK |
0.716 | -0.013 | 3 | 0.728 |
EPHA7 |
0.716 | -0.014 | 2 | 0.733 |
MET |
0.716 | -0.037 | 3 | 0.783 |
ALK |
0.715 | -0.037 | 3 | 0.711 |
EPHA3 |
0.715 | -0.052 | 2 | 0.709 |
NTRK1 |
0.714 | -0.071 | -1 | 0.779 |
BMX |
0.713 | -0.037 | -1 | 0.671 |
BTK |
0.711 | -0.114 | -1 | 0.688 |
NTRK2 |
0.711 | -0.068 | 3 | 0.735 |
PTK6 |
0.711 | -0.113 | -1 | 0.680 |
PTK2B |
0.710 | -0.004 | -1 | 0.714 |
FLT4 |
0.710 | -0.056 | 3 | 0.714 |
EPHA5 |
0.710 | -0.025 | 2 | 0.719 |
FRK |
0.709 | -0.065 | -1 | 0.763 |
NTRK3 |
0.708 | -0.065 | -1 | 0.750 |
INSR |
0.708 | -0.071 | 3 | 0.697 |
FGFR3 |
0.708 | -0.065 | 3 | 0.739 |
FLT1 |
0.708 | -0.076 | -1 | 0.778 |
ERBB2 |
0.708 | -0.097 | 1 | 0.798 |
CK1A |
0.706 | -0.097 | -3 | 0.412 |
WEE1_TYR |
0.705 | -0.086 | -1 | 0.714 |
EPHA8 |
0.704 | -0.060 | -1 | 0.748 |
MATK |
0.704 | -0.064 | -1 | 0.727 |
LYN |
0.703 | -0.101 | 3 | 0.696 |
FYN |
0.703 | -0.072 | -1 | 0.719 |
EGFR |
0.701 | -0.057 | 1 | 0.725 |
MUSK |
0.699 | -0.058 | 1 | 0.704 |
SRC |
0.696 | -0.103 | -1 | 0.728 |
EPHA2 |
0.694 | -0.063 | -1 | 0.722 |
YANK2 |
0.694 | -0.077 | 2 | 0.377 |
FGFR4 |
0.694 | -0.088 | -1 | 0.736 |
CSK |
0.693 | -0.137 | 2 | 0.742 |
IGF1R |
0.692 | -0.089 | 3 | 0.632 |
PTK2 |
0.690 | -0.069 | -1 | 0.696 |
CK1G3 |
0.690 | -0.088 | -3 | 0.363 |
SYK |
0.690 | -0.076 | -1 | 0.716 |
ERBB4 |
0.684 | -0.068 | 1 | 0.733 |
FES |
0.680 | -0.098 | -1 | 0.658 |
ZAP70 |
0.670 | -0.060 | -1 | 0.664 |
CK1G2 |
0.667 | -0.110 | -3 | 0.456 |